Winning the Patent Damages Case
More Praise for the First Edition “Richard Cauley has artfully laid out a precise roa...
31 downloads
753 Views
584KB Size
Report
This content was uploaded by our users and we assume good faith they have the permission to share this book. If you own the copyright to this book and it is wrongfully on our website, we offer a simple DMCA procedure to remove your content from our site. Start by pressing the button below!
Report copyright / DMCA form
Winning the Patent Damages Case
More Praise for the First Edition “Richard Cauley has artfully laid out a precise road map for the practitioner to understand, discover, prove-up and win a damages case . . . a must for every law library.” —Terrence P. McMahon Head of Global Intellectual Property, Media & Technology McDermott Will & Emery LLP “I have never seen in one place such a complete exposition of the case law pertaining to the economic aspects of reasonable royalties. Richard Cauley provides constructive insight for anyone who undertakes patent valuations, both within and outside of litigation.” —Jesse David Vice President, NERA Economic Consulting
Winning the Patent Damages Case A Litigator’s Guide to Economic Models and Other Damage Strategies
Second Edition Richard F. Cauley
1
1 Oxford University Press, Inc., publishes works that further Oxford University’s objective of excellence in research, scholarship, and education. Oxford New York Auckland Cape Town Dar es Salaam Hong Kong Karachi Kuala Lumpur Mexico City Nairobi New Delhi Shanghai Taipei Toronto
Madrid
Melbourne
With offi ces in Argentina Austria Brazil Chile Czech Republic France Greece Guatemala Hungary Italy Japan Poland Portugal Singapore South Korea Switzerland Th ailand Turkey Ukraine Vietnam
Copyright © 2011 by Oxford University Press, Inc. Published by Oxford University Press, Inc. 198 Madison Avenue, New York, New York 10016 Oxford is a registered trademark of Oxford University Press Oxford University Press is a registered trademark of Oxford University Press, Inc. All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise, without the prior permission of Oxford University Press, Inc. _____________________________________________ Library of Congress Cataloging-in-Publication Data Cauley, Richard F. Winning the patent damages case : a litigator’s guide to economic models and other damage strategies / Richard F. Cauley. — 2nd ed. p. cm. Includes bibliographical references and index. ISBN 978-0-19-976756-4 ((pbk.) : alk. paper) 1. Patent infringement—United States—Trial practice. 2. Patent suits—United States—Trial practice. 3. Lost profits damages—United States—Trial practice. I. Title. KF3155.C38 2011 346.7304’860269--dc22 2010045375 _____________________________________________ 1 2 3 4 5 6 7 8 9 Printed in the United States of America on acid-free paper Note to Readers This publication is designed to provide accurate and authoritative information in regard to the subject matter covered. It is based upon sources believed to be accurate and reliable and is intended to be current as of the time it was written. It is sold with the understanding that the publisher is not engaged in rendering legal, accounting, or other professional services. If legal advice or other expert assistance is required, the services of a competent professional person should be sought. Also, to confirm that the information has not been affected or changed by recent developments, traditional legal research techniques should be used, including checking primary sources where appropriate.
(Based on the Declaration of Principles jointly adopted by a Committee of the American Bar Association and a Committee of Publishers and Associations.)
You may order this or any other Oxford University Press publication by visiting the Oxford University Press website at www.oup.com
For Maureen, Elizabeth and Michael
This page intentionally left blank
Contents
INTRODUCTION
SECTION I:
xiii
Background and Initial Considerations of the Patent Damages Case
1
CHAPTER 1: Winning the Reasonable Royalty Case
3
CHAPTER 2: Introducing the Combatants
15
CHAPTER 3: Stranger Than Fiction: Imagining the
SECTION II:
Hypothetical Negotiation
23
A Strategic Look at the Georgia-Pacific Factors
33
CHAPTER 4: Finding the Price of the Patent: Is There
an Established Royalty?
35
CHAPTER 5: Gauging the Infringer’s Price Range:
Licensing-In Practices
59
CHAPTER 6: Keeping it Exclusive: How Valuable
Is That License?
67
CHAPTER 7: Keeping It to Yourself: The Hypothetical
Negotiation Where the Seller Does Not Want to Sell
75
CHAPTER 8: Selling Your Enemy the Stick to Beat You
with: The Hypothetical Negotiation Where the Plaintiff and Defendant Compete
83
CHAPTER 9: Boosting the Royalty Rate with Unpatented
Products: Mercy Sakes Alive! Looks Like We Got Us a Convoy!
91
CHAPTER 10: How Much Time is Left? The Effect of
an Expiring Patent
97
viii
Contents CHAPTER 11: Buy My Product, Buy My Patent! How
the Success of a Patentholder’s (or Even an Infringer’s) Product Can Raise the Royalty Rate
99
CHAPTER 12: Why New and Improved Costs More
Than the Old Stuff: The Better Your Invention, the Higher the Royalty Rate
105
CHAPTER 13: The Smaller the Bang, the Smaller the
Bucks: Allocating the Value of the Patented Component
SECTION III:
111
Winning The Lost-Profits Case
123
CHAPTER 14: The Theory of Lost Profits
125
CHAPTER 15: Market Players
137
CHAPTER 16: Working the Hypothetical Work-Around:
Alternative Non-Infringing Substitutes
145
CHAPTER 17: Lost Profits on Unpatented Products and
Components: The Entire Market Value Rule
153
CHAPTER 18: Recovering Profits Lost by Price Erosion:
Paying Attention to the Demand Curve
161
TABLE OF CASES
167
INDEX
169
Detailed Contents
INTRODUCTION
SECTION I:
Background and Initial Considerations of the Patent Damages Case
CHAPTER 1: Winning the Reasonable Royalty Case 1.01 The Brief Early History of the Reasonable Royalty Remedy [A] The Pre-codified Reasonable Royalty Remedy 1.02 The Modern Era of Reasonable Royalty Begins: Georgia-Pacific [A] List of Factors [B] Consideration of Rigorous Economic Analysis CHAPTER 2: Introducing the Combatants 2.01 The Plaintiff: Six Category Types [A] The Dominant Competitor [B] The Minor Competitor [C] Non-Producing Entities [D] Universities [E] Patent Trolls [F] Individuals 2.02 The Defendant
xiii
1 3 3 3 6 9 12 15 15 16 17 18 19 20 20 21
CHAPTER 3: Stranger Than Fiction: Imagining the
Hypothetical Negotiation
23
3.01 Applying Game Theory to Hypothetical Negotiation [A] A Zero-Sum Game
26 26 27 27 27 27 28 29 30 31
[B] Perfect Exchange of Information [C] You Can’t Walk Away [D] Date of Infringement [E] Assumption of Validity 3.02 Determining the Reasonable Royalty Value [A] Game Theory and the Lemney/Shapiro Analysis [B] Injunctions [C] Two More Variables
x
Detailed Contents SECTION II:
A Strategic Look at the Georgia-Pacific Factors
33
CHAPTER 4: Finding the Price of the Patent: Is There
an Established Royalty?
35
4.01 Relevance and Application 4.02 Economic Criteria
36 37 38 38 38
[A] License Rates Must be Uniform, Timely, and Reliable [B] Time Constraints [C] Can Litigation-Related Licenses Be Used? [D] Example 4.03 The Defendant’s “Established Royalty” Strategy [A] Uniform Royalties and Licensing Rates [B] Market Rate as a Ceiling for Royalty Rate 4.04 The Plaintiff ’s “Established Royalty” Strategy: Considerations [A] Are There Enough Licenses to Establish a Price? [B] Patent-in-Suit [C] Time Period of License [D] Example Case: Monsanto Co v. McFarling [E] Lump-Sum and Paid-Up Royalties [F] Effects on Royalty of Widespread Infringement 4.05 Analysis 4.06 Discovery [A] Obtain Licensing Materials [B] Know the Patent’s Utility [C] Economic/Market Models [D] Using Your Expert and Attacking Your Opponent’s [E] Particular Issues Where Plaintiff Is an NPE
39
40 41 41 42 42 42 43 44 46 48 49 53 54 54 55 56 57
CHAPTER 5: Gauging the Infringer’s Price Range:
Licensing-In Practices
59
5.01 Relevance and Application
59 62 63 63 63 63 64
5.02 Analysis [A] Determining the Type of Patented Technology [1] Core Technology [2] Peripheral Technology [B] Is the Patented Technology Essential to the Product? [C] Defendant’s Strategy 5.03 Discovery and Using Your Expert (and Attacking Your Opponent’s) CHAPTER 6: Keeping it Exclusive: How Valuable Is That License? 6.01 Relevance and Application 6.02 Analysis [A] Who Makes (and How to Make) the Exclusive License Argument [B] Defendant’s Strategy
65 67 67 69 70 71
Detailed Contents 6.03 Discovery [A] Use Your Economic Experts [B] If the Plaintiff Is an NPE
72 73 73
CHAPTER 7: Keeping It to Yourself: The Hypothetical Negotiation
Where the Seller Does Not Want to Sell
75
7.01 Relevance and Application
75 76 77 79 80
[A] Sample Scenario: Tiny Motors Corporation [B] Establishing Historical Practices 7.02 Analysis 7.03 Discovery and Using Your Experts CHAPTER 8: Selling Your Enemy the Stick to Beat You with:
The Hypothetical Negotiation Where the Plaintiff and Defendant Compete 8.01 Relevance and Application 8.02 Analysis 8.03 Discovery and Using Your Experts
83 83 86 89
CHAPTER 9: Boosting the Royalty Rate with Unpatented
Products: Mercy Sakes Alive! Looks Like We Got Us A Convoy! 9.01 Relevance and Application 9.02 Analysis [A] Plaintiff ’s Considerations [B] Defendant’s Perspective 9.03 Discovery and Using Your Experts
91 91 94 94 95 95
CHAPTER 10: How Much Time is Left? The Effect of an
Expiring Patent
97
10.01 Relevance and Application 10.02 Discovery
97 98
CHAPTER 11: Buy My Product, Buy My Patent! How the Success
of a Patentholder’s (or Even an Infringer’s) Product Can Raise the Royalty Rate 11.01 Relevance and Application 11.02 Discovery
99 99 102
CHAPTER 12: Why New and Improved Costs More Than the
Old Stuff: The Better Your Invention, the Higher the Royalty Rate 12.01 Relevance and Application 12.02 Analysis 12.03 Discovery
105 105 107 108
xi
xii
Detailed Contents CHAPTER 13: The Smaller the Bang, the Smaller the Bucks: Allocating
the Value of the Patented Component
111
13.01 Relevance and Application
111 114 121 121
13.02 New Developments for the Entire Market Value Rule 13.03 Analysis 13.04 Discovery
SECTION III:
Winning the Lost-Profits Case
CHAPTER 14: The Theory of Lost Profits 14.01 The Panduit Factors 14.02 The Demand Factor 14.03 Competition Between the Plaintiff and the Defendant and the Defining Market: The Battle of the Flying Bikes 14.04 Analysis 14.05 Discovery CHAPTER 15: Market Players 15.01 How Many Players are in the Market? And Why Does it Matter? 15.02 Analysis
123 125 127 128 129 132 134 137 137 142
CHAPTER 16: Working the Hypothetical Work-Around: Alternative
Non-Infringing Substitutes
145
16.01 Analysis 16.02 Discovery
149 150
CHAPTER 17: Lost Profits on Unpatented Products and
Components: The Entire Market Value Rule
153
17.01 Analysis 17.02 Discovery
157 159
CHAPTER 18: Recovering Profits Lost by Price Erosion: Paying
Attention to the Demand Curve
161
18.01 Analysis 18.02 Discovery
164 165
TABLE OF CASES
167
INDEX
169
Introduction
Patent litigation is obviously an expensive exercise. For a defendant, being sued for patent infringement can be deadly. An accused infringer is faced with the prospect of massive legal fees, the possibility of a crippling injunction, and the spectre of a huge damages award. For a defendant, any patent infringement complaint is a potential death sentence. Indeed, in 2010, the total of just the top three damages verdicts totaled over $2 billion. On the other side of the table, for a patentholder, especially one who relies on its patented technology to compete in the marketplace, the experience of watching its rival use the technology it developed and patented to take over the market can be excruciating. For many, bringing a lawsuit to recover for such infringement may be the only way that company can get back in the game. Thus, you would think that once the litigation begins the attorneys would bend every effort to maximizing the recovery on the plaintiff’s side and minimizing the risk of loss for the defendant. No stone would be unturned. No detail would be ignored. The firm’s top talent would be devoted to wringing the last penny out of the defendant or slicing and dicing the plaintiff ’s claim for lost profits. You would be wrong. Once a patent case begins, the engineers and scientists take over. Preparation for Markman hearings and the endless search for the elusive “killer” prior art pushes every other concern out of the way—until the last minute. The damages the plaintiff may be entitled to and the potentially devastating financial consequences to the defendant are often given little priority. Opportunities to use sophisticated economic analysis and creative discovery are passed up and the damages case is often just turned over to the accountants. The result: a massive damages award which the defendant could have reduced or a substantial verdict for the plaintiff which does not hold up on appeal. This does not have to happen. Properly employed, the tools of economic analysis provided by the courts can often make a substantial difference in the outcome of a lawsuit. These economic principles are not difficult to understand, apply, or explain to a jury. What is critical, however, is that the economic underpinnings of a patent
xiii
xiv
Introduction
case be thought through and the principles applied from the very beginning of the lawsuit. The collection of documents and economic information from your own client and from the other side in discovery must be done early and pursued throughout the case. There is one issue, however, which will not be covered here because it is contrary to the stated purpose of this work, the proper employment of economic analysis in patent litigation. It is the so-called “Rule of Thumb,” which purportedly holds that a “reasonable royalty” for patent infringement is one-quarter of the defendant’s profits on the infringing product. Although this “model” has, in fact, been used by courts and juries to award damages in patent cases, it has so little worth as an economic tool and so little support in the case law that it simply has no place here. In the face of the Federal Circuit’s instruction to employ rigorous economic analysis in patent damages calculation, this “thumbbased” model should simply be discarded. I encourage parties and litigants alike to employ this work as a tool to understand the creative use of economic analysis in presenting a winning damages cases.
SECTION
I Background and Initial Considerations of the Patent Damages Case
This page intentionally left blank
CHAP T ER
1 Winning the Reasonable Royalty Case
1.01 The Brief Early History of the Reasonable Royalty Remedy [A] The Pre-codified Reasonable Royalty Remedy 1.02 The Modern Era of Reasonable Royalty Begins: Georgia-Pacific [A] List of Factors
3 3 6 9
[B] Consideration of Rigorous Economic Analysis
12
1.01 The Brief Early History of the Reasonable Royalty Remedy [A] The Pre-codified Reasonable Royalty Remedy The reasonable royalty remedy is the most democratic of patent damages awards. It is available to every patentholder as a minimum, whether or not the patentholder can prove any actual competitive injury as a result of the defendant’s infringement. A plaintiff can collect a reasonable royalty even if it has never used its patent in its business or even had a business at all. As the Supreme Court noted in Aro Mfg. Co. v. Convertible Top Replacement Co., 377 U.S. 476, 507 (1964), in a patent infringement action, a plaintiff can recover, as damages, “the difference between his pecuniary condition after the infringement, and what his condition would have been if the infringement had not occurred.” As the Supreme Court observed, the question to be asked in determining damages is “how much had the Patent Holder and Licensee suffered by the infringement. And that question [is] primarily: had the Infringer not infringed, what would Patent Holder-Licensee have made?” When a plaintiff cannot show that the defendant’s infringement caused it to lose profits, either through lost sales or having to lower its prices, the plaintiff will at least be able to show that its right to exclude others from practicing its invention was violated. The “damages,” therefore, are measured by the amount the plaintiff could have charged the defendant to license the 3
4
Chapter 1 Winning the Reasonable Royalty Case
patent—money that was lost because the defendant chose to infringe instead of taking a license. Since the reasonable royalty remedy came into full flower in 1970, with the landmark Georgia-Pacific decision, proper application of this remedy has often fallen by the wayside. Damages are often calculated mechanically, with little or no economic analysis, and are often imposed on the basis of rules of thumb that have little or no relationship to the parties, to the patent, to the technology, or to the marketplace. While often the most useful—and sometimes the only—remedy for patent infringement, it is also the most abused and neglected remedy. To win its reasonable royalty case—and to make sure that any award stands up to posttrial motions and on appeal—each party must dig deep into the economic underpinnings of the reasonable royalty analysis and understand how the pieces of this analysis fit together. The hypothetical negotiation methodology that forms the basis of modern reasonable royalty analysis provides myriad opportunities for each side to maximize its leverage in increasing or decreasing the eventual award. For a remedy that has virtually universal application, its history is remarkably sparse. Indeed, the remedy seems to have initially been virtually an afterthought—one that the courts came up with when the plaintiff was unable to show more than nominal real damages and was unable, for either evidentiary or procedural reasons, to show that the defendant had profited from infringement of the patent. The courts believed that such a plaintiff deserved some remedy for the defendant’s infringement and decided that the patentholder was at least entitled to a royalty as compensation for the defendant’s use of its valuable invention. Originally, awarding damages in patent cases was complicated by the requirement that the patent plaintiff decide whether it would pursue the infringement action in law or in equity. If the plaintiff brought an action in law, it would be able to collect damages—the amount of the injury—from the defendant. If, on the other hand, the plaintiff chose to pursue an action in equity against the defendant, it would be able to obtain an injunction and the defendant’s profits—which were deemed to be held “in trust” for the plaintiff. In an action in law, one measure of damages was an established royalty— the amount for which the plaintiff could have licensed the patent with proof that it had actually licensed the patent and had obtained royalties. However, since, as discussed below, an established royalty is often difficult to prove, the courts were often stuck as to how to properly compensate a plaintiff for the infringement of its patent. The Supreme Court was presented with this quandary in Suffolk Mfg. Co. v. Hayden, 70 U.S. 315, 320 (1866), which admitted that the question of damages “is always attended with difficulty and embarrassment both to the court and jury.” There being no established license fee, the court was forced
The Brief Early History of the Reasonable Royalty Remedy
to resort to “general evidence” to determine damages, including “the utility and advantage of the invention over the old modes or devices that had been used for working out similar results,” the “benefits to the persons who have used the invention, and the extent of the use by the infringer.” The court determined that this information would provide enough information to the jury to “enable them, in the exercise of a sound judgment, to ascertain the damages, or, in other words, the loss to the patentee or owner, by the piracy, instead of the purchase of the use of the invention.” This decision, however, obviously gave little guidance to the courts as to the actual procedure a court or jury should follow in awarding damages to a plaintiff that was unable to demonstrate any competitive injury or show that there was an already established royalty for its patent. In 1894, however, the Ninth Circuit lit upon a solution in Hunt Bros. Fruit-Packing Co. v. Cassiday, 64 F. 585, 587 (9th Cir. 1894): “Where damages cannot be assessed upon the basis of a royalty, nor on that of lost sales, nor on that of hurtful competition, the proper method of assessing them is to ascertain what would have been a reasonable royalty for the infringer to have paid.” Although the court did not lay out a mechanism for calculating such a royalty or determining its reasonableness, the court held that, in that case, the patentholder’s estimate of what would be a reasonable royalty was sufficient to support the jury’s verdict, as such opinion was based on “figures and estimates”—“the cost of manufacture, the selling price, so far as he had sold, the profit, and his estimate of the proportion of the profit that should be attributable to the infringed invention.” This approach was finally adopted by the Supreme Court in Dowagiac Mfg. Co. v. Minnesota Moline Plow Co., 235 U.S. 641, 648 (1914), the Court finding that “it was permissible to show the value [of the patent] by proving what would have been a reasonable royalty, considering the nature of the invention, its utility and advantages, and the extent of the use involved. Not improbably such proof was more difficult to produce, but it was quite as admissible as that of an established royalty.” After Dowagiac, the courts continued to award damages in the form of a reasonable royalty where no other remedy was available. Where the courts were unable to determine an established royalty for the patent, they would estimate what royalty the plaintiff and defendant would have agreed to, assuming a willing buyer and willing seller. As the Sixth Circuit noted in Horvath v. McCord Radiator & Mfg. Co., 100 F.2d 326, 335–36 (6th Cir. 1938), “In fixing damages on a royalty basis against an infringer, the sum allowed should be reasonable and that which would be accepted by a prudent licensee who wished to obtain a license but was not so compelled and a prudent patentee, who wished to grant a license but was not so compelled. In other words, the sum allowed should be that amount which a person desiring to use a patented machine and sell its product at a reasonable profit would be willing to pay.”
5
6
Chapter 1 Winning the Reasonable Royalty Case
By 1946, the right to a reasonable royalty was formally engrained in the Patent Act, with the statute providing that “upon finding for the claimant the court shall award the claimant damages adequate to compensate for the infringement, but in no event less than a reasonable royalty for the use made of the invention by the infringer, together with interest and costs as fixed by the court.” The courts continued to wrestle, however, with the procedure to be used in determining a reasonable royalty and the evidence to be employed. Judge Lindley, in Activated Sludge, Inc. v. Sanitary Dist. of Chicago, 64 F. Supp. 25, 36 (N.D. Ill. 1946), set forth the factors he considered: “[I]n arriving at my award I have had in mind the proof as to all factors proper for consideration, including the utility, practicability and advantages of the patents, the population served, the cost of the infringing plants, the fact that substantial savings accrued to defendants from the infringing use of the patented process, the fact that plaintiffs granted licenses to others at certain figures, that offers to license defendant at certain figures were made, the facts as to settlements made with other infringers, the circumstances under which they were made, the testimony as to a reasonable royalty and all other relevant and pertinent circumstances appearing in the record.” Likewise, the special master in Hartford Nat’l Bank & Trust Co. v. E. F. Drew & Co., 188 F. Supp. 353, 359 (D. Del. 1960), took a number of economic factors into account: “This Circuit in defining a reasonable royalty to be an established royalty, as the amount which an infringing party using another’s patent must pay, did not exclude, I think, consideration of all other factors, including the tort-feasor’s profits, in arriving at the patent owner’s damages. For example, the nature of the invention, its utility, its novelty over and advance in the art, and the extent of its use by the infringer are all entitled to judicial consideration. Damages may be measured by the defendant’s gain or the plaintiff ’s loss. Yet, no matter how measured, it can never be less than a reasonable royalty—and, there must be the factor of the infringer’s profits to be considered as one of the elements of measurement.” However, it was not until 1965, with the decision in Georgia-Pacific Corp. v. United States Plywood Corp., 318 F. Supp. 1116 (S.D.N.Y. 1970), that the factors that should be taken into account in a reasonable royalty analysis were finally virtually codified in a form that the courts have used for the past forty years.
1.02 The Modern Era of Reasonable Royalty Begins: Georgia-Pacific The modern era of patent damages began in 1955, when the management of the Georgia-Pacific Plywood Company decided to begin manufacturing
The Modern Era of Reasonable Royalty Begins: Georgia-Pacific 7
a highly decorative type of plywood, with a “multiplicity” of grooves parallel to the grain of the wood. Management of the United States Plywood Corporation, who had obtained a patent on just this type of plywood thirteen years earlier, took exception to these activities and notified Georgia-Pacific that this product was covered by its patent. Georgia-Pacific filed a declaratory relief action, U.S. Plywood counterclaimed, and fifteen years later the most influential decision in patent damages law was issued. The Georgia-Pacific decision is a particularly appropriate place to begin a survey of the law of patent damages. Not only is it the touchstone of modern reasonable royalty analysis, but it highlights most of the important issues in patent damages law that continue to be debated almost forty years later. The litigation arose out of Georgia-Pacific’s alleged infringement of three patents held by U.S. Plywood, the only one of relevance being a patent issued in 1942 to Donald Deskey. This patent covered a plywood panel whose surface was covered with grooves parallel to the grain of the wood. This treatment, known as “striation,” was not only highly decorative but also served to prevent warping of the wood. U.S. Plywood sold products covered by this patent under the name “Weldtex,” and these products proved extremely popular. Even though, for reasons that are not explained, U.S. Plywood did not make a claim for willful infringement, Georgia-Pacific’s infringement of the Deskey patent was quite deliberate. Not only was the company aware of the Deskey patent and its scope, it consulted its counsel as to the danger the patent posed to its prospective product offerings and received an opinion that there was a substantial risk that the company would be sued for infringement. Georgia-Pacific, however, was highly motivated to enter the market because, as its lab chief admitted, the manufacture of this product was “extremely advantageous from a profit standpoint.” Georgia-Pacific relied on its counsel’s opinion that, although its product might infringe, the patent was invalid. It started manufacturing its product in February 1955 and delivered a sample to U.S. Plywood in March. Almost immediately thereafter, Georgia-Pacific’s president Owen Cheatham received a letter from U.S. Plywood noting that, although “imitation is supposed to be the sincerest form of flattery, I must confess to a different reaction when I learned that you are imitating Weldtex.” U.S. Plywood threatened “vigorous action” to enforce its patent rights and stated that it would turn the matter over to its attorneys “for appropriate action.” Based on this letter, Georgia-Pacific sued for declaratory judgment. At the time Georgia-Pacific started selling its product, U.S. Plywood’s striated plywood product was without substantial competition. Although it had been selling this product since 1946, no other company had posed a competitive threat, and U.S. Plywood was able to keep its prices for its Weldtex products high. Given the lucrative opportunities presented, the temptation for GeorgiaPacific to enter the market, even if it were sued, was too hard to resist.
8
Chapter 1 Winning the Reasonable Royalty Case
Litigation ensued almost immediately, with Georgia-Pacific simultaneously reaping huge profits from its sale of its striated plywood products. Indeed, the company was barely able to keep up with demand. Georgia-Pacific’s calculated risk initially appeared to have been a good one; in 1956, Judge Herlands of the Southern District of New York held all three U.S. Plywood patents invalid. Judge Herlands noted the acquiescence of virtually the entire plywood industry in respecting U.S. Plywood’s monopoly but discounted it, noting that the resources necessary to challenge even a “spurious” patent are more than most companies can bear. Georgia-Pacific, however, was less successful in the Second Circuit. That court held in 1958 that claim 1 of the Deskey patent was valid and infringed. The case then returned to the district court, where the court expended the next twelve years in determining the damages U.S. Plywood had suffered by Georgia-Pacific’s infringing sales from 1955 through 1958. The case was initially referred to a special master in April 1959. After a year of discovery, six days of hearing in Portland, Oregon, and a trip to U.S. Plywood’s factory in Washington, the special master issued his report in December 1961, awarding U.S. Plywood the profits earned by GeorgiaPacific on the infringing product. In January 1962, the parties filed objections to this report with Judge Herlands. Over two years later, in April 1964, Judge Herlands apparently held the first hearing on these objections and, in June 1965, issued his opinion. This opinion, based on the Supreme Court’s decision in Aro Mfg. Co. v. Convertible Top Replacement Co., which placed the focus in a patent infringement case on what the patentholder lost rather than on what the infringer gained, required, in Judge Herlands’s opinion, overturning the special master’s opinion and instituting a new inquiry as to a reasonable royalty for the Deskey patent. Five more years passed. Judge Herlands held thirteen more days of hearing on the issue of reasonable royalty during 1967, 1968, and 1969, and the parties filed five more sets of briefs. Finally, after presiding over the case for thirteen years and after apparently drafting a comprehensive opinion, Judge Herlands died without ever having ruled on the issue of reasonable royalty. Judge Tenney, future chief judge of the district, was handed the case and, after obtaining the stipulation of all parties that he could freely draw upon the notes, memoranda, and draft opinion of Judge Herlands, finally issued his opinion in May 1970, fourteen years after the suit had been brought. However, it is clear that Judges Herlands and Tenney did not simply draw on a “conspectus of the leading cases” to determine the factors that are most relevant to determining a reasonable royalty. As they put it, they adapted these factors, “mutatis mutandis,” to fit the facts before them. Indeed, it is clear that the particular circumstances presented in the case before them—Georgia-Pacific’s deliberate infringement and the extreme popularity of both the patentee’s and the infringers’ products—was a significant
The Modern Era of Reasonable Royalty Begins: Georgia-Pacific 9
factor in the development of the factors that have dominated reasonable royalty analysis ever since. Accordingly, it is highly instructive to examine how Judges Herlands and Tenney developed these factors against the background of the unique factual history they had before them.
[A] List of Factors Judge Tenney began his discussion of reasonable royalty with a listing of the famous “factors” (Georgia-Pacific, 318 F. Supp. at 1120): 1. The royalties received by the patentee for the licensing of the patent in suit, proving or tending to prove an established royalty. 2. The rates paid by the licensee for the use of other patents comparable to the patent in suit. 3. The nature and scope of the license, as exclusive or non-exclusive; or as restricted or non-restricted in terms of territory or with respect to whom the manufactured product may be sold. 4. The licensor’s established policy and marketing program to maintain his patent monopoly by not licensing others to use the invention or by granting licenses under special conditions designed to preserve that monopoly. 5. The commercial relationship between the licensor and licensee, such as, whether they are competitors in the same territory in the same line of business; or whether they are inventor and promoter. 6. The effect of selling the patented specialty in promoting sales of other products of the licensee; the existing value of the invention to the licensor as a generator of sales of his non-patented items; and the extent of such derivative or convoyed sales. 7. The duration of the patent and the term of the license. 8. The established profitability of the product made under the patent; its commercial success; and its current popularity. 9. The utility and advantages of the patent property over the old modes or devices, if any, that had been used for working out of results. 10. The nature of the patented invention; the character of the commercial embodiment of it as owned and produced by the licensor; and the benefits to those who have used the invention. 11. The extent to which the infringer has made use of the invention; and any evidence probative of the value of that use. 12. The portion of the profit or of the selling price that may be customary in the particular business or in comparable businesses to allow for the use of the invention or analogous inventions. 13. The portion of the realizable profit that should be credited to the invention as distinguished from non-patented elements, the manufacturing
10
Chapter 1 Winning the Reasonable Royalty Case
process, business risks, or significant features or improvements added by the infringer. 14. The opinion testimony of qualified experts. 15. The amount that a licensor (such as the patentee) and a licensee (such as the infringer) would have agreed upon (at the time the infringement began) if both had been reasonably and voluntarily trying to reach an agreement; that is, the amount which a prudent licensee—who desired, as a business proposition, to obtain a license to manufacture and sell a particular article embodying the patented invention—would have been willing to pay as a royalty and yet be able to make a reasonable profit and which amount would have been acceptable by a prudent patentee who was willing to grant a license. These factors, apparently drafted by Judge Herlands, are, remarkably, without explicit citation. Indeed, the court did not even use all of these factors in coming up with a reasonable royalty for the infringement of the Deskey patent. However, how the court used these factors says more about how the facts of this particular case influenced Judges Herlands’s and Tenney’s analysis than might generally be appreciated. Their analysis also gives greater weight to the “hypothetical negotiation” mode for constructing a reasonable royalty than had even been done before. Since there was admittedly no established royalty, Judges Herlands and Tenney were forced to examine “a broad spectrum of other evidentiary facts” to determine a reasonable royalty. Their basic approach was that of a “hypothetical negotiation,” which they described as “more a statement of approach than a tool of analysis.” More economic than legal, this approach “requires consideration not only of the amount that a willing licensee would have paid for the patent license but also of the amount that a willing licensor would have accepted.” This analytical tool, also referred to as the “willing buyer and willing seller” rule, had been previously used by the Sixth and the Ninth Circuits but had never been given the kind of intense analysis and examination employed by Judges Herlands and Tenney here. As the court noted, “Where a willing licensor and a willing licensee are negotiating for a royalty, the hypothetical negotiations would not occur in a vacuum of pure logic,” but would involve a “market place confrontation of the parties. . . . In applying the formulation, the Court must take into account the realities of the bargaining table and subject the proofs to a dissective scrutiny.” The parties would consider such factors as “their relative bargaining strength; the anticipated amount of profits that the prospective licensor reasonably thinks he would lose as a result of licensing the patent as compared to the anticipated royalty income; the anticipated amount of net profits that the prospective licensee reasonably thinks he will make; the commercial past performance of the invention in terms of public acceptance and profits; the market to be tapped; and any other economic factor that normally prudent
The Modern Era of Reasonable Royalty Begins: Georgia-Pacific 11
businessmen would, under similar circumstances, take into consideration in negotiating the hypothetical license.” Without any independent analysis, the court held that the hypothetical negotiation would be assumed to have taken place on the date that GeorgiaPacific started infringing the Deskey patent—February 1955—although it stated that it would take into account events subsequent to that date, but only as those facts bore on the assumptions that the parties would have had if they had actually conducted a negotiation in 1955. The most important fact for this court was the incredible success of the products—both of U.S. Plywood and Georgia-Pacific—that were covered by the patent and the fact that the parties were direct competitors. U.S. Plywood’s commercial success with its Weldtex product would, according to the court, have made it extremely resistant to licensing the patent to a competitor and giving up its monopoly on the sale of striated plywood. At the time of the hypothetical negotiation, U.S. Plywood legitimately believed that sales of striated plywood would remain high and that, as a monopolist, it would be able to keep its prices—and its profits—extremely high. As the court noted, “in the hypothetical negotiations, USP would have been reasonable in taking the position that it would not accept a royalty significantly less than the profit it was making by its policy of licensing no one to sell striated fir plywood in the United States.” Likewise, the court put great weight on the fact that Georgia-Pacific chose to “deliberately” duplicate the Weldtex product “notwithstanding the caveat of GP’s own counsel that an expensive infringement suit was inevitable,” even though there was intense competition in the market for decorative plywood from suppliers who did not use the patented process. Obviously, GeorgiaPacific thought that the U.S. Plywood process was particularly valuable and would, presumably, have paid dearly for the ability to use it. Indeed, there was substantial evidence that Georgia-Pacific had a very good idea of the profits U.S. Plywood was actually making on its striated plywood products and “took, as its own guide for the purpose of profit expectations, the profit that USP was then making on its Weldtex sales.” The court also considered two issues that have bedeviled courts having to deal with damages issues ever since: (1) where the defendant’s infringement has caused the patentholder to lose sales of both the patented product and non-patented products sold with the patented product (like a camera and a camera case); and (2) where the patent only covers a particular component or feature of of a larger product. With regard to the first issue (so-called “collateral and convoyed” items), although the court did not award damages based on those sales, it did note that, in the hypothetical negotiation, U.S. Plywood would have been well aware that granting a license to Georgia-Pacific would also cost it sales of these other, non-patented, products and that this would also have been a factor that would have increased the amount of the royalty. The court noted
12 Chapter 1 Winning the Reasonable Royalty Case
that Georgia-Pacific managed to increase its own sales of these collateral products by selling the infringing product. The Georgia-Pacific court also tackled the sensitive issue of allocation— determining how much of the revenue attributable to the infringing product should be allocated to the patented invention. The court’s analysis, prescient in light of subsequent controversy, applied what has become known as the “entire market value rule,” which holds that the “reasonable royalty” should be applied to the entire price of the infringing product where the reason that the consumer purchases the item is because of the invention claimed in the patent – i.e., where the “entire market value” of the infringing product is attributable to the patented technology. As the court put it, “there is a basic distinction between a patent which is only a part of a machine or structure and which creates only a part of the profits and, on the other hand, a patented article or a patent which gives the entire value to the combination or an article patented as an entirety. Consequently, it is necessary to determine whether the invention extends to and affects the whole article, giving it its essential marketability, or whether it is only for an improvement.” In this case, the court found that it was the “value of the striated face that created the value of the striated fir plywood panel” and that “the entire market value of Weldtex and GP striated was attributable to the Deskey patent.” The court rejected the argument made by many defendants that a portion of the “value” of the infringing product was attributable to other patents simply because those inventions may have been used in the product. The court preferred an economic argument: without using the patented invention, the infringing product would have “no commercial value at all,” therefore the royalty should be calculated with respect to the entire value of the infringing product. The court also refused to deduct any value attributable to the unpatented decorative appearance of the plywood, which admittedly was a substantial reason for its popularity, because this decorative appearance could not have been obtained without using U.S. Plywood’s patent. “The fact—as we now know it in retrospect, according to the evidence of the motives of the purchasers of striated fir plywood—that the buyers of that product were attracted to it by its decorative appearance is irrelevant to the hypothetical negotiations of a reasonable royalty where GP’s expectations of profits could be lawfully fulfilled only by a license of the Deskey patent and where the rate of profit could be estimated by both USP and GP on the basis of a long and recognized record of past performance.”
[B] Consideration of Rigorous Economic Analysis The Georgia-Pacific decision is noteworthy for many reasons. This decision established principles that have been used by virtually every court since in
The Modern Era of Reasonable Royalty Begins: Georgia-Pacific 13
determining a reasonable royalty. Although its lessons are often misapplied and the policy behind its factors is often distorted or ignored, the decision provides subsequent decision makers with a rational basis for compensating plaintiffs who cannot be awarded lost profits. Even more important, however, Georgia-Pacific marks one of the first real attempts to apply economic principles to the computation of reasonable royalties in patent cases. In creatively interpreting that for a royalty to be “reasonable” under the statute it should reflect what the parties themselves would have agreed to, the court gave thoughtful parties the opportunity to bring virtually any economic factor the parties might have considered to the table. After Georgia-Pacific, the fact finder is encouraged to consider such issues as the nature of the marketplace, the competition between the parties (and the competition with third parties), and the relative strengths of the parties, both in terms of their ability to impose their will in the hypothetical negotiation and in the marketplace generally. Indeed, under this construct, the fact finder can consider both the interest and need of each party to enter into a license and the ability of each side to walk away from the table. By permitting the fact finder to take into account every economic factor that the parties could have considered at the time of infringement, the Georgia-Pacific court fully implemented a true economic regime into awarding damages in a patent case. Although this opportunity is honored much more often in the breach than in the observance, the ability of either party to bring economic rationality to the table in calculating damages is fully available and, more often than not, acts more to the benefit of the party utilizing this sophisticated analysis over parties that do not. Attorneys can properly apply these factors to either maximize or minimize a reasonable royalty award only if they understand both the legal basis and the economic policy underlying each factor. Only with an understanding of the reasons the Georgia-Pacific court believed these factors to be important in determining the basic compensation to be awarded to a prevailing plaintiff can counsel effectively communicate with his or her expert in constructing the damages analysis and, later, communicate with the jury in presenting this analysis in a persuasive manner. Attorneys who understand not only the theory but also the reasons behind the theory are much more likely to have their damages position prevail at trial.
This page intentionally left blank
CHAP T ER
2 Introducing the Combatants
2.01 The Plaintiff: Six Category Types
15
[A] The Dominant Competitor
16
[B] The Minor Competitor
17
[C] Non-Producing Entities
18
[D] Universities
19
[E] Patent Trolls
20
[F] Individuals
20
2.02 The Defendant
21
2.01 The Plaintiff: Six Category Types The purpose of the reasonable royalty remedy is to provide the patentholder with a monetary remedy when there is no other way to compensate for its missed opportunity to enforce exclusive use of the patent. Sometimes the plaintiff ’s entire compensation for the defendant’s infringement will come from a reasonable royalty award. On other occasions, the plaintiff will be able to prove competitive injury in the form of lost profits or price erosion for some sales or for some infringing products, but not for others. The patentholder’s compensation for the remaining infringing sales will be covered by an award of a reasonable royalty. Although the royalty that would be reasonable for a given patent and for a given infringing product will depend substantially on the scope of the patent and the way in which the product uses that patented invention, the amount of that royalty is also highly dependant on each party’s participation in the marketplace and the parties’ competitive relationship with each other. The individual economic status of each party at the time infringement began is highly relevant to the determination of a reasonable royalty. The economic role of each party in the marketplace is critical to that party’s advantage in litigating the issue of reasonable royalty. A party’s ability to maximize that advantage depends on its counsel’s understanding of that economic role.
15
16
Chapter 2 Introducing the Combatants
In determining a reasonable royalty, the most important player is, of course, the plaintiff. Whether the plaintiff uses the patent in a business—and how that patent is used—makes a big difference in the royalty it would have been reasonable for that plaintiff to license the patent in suit to the defendant. A patent plaintiff seeking a reasonable royalty falls into one of six categories: (1) a company that sells products covered, in whole or in part, by the patentin-suit and is dominant in the market; (2) a company that sells products covered by the patent and is a minor player in the market; (3) a “non-producing entity” that developed the technology at issue and that, at one time, sold a product covered by the patent, but no longer does so; (4) a university whose faculty members develop patented technology—often with the help of government grants; (5) a “patent troll,” that is, a company that did not develop the technology in the patent and has never sold a product but was formed for the purpose of generating revenue from the licensing of the patents in their portfolio; (6) an individual inventor. The strategies a plaintiff can and should pursue to maximize its return on “investment” in the patent-in-suit depends, to a large extent, on the plaintiff ’s economic status and the use it has made of the patented invention. Although a particular plaintiff ’s economic position may be weak with respect to some factors relevant to the reasonable royalty analysis, the plaintiff should recognize that weakness and bolster its position in other areas. The defendant needs to recognize the obstacles such a plaintiff has in justifying a substantial reasonable royalty and capitalize on those weaknesses.
[A] The Dominant Competitor In many instances, a patent plaintiff dominates its market. Such a plaintiff has developed innovative products based on its own advances in technology, which enables it to command a substantial market share and set prices that are relatively unaffected by competitive products. Think, for example, Apple’s iPod. This dominant company has invested millions of dollars in research and development to create innovative products and has usually carefully protected its advances in technology by obtaining patents for its inventions. Many of this company’s patents tend to be “pioneer patents” and have enabled it to quickly move to the top of the heap. Such a company continues to improve its technology and patent those improvements, often reinvesting the money generated from its successful domination of the marketplace to fund its advancements. The company then uses the patent laws’ power to exclude as yet another competitive tool to make it even more difficult for a rival to get a toehold in the marketplace. The products that a dominant company markets are often unique (or offer some unique features) and differentiate these products from those offered
The Plaintiff: Six Category Types 17
by a competitor. A dominant company’s patented technology usually is what gives it the edge in the marketplace. The competitor is forced to design around the dominant company’s patents or to develop completely independent technologies. This slows down the other competitor and gives the dominant player an opportunity to cement its advantage in the marketplace by effective sales and marketing. The dominant company’s patents are usually tied closely to its product offerings—the company tends to actually use the patented technology it offers in the products it sells. Because the company uses the patent’s exclusionary power to prevent a smaller competitor from developing competitive technologies, it is unlikely to offer its patents for license to anyone. A company that is presently employing its patented technology in its products is much more likely to use patents as a weapon, to prevent the smaller competitor from gaining a foothold. Such a company will sue its infringing competitor rather than offer a license. This patentholder, if it chooses (or is forced) to pursue a reasonable royalty remedy, is likely to demand a substantial return for the infringement of its patents, reflecting the very high royalty it would have demanded for licensing its valuable patents to a competitor who would, in turn, use that technology against the patentholder.
[B] The Minor Competitor Another type of competitor in the marketplace tends to use its technological advantage to differentiate itself both from the other minor competitors and from the dominant player in the market. This company is jealous of its market niche and tries to use its technological advantage to keep prices high, so as not to be overwhelmed by the lower prices that may be offered by the dominant player and to protect itself from other minor competitors and new entrants who are also seeking entry into the market. Because such a company lacks the marketing muscle of a major player in the market and the ability to cut costs through economies of scale, it needs to develop a “better mousetrap” to compete against a larger rival. A good example of this type of company is Bose, which has based its technological and market niche—and the very high prices for its products—on the particular advantages its innovative technology gives the company. Not surprisingly, Bose vigorously asserts its patent portfolio against its competitors. Like the dominant player, the minor competitor will also jealously guard its patented innovations because they are the key to its ability to compete in the market at all. It is this company’s exclusive ability to use its patented technological advantages that allows it to participate effectively in the market. Such a company is unlikely, therefore, to be willing to voluntarily license its technology to even another minor competitor and would view licensing its distinctive technology to a large competitor as akin to slitting its own throat.
18 Chapter 2 Introducing the Combatants
Like the dominant participant in the market, the minor competitor has a strong incentive not to license patents to a rival. This company would therefore only be satisfied with a substantial royalty for allowing its patented technology to be used.
[C] Non-Producing Entities A substantial number of other patent plaintiffs fall into the category of nonproducing entities (NPEs)—companies that developed the patented technology at issue but, for some reason, do not presently market products using that technology. This type of company may have sold products using this technology at one time but was not able to compete in the marketplace. Another such company may have had a successful product that used the patent, but may have failed for reasons having nothing to do with that product. Still another company may be successfully selling some products but may not have found a use for the patented technology in those products and is thus willing to license that technology to others. A good example of this type of NPE company is NTP, who successfully sued RIM—the owner of the Blackberry technology—for patent infringement. At one time, NTP had developed a product based on its patented technology, but did not have the resources necessary to compete in the marketplace. It thus chose to base its business model on its patent portfolio. For the most part, this type of company does not maintain its competitive advantage by selling products. Rather, its business is to license its patents to as many companies as possible for the highest possible price. The only exception would be where an NPE company presently sells products but does not use the patented technology for the products it sells. If that NPE company’s products compete with an infringer’s products, then the economic considerations for that plaintiff in determining a reasonable royalty would be similar to those for a company that does use its patented technology to compete, whether or not the patentholder uses its patent in its products. Another important economic consideration for most NPE plaintiffs is that the company will not have any other source of income besides the licenses it grants and will have a substantial incentive to keep the price of the license less than the maximum it could obtain in order to actually sign up licensees and generate revenue. This NPE will also tend to license the patent on a nonexclusive basis so as to expand the “customer base” for these patents. A countervailing consideration for an NPE plaintiff is the fact that it may have substantial sunk costs—whether related to the development of the technology or to its failed attempts to develop and sell actual products that use the technology—and may feel the need to recover them by licensing the patent to others. This type of company will seek to recover those costs through licensing. Such a strategy may make the NPE more eager to grant a license to
The Plaintiff: Six Category Types 19
the patents, but may force it to hold out for a higher royalty amount. The royalty demanded by the NPE plaintiff may also be tied closely to the costs expended to develop the technology, because these costs will represent, to this party, how much the patent is “worth.” Another plaintiff, without such sunk costs, is more likely to rely on market considerations in agreeing to a license.
[D] Universities The university, while in a similar position to an NPE plaintiff, has different economic considerations. Although it does have an incentive to license the patent rather than use it to maintain some competitive advantage, it does not have the same competitive pressures that a plaintiff in private business would have. Indeed, the university’s patent portfolio is more or less a byproduct of the research its faculty members are doing anyway—either under government grant or not. The university’s patent portfolio has economic value (as opposed to the “reputational” value cutting edge research may give the institution) in two ways. First, the university can enable its faculty members to organizationally “own” that technology so that a company can later be spun out of the institution run by the participating faculty member. This gives faculty members a personal incentive to devote themselves to performing relevant research because they will able to personally benefit from its exclusive use. The more likely outcome, however, is that the university will simply license the technology to an outside company. The university’s financial incentive, then, is to ensure the patented invention is used by as many companies as possible, so as to generate the greatest amount of licensing revenue. The university has little incentive to maintain its exclusivity in the technology or to demand a high royalty rate. Indeed, as an institution that has no real need to make money from the technology it develops, the university has an even lower incentive than an outside company to demand a high royalty. What might, therefore, be a reasonable royalty for a university might not be reasonable for a profit-making institution in the commercial world. As a nonprofit institution, the university also does not have the same incentive to license the patent quickly and cheaply as a private business that was depending on this licensing income to stay alive. On the other hand, it does not have the same incentive to hold out for a higher price in order to recover its sunk costs as a business would. Indeed, if the patent was the result of a government grant, the university may not have any sunk costs at all. In fact, many universities have a disincentive to be overly aggressive in licensing their patents or in threatening litigation against recalcitrant targets. Prominent companies are often major contributors to such institutions, and their executives often serve on the board of trustees. A university may well
20 Chapter 2 Introducing the Combatants
decide that driving the hardest bargain possible with such targets may not be in its long-term interest. Accordingly, universities will not, by and large, have an economic incentive to hold out for a high reasonable royalty rate.
[E] Patent Trolls In this work, the term patent troll will be reserved for a patent plaintiff that did not develop the patented technology itself and has never marketed, or even sought to market, a product using this technology. This type of plaintiff has usually purchased or licensed the patents at issue from the company or individual that actually developed the technology. In some cases, the troll was established solely for the purpose of licensing one patented technology or even one patent. Often such trolls’ principal place of business is in the Eastern District of Texas, so as to maximize the chance that a patent case filed in that district will not be transferred. The patent troll is solely in the business of licensing the patents it owns— it has no other business other than licensing. This plaintiff has no economic incentive to hold out for the highest royalty and has no incentive to maximize its competitive influence or to seek to maximize the power to exclude another company from using the technology. The patent troll has little incentive in maximizing the price obtained from any one licensee, but, rather, it seeks to “sell” the patented technology to as many parties as possible. There also is little economic incentive to keep “prices” high, because this strategy will make it harder to “sell” the patent to those who wish to license it. There are no “sunk costs” that the patent troll needs to recover through a high licensing rate, because, apart from the amount that may have been spent to obtain the patent, no money at all was spent in obtaining the rights sought. Since trolls normally operate through attorneys working on contingency, they also have few, if any, sunk legal costs associated with enforcing their patents. Thus, as an economic matter, the patent troll has little economic incentive to demand a high reasonable royalty, since it makes a “profit” on every sale and needs to make as many “sales” as possible.
[F] Individuals The individual inventor, to a certain extent, is similar to the patent troll, in that he or she has little economic incentive to maximize each licensing opportunity but needs to simply maximize the number of licenses closed. However, the individual is unlike the troll (and like the NPE) in that, at least personally, the individual has substantial “sunk costs” in developing the
The Defendant
patented technology that must be recovered, and the patent license may be necessary for financial support. Often an individual inventor will have spent many years developing a patent and have made many personal economic sacrifices to do so. The individual may even have tried to develop an actual product but was unsuccessful because of the lack of economic resources for doing so. The individual inventor will, thus, have an incentive to maximize the total revenue obtainable from the licensing of a patent and will not have the incentive—or even the ability—to “hold out” for the best offer. This individual may, like the troll, accept a “reasonable royalty” far lower than a company that uses the technology in its business. However, because of the incentive to make sure that money is recovered for the time and effort spent developing the technology in the first place, the individual will be unlikely to let go of the technology as easily or as cheaply as a troll would.
2.02 The Defendant For the most part, a defendant that would be subject to a damages award in a patent infringement will be a company that is actually participating in the marketplace selling infringing products. The primary market criteria for such a defendant that will affect the reasonable royalty award are its domination of the marketplace, the breadth of its product line, its general financial health, and how critical the patented invention is to its ability to compete in the market. The most important of these characteristics of a defendant is how much the defendant depends on the infringing product to compete in the marketplace. The more that defendant needs the particular product to compete, especially if it is the patented invention that makes the defendant’s product popular, the more that defendant would pay to license the plaintiff ’s patent, and the higher the reasonable royalty. If the infringing product constitutes virtually the entire product line of the defendant, the plaintiff can justify a very high reasonable royalty with regard to that defendant, even if a much lower royalty might result from a lawsuit against another infringer. Assume, for example, that the patented invention is a glow-in-the-dark hula hoop that has virtually taken over the previously moribund hula hoop market, and there are two infringers. One has chosen to get in on the bandwagon and sells virtually nothing but its “Hula Lite” product. The other defendant sells a variety of toys and games. The first defendant, whether competing with the plaintiff or not, is likely to be hit with a high reasonable royalty because it chose to devote an entire product line to the infringing product. For this reason, the defendant would have paid a high amount to license the plaintiff ’s patent, since the survival of
21
22 Chapter 2 Introducing the Combatants
the business depends on that product, and it would be difficult, expensive, and risky to shift focus to a non-infringing alternative. The other defendant, by contrast, might have suffered a minor decrease in sales if it had been forced to discontinue its sales of the light-up hula hoop, but, since it had a broad-based product line, it would not pay a great deal to license the patent so it could keep selling the product. Its reasonable royalty, therefore, would be substantially less than the other defendant’s.
CHAP T ER
3 Stranger Than Fiction Imagining the Hypothetical Negotiation
3.01 Applying Game Theory to Hypothetical Negotiation
26
[A] A Zero-Sum Game
26
[B] Perfect Exchange of Information
27
[C] You Can’t Walk Away
27
[D] Date of Infringement
27
[E] Assumption of Validity
27
3.02 Determining the Reasonable Royalty Value
28
[A] Game Theory and the Lemley/Shapiro Analysis
29
[B] Injunctions
30
[C] Two More Variables
31
The most important Georgia-Pacific factor is the last: the hypothetical negotiation. It is the theoretical underpinning of every other factor and, while easy to understand, is remarkably hard to apply: The amount that a licensor (such as the patentee) and a licensee (such as the infringer) would have agreed upon (at the time the infringement began) if both had been reasonably and voluntarily trying to reach an agreement; that is, the amount which a prudent licensee—who desired, as a business proposition, to obtain a license to manufacture and sell a particular article embodying the patented invention—would have been willing to pay as a royalty and yet be able to make a reasonable profit and which amount would have been acceptable by a prudent patentee who was willing to grant a license.
As an economic matter, the hypothetical negotiation simply involves dividing up the “pot” of money representing the sum of the patent’s value to the plaintiff (either by excluding all others from using the patent or by licensing
23
24
Chapter 3 Stranger Than Fiction
it to others) and the patent’s value to the defendant (i.e., the economic impact on the defendant of being precluded from using the patent). The portion of this pot of money that would end up in the plaintiff ’s hands at the close of this negotiation represents the reasonable royalty. The hypothetical negotiation involves, of course, a completely fanciful situation. It assumes a negotiation between a plaintiff that is not a willing licensor and a defendant that, more often than not, had no idea it was infringing the patent and would probably have had no interest in taking a license. It puts these two parties in a room at a time in which they may not have even known each other existed—at the time the defendant started infringing—and forces them to reach an agreement that they might never have been able to reach. It forces the plaintiff to lower its price for licensing its patent to a level at which the defendant could still have made a profit and forces the defendant to agree to pay an amount that would still have been “acceptable” to the plaintiff. It also forces them to assume a fact that the actual parties would never have assumed—that the patents are both valid and infringed. The court has to be careful not to view this hypothetical negotiation as though it were a real commercial transaction and acting as though the defendant had not infringed the patent. Such analysis, obviously, simply rewards the defendant for infringing—giving it the same deal as it would have had absent the lawsuit, while putting the plaintiff to the trouble and expense of suing. With all of these competing considerations, it is remarkable that any expert is able to construct a scenario in which these parties could have “agreed” to anything or that any fact finder could come to any kinds of conclusion as to what these parties might have agreed to in this fictitious negotiation. However, this theoretical construct has proven to provide the best measure of what royalty fulfills the statutory mandate of being “reasonable.” The court in Innogenetics, N.V. v. Abbott Labs., 578 F. Supp. 2d 1079, 1093 (W.D. Wis. 2007), gave a good summary of the hypothetical negotiation model: “In calculating the amount of a reasonable royalty, the jury has to pretend that the parties sat down and negotiated a reasonable royalty before the day that defendant began its infringement of the plaintiff ’s patent. Unlike a real negotiation, this hypothetical negotiation assumes that the infringer must agree to some amount of royalty payment; it does not have the option of walking away from the table. The jury must put itself in the shoes of the parties and look at the relevant circumstances as they were at the time the negotiations would have taken place. The reasonable royalty calculus assesses the relevant market as it would have developed before and absent the infringing activity.” The courts, however, are quite aware of the limitations of this model. As the Sixth Circuit observed in the leading case on lost profits, Panduit Corp. v. Stahlin Bros. Fibre Works, Inc., 575 F.2d 1152, 1164 (6th Cir. 1978), “[d]etermination of a ‘reasonable royalty’ after infringement, like many devices in the law, rests on a legal fiction. Created in an effort to ‘compensate’
Imaging the Hypothetical Negotiation 25
when profits are not provable, the ‘reasonable royalty’ device conjures a ‘willing’ licensor and licensee, who like Ghosts of Christmas Past, are dimly seen as ‘negotiating” a “license.’ There is, of course, no actual willingness on either side, and no license to do anything, the infringer being normally enjoined, as is Stahlin, from further manufacture, use, or sale of the patented product.” The Federal Circuit concurred in Rite-Hite Corp. v. Kelley Co., 56 F.3d 1538, 1576 (Fed. Cir. 1995), noting that while “[t]he hypothetical negotiation is often referred to as a ‘willing licensor/willing licensee’ negotiation. . . this is an inaccurate, and even absurd, characterization when, as here, the patentee does not wish to grant a license.” Indeed, “the use of a willing licensee-willing licensor model for determining damages risks creation of the perception that blatant, blind appropriation of inventions patented by individual, nonmanufacturing inventors is the profitable, can’t-lose course.” Maxwell v. J. Baker, Inc., 86 F.3d 1098, 1109–10 (Fed. Cir. 1996). The Federal Circuit noted in Fromson v. Western Litho Plate & Supply Co., 853 F.2d 1568, 1576 (Fed. Cir. 1988), that “[f]orced to erect a hypothetical, it is easy to forget a basic reality—a license is fundamentally an agreement by the patent owner not to sue the licensee. In a normal negotiation, the potential licensee has three basic choices: forego all use of the invention; pay an agreed royalty; infringe the patent and risk litigation. The methodology presumes that the licensee has made the second choice, when in fact it made the third. Thus Western must be viewed as negotiating for the right to exclude competitors or to compete only with licensed competitors, a landscape far different from that created. . . by the infringement of [the defendant] and others. Whatever royalty may result from employment of the methodology, the law is not without means for recognizing that an infringer is unlike a true “willing” licensee; nor is the law without means for placing the injured patentee in the situation he would have occupied if the wrong had not been committed.” In an early case, the Federal Circuit was of the opinion that the hypothetical negotiation should be entirely hypothetical—having no relationship to the real world. “[I]n determining a reasonable royalty in hypothetical negotiations, a willing ‘hypothetical’ licensee would not have been a party to any prior transactions and, thus, would not have had the same psychological reluctance as Heublein.” Stickle v. Heublein, Inc., 716 F.2d 1550, 1563 (Fed. Cir. 1983). However, in more recent cases, the courts have considered the actual market and competitive pressures that the parties were under at the time the hypothetical negotiation is deemed to have taken place—at the time the infringement began. For example, in Ball Aerosol & Specialty Container, Inc. v. Limited Brands, Inc., 514 F. Supp. 2d 1051, 1065 (N.D. Ill. 2007), the court noted that since, at the time of infringement, the commercial relationship between the plaintiff and defendant made buying the necessary component
26 Chapter 3 Stranger Than Fiction
“not a viable option,” the plaintiff was “in a superior negotiating position” and could have demanded a higher reasonable royalty. Likewise, in Minco Inc. v. Combustion Eng’g, 95 F.3d 1109, 1119 (Fed. Cir. 1996), the court considered such real-world factors as the fact that, at the time of infringement, the plaintiff had an “inferior product” and that the industry “enjoyed high rates of profit.” Indeed, in Avocent Huntsville Corp. v. ClearCube Tech., Inc., 2006 U.S. Dist. LEXIS 55307 (D. Ala. 2006), the court explicitly took into account the “mental state” of the respective “hypothetical negotiators,” considering the real economic pressures they would have been under at the time. However, the utility of these real-world considerations has its limits, as the court cautioned in Cummins-Allison Corp. v. SBM Co., Ltd., 584 F. Supp. 2d 916, 918 (E.D. Tex. 2008), especially because of the requirement of the hypothetical negotiation that the parties assume the validity and infringement of the patent: “The problem with ignoring or overruling Georgia-Pacific and basing the royalty rate calculation entirely on a ‘real world’ view of the hypothetical negotiation or future damages is that the damages expert should then, as real world lawyers and business owners would do, also consider the relative strength of the infringement and invalidity cases, current trends of patent law, the merits of the parties’ lawyers, their perceived influence with judges, and even factors such as their willingness to engage in abusive attempts to spend opponents into bankruptcy.”
3.01 Applying Game Theory to Hypothetical Negotiation These artificial constraints, however, need not prevent the parties and the court from determining an equitable reasonable royalty using the hypothetical negotiation model. Negotiation modeling drawn from game theory can often provide valuable insights into the process by which the parties would have reached a deal in these fictional negotiations. A number of factors specific to the hypothetical negotiation process affect how these negotiations should be viewed and modeled.
[A] A Zero-Sum Game First, the reasonable royalty hypothetical negotiation is what is known as a zero-sum game—any advantage gained by one party disadvantages the other. The hypothetical negotiation model does not allow for the parties working together cooperatively in the future or forming some kind of joint venture— the parties are just dividing up the spoils.
Applying Game Theory to Hypothetical Negotiation 27
[B] Perfect Exchange of Information Second, there is, for the purposes of the patent lawsuit, perfect exchange of information. The hypothetical negotiation model presumes that each party is aware of the economic constraints the other is under. Secrecy regarding information or strategy—which would be a party of any real negotiation—is simply not taken into account. These factors, obviously, push the hypothetical negotiation farther and farther from reality. However, it is easy to see that, in the context of litigation, trying to account for the secrecy and deception that are part of any business deal would make the process entirely unworkable.
[C] You Can’t Walk Away Third, although there is theoretically no ability for either party to walk away from the table, even as a negotiating tactic, the courts often (as covered in more detail below) impose an outside boundary on the results of the negotiation, holding that one party or the other would “never” have agreed to a certain result because it would have been too economically disadvantageous. This is usually expressed in terms of the position of the defendant who, in the opinion of the court, would “never” have agreed to a royalty that did not permit it to retain some profit. Although this factor is inconsistently applied (some courts expressing the strong opinion that they did not care whether an infringing defendant would have ended up with a profit or not), it is a factor that should be taken into account and that a defendant should be sure to emphasize.
[D] Date of Infringement Fourth, the hypothetical negotiation theoretically takes place on the day the defendant started infringing—either the day that the defendant started making using or selling the infringing product or, if the patent issued while the defendant was already selling the product, the date the patent actually issued. As noted elsewhere, the court and jury are supposed to take into account only the facts the parties knew and the assumptions the parties were making as of that date. In certain circumstances, however, the fact finder can take into account facts that occurred after the date of the hypothetical negotiation (usually the actual level of sales of the infringing product)—the so-called Book of Wisdom analysis.
[E] Assumption of Validity Fifth, unlike any actual negotiation outside of the conduct of the litigation, the fact finder assumes, for the purpose of negotiation modeling, that the
28
Chapter 3 Stranger Than Fiction
patent is valid, enforceable, and infringed—making definite a factor that the parties would have considered indefinite during the negotiation. Indeed, the hallmark of any real-world licensing negotiation is the competing analyses of the likelihood that the patent may hold up under an invalidity attack and the strength of the infringement case. Although considering that damages are actually awarded at trial only where the patent is valid and infringed, imposing this constraint on the hypothetical negotiation is certainly fair, this factor in particular imposes a particular level of unreality on the negotiation analysis, because this obviously increases the plaintiff ’s bargaining power dramatically.
3.02 Determining the Reasonable Royalty Value Taking into account all of the factors specific to the reasonable royalty analysis, the first step in splitting up the pot of money between the parties is determining how big the pot is and where the money came from. On the plaintiff ’s side, this issue depends substantially on whether the plaintiff uses the patent in its business and, if so, how it uses the patent. If the plaintiff uses the patent in its products, obtains a competitive advantage from doing so, and would suffer a competitive injury from giving up this exclusive use of the patent, this competitive advantage has a certain measurable value—how much better off would the plaintiff be with the exclusive use of the patent than without it? The more important and central the patent is to the plaintiff ’s maintaining this competitive advantage, the greater the amount of this ascribed “value.” In the hypothetical negotiation, such a value goes into the pot. Where the plaintiff does not use the patent in its business, the value of the patent to the plaintiff is the amount it could obtain by licensing it to third parties. Where the plaintiff has “established” a royalty (more about this later), the amount it loses if the defendant infringes the patent without compensating the plaintiff is clear—the “market price” for licensing the patent. Where the plaintiff, however, has not licensed the patent at all or has licensed it for inconsistent prices (or where it cannot prove a consistent strategy), or where all licensing has been conducted as settlements of real or threatened litigation, the value of what this type of a plaintiff has “lost” by the infringement is less clear. In fact, the amount it puts into the pot may very well depend on the identity and characteristics of the particular infringer. The amount the defendant puts into the pot reflects the competitive value the use of the patent represents to the defendant and the amount the defendant would suffer if that use were taken away. Does infringing the patent enable the defendant to save costs? Increase prices? Increase output? Gain market share? These amounts can be calculated (or at least estimated) and
Determining the Reasonable Royalty Value 29
should be added to the pot of money the plaintiff and defendant are fighting over. One wrinkle that must be taken into account is the extent to which the defendant “needs” the patented invention it is infringing in order to gain these advantages. Could the defendant work around the invention and gain all or part of that competitive advantage in a non-infringing manner? If so, would that process cost the defendant more to implement? Would it take the defendant more time to implement this other solution? Any “non-infringing substitute” solution will decrease the value of the patent to the defendant and will thus decrease the amount the defendant needs to put into the pot to divide with plaintiff. Now that there is an estimate how much money to put into the pot, how, then, should it be divided? Is there a better solution than simply guessing at what the parties would have done? Game theory may provide a solution, or at least an approach, to solving this problem. As noted above, the calculation of a reasonable royalty in a patent case is a two-person, non-cooperative zero-sum-game—these parties are not going to cooperate or work together either now or in the future, and what helps one player hurts the other. There is a limited amount of money in the pot, and the conduct of the parties is not going to create more; the only question is how the pot is going to be divided up.
[A] Game Theory and the Lemley/Shapiro Analysis Mark Lemley and Carl Shapiro’s analysis of real-world royalty negotiation, described in their article Patent Holdup and Royalty Stacking, 85 TEXAS L.REV. 1991(2007), which takes into account the plaintiff ’s ability to obtain an injunction, is useful and enlightening as to the process that should be followed in determining a reasonable royalty. Yet in certain respects, their analysis is incomplete. In Lemley and Shapiro’s analysis, they use the “standard economic theory of Nash Bargaining,” in which “the negotiated royalty rate depends upon the payoff that each party would obtain if the negotiations break down, i.e., on each party’s ‘threat point’ in the licensing negotiations.” They then look at the following economic variables: • V: The value per unit of the patented feature to the defendant, in comparison with the next best alternative technology. For example, if the patented feature enhances the value of the product to consumers by $1 over the next best alternative, then V = $1. • M: The margin per unit earned by the defendant on its product. For example, if the product is sold at a price of $40 and the marginal cost is $30, then M = $40−$30 = $10.
30
Chapter 3 Stranger Than Fiction
• θ: The strength of the patent, that is, the probability that litigation will result in a finding that the patent is valid and infringed by the downstream firm’s product. In the context of a hypothetical negotiation in litigation, this factor must be given the value of 1, since the patent is presumed value and infringed. • C: The cost to the downstream firm of redesigning its product to avoid infringing the patent claims, measured as a fraction of the total value of the patented feature. For example, if the per-unit value of the patented feature is V = $1 and the downstream firm expects to sell ten million units, then the total value of the patented feature is $10 million. If redesigning the product costs $2 million, then C is equal to $2 million/$10 million, or 20 percent. • L: The fraction of the downstream firm’s total unit sales during the lifetime of the patent that would be lost if the downstream firm were forced off the market by an injunction, as reflected by the lag in time required for the downstream firm to redesign a non-infringing product and introduce it to the market. • B: The bargaining power of the patentholder, as measured by the fraction of the combined gains from settling, rather than litigating, that are captured by the patentholder. This variable falls between zero and one. Equal bargaining power, B = 0.5, is a common assumption. Given these variables, Lemley and Shapiro determine a “benchmark” royalty rate, which, assuming equal bargaining power, “split[s] equally any gains from reaching an agreement.” They also consider this equal split as “the proper benchmark for ‘reasonable royalties.”
[B] Injunctions Lemley and Shapiro go on to evaluate the effect of the prospect of an injunction on such real-world negotiations. They note that a plaintiff may obtain an injunction that would prevent a defendant from using the patented feature at all and would, presumably, be able to stop the defendant from selling the infringing product—even if the patented feature was a relatively minor component of the infringing product. This, according to the authors, gives the plaintiff negotiating power in such negotiations that far outweighs the actual economic value of the patent.1 Even taking the injunction factor out of the calculus, under the Lemley and Shapiro analysis, a reasonable royalty is primarily measured by the
1 This article was published before the Supreme Court’s opinion in eBay v. MercExchange, which, contrary to the authors’ predictions, eliminated the automatic imposition of a permanent injunction where patent infringement was found.
Determining the Reasonable Royalty Value 31
advantages gained by the defendant from its infringing use of the patented invention and is usually a matter of splitting the difference—the plaintiff charging the defendant about half of the monetary advantage the defendant gains from it use of the patent. However, that this analysis is incomplete, because it does not take into account the differences between (1) patentholders who use the patent-in-suit in their businesses and obtain competitive advantage from being the sole user of its features and from being able to exclude others from doing so and (2) plaintiffs whose sole use for the patent is to license it and who have little or no money to put into the pot. For these “competitor” plaintiffs (who, for whatever reason, may not be able to utilize the lost-profits remedy), the competitive value of the patent must also be taken into account.
[C] Two More Variables Given the need to take the above differences into account, there should be added to the Lemley and Shapiro analysis two more variables: VP, the competitive value of the patent to the plaintiff, representing its increased sales, increased pricing, or decreased costs that result from being the only player in the market that offers the patented feature; and DMP, the difference in the plaintiff ’s margins between the plaintiff ’s position as a monopoly user of the patented feature and its margin with the defendant selling the infringing product. These two factors will represent something similar to what is commonly called “monopoly profits” in antitrust analysis. Where the plaintiff uses the patented feature in products it sells, this factor will be significant, because the plaintiff would be unlikely to simply split the defendant’s net advantage from infringing. Rather it is more likely that the plaintiff will split the entire pot with the defendant—both the plaintiff ’s competitive advantage from excluding others from using the product and the advantage the defendant obtains from infringing. If the plaintiff ’s portion of the pot is large enough, this will shift the midpoint sharply toward the plaintiff. Indeed, if the plaintiff gets more advantage from keeping others from using the patent than the defendant gets from using it, there is a good argument that all of the defendant’s advantage from using the patent should be taken away in the hypothetical negotiation—a result that many courts have imposed, even in the face of arguments by the infringing defendant that, in the hypothetical negotiation it “never” would have given up all its profits. Where the plaintiff is a university, NPE, or troll, however, the analysis is very similar to that set forth by Lemley and Shapiro; since the plaintiff has nothing to put in the pot, the only advantage the plaintiff actually gets from the patent is from selling it—that is, licensing others to use it in exchange for royalties. These plaintiffs are much more likely to simply split the difference with defendants.
This page intentionally left blank
SECTION
II A Strategic Look at the Georgia-Pacific Factors
This page intentionally left blank
CHAP T ER
4 Finding the Price of the Patent Is There an Established Royalty? Factor 1: The royalties received by the patentee for the licensing of the patent in suit, proving or tending to prove an established royalty.
4.01 Relevance and Application
36
4.02 Economic Criteria
37
[A] License Rates Must be Uniform, Timely, and Reliable
38
[B] Time Constraints
38
[C] Can Litigation-Related Licenses Be Used?
38
[D] Example
39
4.03 The Defendant’s “Established Royalty” Strategy
40
[A] Uniform Royalties and Licensing Rates
41
[B] Market Rate as a Ceiling for Royalty Rate
41
4.04 The Plaintiff’s “Established Royalty” Strategy: Considerations
42
[A] Are There Enough Licenses to Establish a Price?
42
[B] Patent-in-Suit
42
[C] Time Period of License
43
[D] Example Case: Monsanto Co. v. McFarling
44
[E] Lump-Sum and Paid-Up Royalties
46
[F] Effects on Royalty of Widespread Infringement
48
4.05 Analysis
49
4.06 Discovery
53
[A] Obtain Licensing Materials
54
[B] Know the Patent’s Utility
54
[C] Economic/Market Models
55
[D] Using Your Expert and Attacking Your Opponent’s
56
[E] Particular Issues Where Plaintiff Is an NPE
57
35
36
Chapter 4 Finding the Price of the Patent
4.01 Relevance and Application The first Georgia-Pacific factor is, in one sense the essence of the hypothetical negotiation and, in another sense, is its starkest exception. In this case, the patentholder does not, in fact, negotiate with the infringer as to the royalty rate the defendant would find acceptable or would guarantee the defendant a profit. The plaintiff and defendant do not take into account the economic factors that govern their respective businesses or their competition between each other, if any. Indeed, there is no more negotiation than when a consumer shops at Wal-Mart. The courts simply presume that, where a patentholder has already established the royalty it will charge for licensing its patent, this patentholder would also charge the defendant that same royalty. Where the plaintiff has already been licensing a patent with sufficient frequency, and with sufficient consistency to make the royalty “established,” it is not hard to assume that the plaintiff would have insisted, in the hypothetical negotiation, that the defendant agree to that same royalty. In cases where this factor can be shown, it is not only the most important factor in determining a reasonable royalty, it is normally the only factor considered. This is not surprising since, as the Federal Circuit noted in Monsanto Co. v. McFarling, 488 F.3d 973, 978–79 (Fed. Cir. 2007), “[a]n established royalty is usually the best measure of a ‘reasonable’ royalty for a given use of an invention because it removes the need to guess at the terms to which parties would hypothetically agree. When the patentee has consistently licensed others to engage in conduct comparable to the defendant’s at a uniform royalty, that royalty is taken as established and indicates the terms upon which the patentee would have licensed the defendant’s use of the invention.” Indeed, even the earliest cases found an established royalty, where it could be proven, to be an important factor in determining the appropriate recovery for a patent plaintiff. As the Supreme Court held in Seymour v. McCormick, 57 U.S. 480, 490 (1854), “[w]here an inventor finds it profitable to exercise his monopoly by selling licenses to make or use his improvements, he has himself fixed the average of his actual damage, when his invention has been used without his license. If he claims any thing above that amount, he is bound to substantiate his claim by clear and distinct evidence. When he has himself established the market value of his improvement, as separate and distinct from the other machinery with which it is connected, he can have no claim in justice or equity to make the profits of the whole machine the measure of his demand.” These early cases also recognized, however, that even an established royalty was not an infallible guide to determining the plaintiff ’s damages and that the court must examine the market conditions under which the license was granted. Evidence of an established royalty will undoubtedly furnish the true measure of damages in an action at law, where the unlawful acts consist in making and selling the patented improvement, or in the extensive and
Economic Criteria
protracted use of the same, without palliation or excuse; but where the use is a limited one and for a brief period, as in the case before the court, it is error to apply that rule arbitrarily and without any qualification.” Birdsall v. Coolidge, 93 U.S. 64, 70 (1876). As a purely economic matter, this makes sense. Clearly, if the patentholder has already set a “price” for licensing the patent that the market recognizes as “established,” it is unlikely in the hypothetical negotiation that the patentholder would agree to any lower royalty rate than the “market” rate. Conversely, it is also unlikely that the accused infringer would agree to pay a royalty that was higher than the rate that other licensees were paying. Moreover, it is unlikely that any court would hold that a royalty rate that the patentee uniformly charged to license its patent and that was generally recognized by the market as being established was not “reasonable.” The problem with this factor is not the theory but rather its application in the real world. It is often a contentious matter as to whether a patentholder’s separate agreements with various different customers, who may use the patented invention in different ways and who may have licensed the patent at a different rate can still be evidence of an “established royalty,” and if so, what that royalty is. Courts often wrestle with the tangled economic issue of how to tease out a “reasonable royalty” rate from licenses that involve lump-sum payments for a paid-up license. Finally, as Professor Chisum notes, “[w]hile existence of an established royalty usually sets the minimum recovery by a patent owner for infringement, it does not necessarily set the maximum recovery. Such an established royalty does not preclude the patent owner from recovering a greater sum under a reasonable royalty theory where the established rate was unfairly depressed because the patent had not yet gained recognition or because of widespread infringing activity.” 7 Chisum, Patents § 20.03[2] at 20–145. The essence of an “established royalty” is that it not only be established, but known to the “market.” It “must be paid by such a number of persons as to indicate a general acquiescence in its reasonableness by those who have occasion to use the invention.” Hanson v. Alpine Valley Ski Area, Inc., 718 F.2d 1075, 1078 (Fed. Cir. 1983). Because of the stringent criteria for finding that a royalty is actually “established,” few courts have actually found one. Phillips Petroleum Co. v. Rexene Corp., 1997 U.S. Dist. LEXIS 18460 (D. Del. 1997).
4.02 Economic Criteria In 1889 the United States Supreme Court set forth economic criteria for an “established” royalty that are still being applied today. “It is undoubtedly true that where there has been such a number of sales by a patentee of licenses to make, use and sell his patents, as to establish a regular price for a license, that price may be taken as a measure of damages against infringers.” Rude v. Westcott,
37
38
Chapter 4 Finding the Price of the Patent
130 U.S. 152, 165 (1889). The court emphasized that, for a license to be used as a basis for an established royalty, “it must be paid or secured before the infringement complained of.”
[A] License Rates Must be Uniform, Timely, and Reliable As the Supreme Court held, a “market price” for a license can only be established by market data that is uniform, timely, and reliable: The royalty “must be paid by such a number of persons as to indicate a general acquiescence in its reasonableness by those who have occasion to use the invention; and it must be uniform at the places where the licenses are issued. . . . Sales of licenses, made at periods years apart, will not establish any rule on the subject and determine the value of the patent. Like sales of ordinary goods, they must be common, that is, of frequent occurrence, to establish such a market price for the article that it may be assumed to express, with reference to all similar articles, their salable value at the place designated.” 130 U.S. at 165.
[B] Time Constraints The fact that licenses are offered at a particular rate does not show that that rate is the “established” rate, since this factor requires actual licenses, not mere offers to license. Alpine Ski Area, Inc. v. Hanson, 718 F.2d 1075, 1078–79 (Fed. Cir. 1983). Additionally, “offers made after the infringement had begun and litigation was threatened or probable should not be considered evidence of an ‘established royalty,’ since license fees negotiated in the face of a threat of high litigation costs may be strongly influenced by a desire to avoid full litigation.” Id.
[C] Can Litigation-Related Licenses Be Used? It has been the rule since Rude v. Westcott that licenses obtained though litigation or the threat of litigation could not be used to determine an established royalty. As the Supreme Court held, “a payment of any sum in settlement of a claim for an alleged infringement cannot be taken as a standard to measure the value of the improvements patented, in determining the damages sustained by the owners of the patent in other cases of infringement.” 130 U.S. at 165. This rule makes both economic and legal sense since, in litigation, the parties are faced with economic pressures specific to the litigation itself that would not be present in the hypothetical negotiation. Additionally, as some courts have noted, litigation may be evidence of widespread infringement that may have led to artificially depressed royalty rates. Nickson Indus., Inc. v.
Economic Criteria
Rol Mfg. Co., 847 F.2d 795, 798 (Fed.Cir.1988); Fromson v. Western Litho Plate & Supply Co., 853 F.2d 1568, 1577 n. 15 (Fed. Cir. 1988) Indeed, many courts simply reject using such licenses as a policy matter. TWM Mfg. Co. v. Dura Corp., 789 F.2d 895, 900 (Fed. Cir. 1986) (“That [the patentee] might have agreed to a lesser royalty is of little relevance, for to look only at that question would be to pretend that the infringement never happened.”). Some believe that another reason that litigation-related licenses should not be used to determine an established royalty is that the parties, when they are determining the royalty rate, do not assume (as the parties to the hypothetical negotiation do) that the patents are valid and infringed. This, however, is not a good reason to exclude these licenses from consideration while permitting the use of licenses negotiated on the “open market” since the parties to licenses that are not the product of litigation certainly consider the validity and possible infringement of the patents and take those opinions into account when deciding the royalty to be paid to license the patent—they simply do not have as much information as parties who have actually litigated the patents at issue. Additionally, there is no good economic reason to completely exclude litigation-related licenses from the established royalty analysis. A good economist could testify what effect he believed the litigation had on the royalty rate, as well as how the parties’ disagreement regarding validity and infringement would have affected the rate. In any event, in 2010, the Federal Circuit, in a opinion by Chief Judge Rader, in ResQNet.com v. Lansa, 594 F.3d 860 (Fed. Cir. 2010), held that licenses entered into in settlement of real or threatened litigation may, in fact, be used to determine an established royalty and, in some cases, may be more reliable than other licenses. In that case, the Court found that the other licenses considered by the expert were not reliable because they were not “straight” licenses for the patent but were “bundled” with additional software and code that was not covered by the patent. Because the litigation-based licenses were the only such agreements that involved the patent alone, the Court considered these licenses to be the “most reliable.” Id. at 872. This renewed interest in litigation-based licenses may be short lived, however. Some district courts have questioned the use of litigation-based licenses, even in the light of ResQNet. Fenner Investments, Ltd. v. Hewlett-Packard Co., 2010 WL 1727916 (E.D. Tex. 2010). Indeed, sitting by designation in IP Innovations v. Red Hat, 705 F. Supp. 2d 687, 691 (E.D. Tex. 2010), Judge Rader himself noted that only the non-litigation licenses at issue were “appropriate as touchstones for determining the appropriate royalty rate in this case.”
[D] Example A good example of an established royalty being used as the proper measure for a reasonable royalty is Seal-Flex, Inc. v. W.R. Dougherty & Assocs., 254 F.
39
40 Chapter 4 Finding the Price of the Patent
Supp. 2d 647, 650 (E.D. Mich. 2003). In that case, which involved infringement of a patent for all-weather surfaces for running tracks, the plaintiff had entered into a licensing agreement with “The Track Group, Inc.” as “Licensee,” and six “Members” as “Sub-Licensees.” That licensing agreement provided that “[e]ach Member shall pay royalties to Seal-Flex of Five Cents (5 [cents]) per pound and to Licensee of Three Cents (3 [cents]) per pound for each pound of ground rubber used by such member in the application of the SealFlex process. The combined royalty of Eight Cents (8 [cents]) per pound shall be collected by Licensee as a matter of convenience to all parties.” Indeed, the defendant itself had signed that license agreement. The court found that this was sufficient evidence of an “established royalty.” “First, the licensing agreement was secured prior to the infringement in this case. Second, the number of sub-licensees supports a finding that the royalty rate is reasonable. Of particular relevance is the fact that Defendant’s President, Richard Dougherty, signed the 1983 licensing agreement on behalf of Dougherty Contractors. Third, the rate of eight cents per pound was uniform among all sub-licensees. Fourth, there is no evidence that the 1983 license agreement was entered into upon threat of suit or upon settlement of litigation. Fifth, the licensing agreement granted the sub-licensees the right to use the method that was ultimately patented in the ‘622 patent and infringed by Defendant. Defendant has presented no evidence that the method licensed to Dougherty Contractors in May, 1983, was in any respect different from the method protected in the ‘622 patent.” Id. The court thus found the plaintiff had “proven the existence of an established royalty rate of eight cents per pound of rubber.” Id. at 655.
4.03 The Defendant’s “Established Royalty” Strategy The “established royalty” principle can also be used by defendants to prevent a plaintiff from seeking to recover more in a “reasonable royalty” in litigation than it had been able to do in the marketplace. A good example of this is Mobil Oil Corp. v. Amoco Chems. Corp., 915 F. Supp. 1333 (D. Del. 1994), which involved Amoco’s infringement of Mobil’s patents for a xylene isomerization process. In this case, it was the defendant, Amoco, which was contending that a “reasonable” royalty was equal to the plaintiff ’s “established licensing rate”— with Mobil arguing that it should be awarded 50 percent of Amoco’s anticipated economic benefits from its infringement. Amoco’s argument was that “Mobil had instituted standard, established rates for its MVPI process license and catalyst lease by offering and/or granting MVPI process licenses and catalyst leases at the same rate to virtually the entire PX industry” and that it should not be awarded any higher royalty as damages in an infringement
The Defendant’s “Established Royalty” Strategy 41
lawsuit. Id. at 1340. The court agreed with Amoco, finding, in a detailed analysis, both that Mobil had an established royalty for the patents in suit and that this established royalty was reasonable. The court found that Mobil’s rates for licensing the patents were paid or secured before Amoco’s infringement began. In fact, by that time, Mobil had already licensed eleven companies at the same established rates. Additionally, Mobil’s rates “were paid by a sufficient number of licensees, to indicate the reasonableness of the rates.” Mobil’s standard rates were paid by eleven companies, including some quite large and sophisticated. There was no evidence that any of the licenses were entered into under threat of suit or settlement of litigation. The court also held that Mobil’s rates were for rights comparable to those claimed by the patents in suit. Mobil argued that the patents that were the subject of the licenses were not comparable to the rights granted under its standard licenses because of differences in the process used by Amoco. The court disagreed, however, holding that “the word ‘comparable’ means ‘similar’ rather than ‘exactly the same.’” Id. at 1344.
[A] Uniform Royalties and Licensing Rates The most important factor from an economic standpoint, however, was that Mobil’s rates were uniform. Mobil, in fact, had a standard license agreement with its licensees that set forth rates that varied with the number of pounds of product processed by the patented method. All eleven of these licensees agreed to these rates, which Mobil continued to offer eleven years after Amoco started infringing. Although there was some evidence that Mobil, in some cases, offered concessions on its royalty rates, there was no evidence that anyone had paid, or even been offered, a license at rates higher than Mobil’s standard rates.
[B] Market Rate as a Ceiling for Royalty Rate Indeed, the court particularly took into account the fact that, around the time Amoco started infringing, Mobil had offered its license at its standard rates to numerous companies that rejected the license. This was a clear indication to the court that “Mobil’s standard rates were indeed about all the market could bear.” Amoco’s damages expert analogized these rejections to a car dealer that was not moving any inventory: “Now, in that situation, you as the car dealer would not start raising your prices, and you would certainly not conclude from the evidence [of the rejections] in front of you that the price ought to be held a lot higher than it actually is, even though you can’t tell for sure the reasons why your customers turned you down.” Id. at 1338–39. This conclusion was further
42 Chapter 4 Finding the Price of the Patent
supported by the fact that “Mobil was forced to give concessions to its existing licensees in order to keep them on board.” Id. at 1339.
4.04 The Plaintiff ’s “Established Royalty” Strategy: Considerations For a plaintiff, the challenge is to establish that the licenses it may have entered into establish a “price” for the patent rights that it can argue are sufficiently consistent so that the court or jury should award the plaintiff that royalty rate without considering any other economic factors or analyzing the defendant’s willingness, or even ability, to pay. The analysis to defeat a claim for an established royalty begins by winnowing out the licenses that do not apply. All licenses that were entered into after the date of the hypothetical negotiation are irrelevant, as, in most courts, are licenses that are part of the settlement of a lawsuit or threatened lawsuit. Licenses in the first category can, of course, give no insight into what royalty rate the parties would have entered into on the date the defendant started infringing. As noted above, it is still generally held that the usefulness of licenses that are the product of the settlement of litigation are poor evidence of what the market rate for licensing the patent would have been on the date of infringement. The remaining licenses must be analyzed to determine whether they can set a “market rate” for the patent rights that are alleged to be infringed by this defendant. Determining whether there is a market price for licensing the patent at issue and, if so, what it is, is very similar to determining the market price of any other product.
[A] Are There Enough Licenses to Establish a Price? First, there must be a large enough sample of “qualifying” licenses to determine what the “market” would bear for licensing the patent rights at issue. One or two would normally not be a sufficiently large sample for this purpose.
[B] Patent-in-Suit The licenses must also obviously be for either the patent-in-suit or for a patent very comparable to it. The patentee’s “normal” rate for licensing patents, even in a comparable technology, is virtually irrelevant to the issue of whether the rate is “established” (although, as will be shown later, it may be relevant in other ways to the overall issue of a reasonable royalty). This issue was highlighted by the Federal Circuit in Lucent v. Gateway, 580 F.3d 1301 (Fed. Cir. 2009). Although, in that decision, the court was
The Plaintiff ’s “Established Royalty” Strategy: Considerations
determining the applicability of particular licenses to Georgia-Pacific Factor 2—the in-licensing practices of the defendant—its comments on the criteria that courts should use to determine the utility of licenses are equally applicable to determining an established royalty under Factor 1. In that case, most of the agreements proffered by Lucent to support its request for damages had little or nothing to do with the intellectual property at issue in that case. The licenses that Lucent relied on were a motley collection of multipatent agreements (as opposed to the one patent involved in the litigation with Gateway), cross-licenses, or involved technology that had nothing whatever to do with the technology at issue in the case or which were running-royalty licenses, as opposed to the lump-sum hypothetical license that underlay the jury’s damages award. Noting that the inapplicability of these licenses to the damages award Lucent was attempting to defend and that it was Lucent’s burden to prove that the licenses relied on were sufficiently comparable to sustain a lump-sum damages award of $358 million, the court held that these licenses should be given very little weight in the GeorgiaPacific analysis. Id. at 1331. An even more rigorous standard was applied by the Federal Circuit in ResQNet, where the plaintiff ’s expert had, according to the Court, “used licenses with no relationship to the claimed invention to drive the royalty rate up to unjustified double-digit levels.” Although the technology involved in these licenses was similar to the patented technology at issue, the Court found that these licenses were not applicable because they were “re-branding or re-bundling licenses” which “furnished finished software products and source code, as well as services such as training, maintenance, marketing, and upgrades, to other software companies in exchange for ongoing revenue-based royalties.” 594 F.3d 860, 870. Although a vigorous dissent by Judge Newman noted that the licenses considered by the expert bore some relation to the patented technology at issue and that the expert had, in fact, accounted for the differences, ResQNet stands as a firm warning to litigants who believe, as Gateway did, that any license however far afield from the patent at issue may be used to support an “established royalty” and that the courts will insist on close conformance between those other license agreements and the particular technology involved in the litigation before the licenses may be use to dictate a reasonable royalty.
[C] Time Period of License Finally, the licenses must have been entered into within some reasonable period of time before the date of the hypothetical negotiation. Licenses entered into years before may reflect quite different market conditions and will also involve a patent that is considerably further from expiration. The Mobil court also considered the economic factor, which, in some cases, makes even an established royalty rate “unreasonable”—whether the
43
44 Chapter 4 Finding the Price of the Patent
“established” rate had been artificially depressed by widespread infringement. Here, however, this was not the case. Most important, it was undisputed that the standard rates were not set during a period of widespread infringement. There was also no evidence the standard rates were set artificially low to avoid invalidity challenges to the patent. As the court found, “to the contrary, Mobil recognized that its rates might be so high as to provoke challenges to the patents,” either through invalidity challenges or by work-arounds. Indeed, Mobil’s own witnesses testified that Mobil’s licensing policy was to charge “as much as the market would bear” and that their job was to “make as much money as possible” on a long-term basis over the life of the licensing program. The court also found that Mobil’s established rates were not artificially depressed because the evidence showed that Mobil itself set such rates and was successful in getting prospective licensees to pay them. The rates were also not set arbitrarily—in some cases the evidence showed that Mobil had to “negotiate hard” with its licensees to get them to pay the established license fees. Finally, the court found that Mobil’s established rates were not artificially depressed because they were set when Mobil’s technology was new. Even though the technology was relatively unproven at that point, Mobil continued to offer licenses at the same rate for years after, even after there was a sudden positive change in the acceptance rate for its licenses. The testimony showed the primary economic factor keeping Mobil’s prices in line was not infringement but rather because, faced with heavy license fees, prospective licensees were finding alternative non-infringing alternatives to the licensed technology. The court summed up its economic analysis of the established royalty by quoting Amoco’s expert: “One of the most important lessons of economics . . . is that the established market prices are the best measures of value” because they distill “all of the quantitative and qualitative factors that affect actual buyers and sellers, and influence what they pay.” Market prices “are a kind of summary measure that is objective and inclusive of all the things that impinge on businessmen, or investors, or on you and me when we make transactions.” Thus, where the value of something has already been determined in market transactions, it is contrary to sound economics to “attempt a theoretical or conjectural calculation of what it ought to be worth.” Since the market value of the license in 1980 when Amoco began infringing was the established royalty rate, this established royalty rate was held “reasonable.” 915 F. Supp. at 1348.
[D] Example Case: Monsanto Co. v. McFarling In Monsanto Co. v. McFarling, 488 F.3d 973, 980–81 (Fed. Cir. 2007), the Federal Circuit analyzed what appeared to be an established royalty and
The Plaintiff ’s “Established Royalty” Strategy: Considerations
awarded a royalty that reflected economic reality, rather than what the licensees appeared to pay. This case involved genetically modified soybeans, called “Roundup Ready.” Monsanto licensed farmers to use this technology under the terms of a standard license agreement. The farmers agreed to pay Monsanto a “Technology Fee” and agreed not to either plant Roundup Ready seed saved from a previous season’s crop or sell Roundup Ready seed from their crop to others for planting. As a result, the farmers had to purchase all the Roundup Ready seed they planted in a given year from an authorized distributor. The distributor seed companies, some of which were owned by Monsanto and some of which were independent, also charged a fee for each bag of Roundup Ready soybeans they sold. The defendant infringed Monsanto’s patent by planting patent-protected seeds without purchasing them from a seed company licensed or owned by Monsanto, neither paying the Technology Fee nor purchasing the Roundup Ready seed from an authorized distributor. The parties agreed that the amount of the Technology Fee was $6.50 per fifty-pound bag of Roundup Ready soybean seed for the pertinent years. The plaintiff argued that this Technology Fee constituted an “established royalty” for Monsanto’s patented technology and that the reasonable royalty should be limited to that amount. The Federal Circuit, however, disagreed, because what appeared to be an established royalty did not reflect the actual injury to Monsanto. Monsanto, according to the court, decided that under its standard licensing program it would extract $6.50 in direct payment and would extract an undertaking to buy seed from Monsanto itself or one of its authorized distributors, which imposed an additional cost of $19 to $22 per bag on the farmers. As the court noted, the “fact that Monsanto elected to allocate its licensing fees by obtaining a direct payment of $6.50 and ensuring a payment to the seed companies of another $19 to $22 does not mean that the royalty for its standard license was only $6.50. It means that, for a variety of economic reasons, Monsanto decided to split the royalty up into two parts and to direct part of the royalty to the third-party seed companies, which promoted and distributed Monsanto’s products. The out-of-pocket cost that the farmers paid for the right to use Monsanto’s technology was thus $25.50 to $28.50. In effect, the amount of that cost that can be characterized as a pure royalty payment was $25.50 to $28.50 minus the modest cost of cleaning and bagging the seeds and other transaction costs.” Id. Limiting the reasonable royalty to just the Technology Fee paid directly by the farmers, without taking into account the additional royalties imposed further up the approved distribution chain (a chain which, by infringing, the defendant had avoided), would, according to the court, “create a windfall for infringers like McFarling. Such infringers would have a huge advantage over other farmers who took the standard Monsanto license and were required to comply with the provisions of the license, including the purchase-of-seed and
45
46 Chapter 4 Finding the Price of the Patent
non-replanting provisions.” The evidence at trial showed that Monsanto would not have agreed to an unconditional license in exchange for a payment of $6.50, and “the explanation—that Monsanto would lose all the benefits it gets from having the cooperation of seed companies in promoting Monsanto ‘s product and controlling its distribution—is a reasonable commercial strategy.” Id.
[E] Lump-Sum and Paid-Up Royalties Slightly different considerations arise when the “established” royalty is a lump-sum or paid-up royalty, and the courts have handled the issue in different ways. One common way is to simply award the plaintiff an “established royalty,” all or part in the form of a lump-sum. This was the approach taken in Third Wave Techs. Inc. v. Stratagene Corp., 405 F. Supp. 2d 991, 1012 (W.D. Wis. 2005), a case involving the infringement of plaintiff ’s biotechnology patents. The court found that, where an up-front fee in addition to a running royalty, as proposed by the plaintiff, is commonly utilized in the industry, an “established royalty” structured in this manner can be proper. In that case, the plaintiff ’s expert noted, first, that up-front fees for patent licenses were “fairly common” in the industry “because companies in the biosciences and life sciences are willing to pay upfront royalties for access to the kinds of technology that will enable them to achieve early entry into markets.” Indeed, both parties had entered into arrangements with up-front royalty fees, and other biotech companies had also entered into multimilliondollar lump-sum licenses. This was also the approach used by the court in Minnesota Mining & Mfg. Co. v. Berwick Industries, Inc., 393 F. Supp. 1230 (M.D. Pa. 1975). In that case, involving 3M’s patents for a machine that made decorative bows, the court found that 3M had entered into two types of licenses. The first type calculated royalties based on the number of bows produced and sold by the licensee— two-tenths of a cent per bow. The second type of license was for a lump-sum royalty not specifically related to actual bow production. In setting the reasonable royalty, the court primarily relied on the one lump-sum license 3M had ever entered into because the court found that on the date of the hypothetical negotiation, the parties “would not have entered into any license agreement other than one involving a lump sum royalty.” This issue has also been handled by “revaluing” the lump-sum licenses as running royalties to generate an “equivalent” percentage royalty that can then be used as “established royalty” data for the reasonable royalty calculation. This method was employed by the court in Studiengesellschaft Kohle v. Dart Industries, Inc., 862 F.2d 1564, 1581 (Fed. Cir. 1988), which involved infringement of patents for polymer catalysts. This case, however, had the additional complication that many of the lump-sum licenses were distant in time from
The Plaintiff ’s “Established Royalty” Strategy: Considerations
the defendant’s infringement. However, instead of rejecting their relevance, the special master in the trial court recognized the differing economic and competitive environments of those licenses and the present case and accounted for those differences, making the appropriate adjustments. As the court noted, the early “licenses were negotiated . . . at the threshold of this technology, before its value was manifest, and before the ‘115 patent was issued. The court recognized that “there were not analogous values between an up-front payment by Dart, twenty-four years after the “front” has passed (Dart’s infringement commenced in 1964), and the up-front payments of the 1950s, paid several years before a commercial process and running royalties were generated. The early up-front payments were plainly of different value to the licensor, for they produced immediate income to Ziegler, and were non-returnable even if no commercial production was ever achieved by the licensee.” The court held that “[t]he master did not err in crediting the expert’s testimony that the royalty equivalent of the early licenses would be an overall rate of 3.7–4.0% if the up-front payments were appropriately valued.” The substantial differences between running royalty and lump-sum licenses, when they are used to prove the amount of a claimed established royalty were highlighted by the Federal Circuit in Lucent v. Gateway. As the court noted, “[s]ignificant differences exist between a running royalty license and a lump-sum license. In a standard running royalty license, the amount of money payable by the licensee to the patentee is tied directly to how often the licensed invention is later used or incorporated into products by the licensee. A running royalty structure shifts many licensing risks to the licensor because he does not receive a guaranteed payment. Royalties are dependent on the level of sales or usage by the licensee, which the licensee can often control.” 580 F.3d 1301, 1326.1 As the Federal Circuit noted, “[t]he lump-sum license removes or shifts certain risks inherent in most arms-length agreements. A lump-sum license removes any risk that the licensee using the patented invention will underreport, e.g., engage in false reporting, and therefore underpay, as can occur with a running royalty agreement. Additionally, for both contracting parties, the lump-sum license generally avoids ongoing administrative burdens of monitoring usage of the invention.” A further consideration, as the Court noted, “is that an upfront, paid-in-full royalty removes, as an option for the licensee, the ability to reevaluate the usefulness, and thus the value, of the patented technology as it is used and/or sold by the licensee. . . . A licensee to a lump-sum agreement, under usual licensing terms, cannot later ask for
1 The Federal Circuit cited a previous edition of this work in its analysis of the differences between lump-sum and running royalty licenses.
47
48 Chapter 4 Finding the Price of the Patent
a refund from the licensor based on a subsequent decision not to use the patented technology. There is no provision for buyer’s remorse.” Id. Of course, as the Court noted, “[t]he lump-sum structure also creates risks for both parties. The licensed technology may be wildly successful, and the licensee may have acquired the technology for far less than what later proved to be its economic value. The alternative risk, of course, is the licensee may have paid a lump-sum far in excess of what the patented invention is later shown to be worth in the marketplace.” Id. Thus, when parties attempt to use royalties paid under an existing lump sum agreement to prove what royalties would be under a hypothetical running royalty or vise versa, the very different economic considerations underlying each type of license must be considered and accounted for when “converting” from one type of license to the other.
[F] Effects on Royalty of Widespread Infringement Another issue that may influence the application of an established royalty is whether the supposed “established royalty” was artificially depressed by widespread infringement of the patent. For example, a higher figure may be awarded when the evidence clearly shows that widespread infringement made the established royalty artificially low. Nickson Industries, Inc. v. Rol Mfg. Co., 847 F.2d 795, 798 (Fed. Cir. 1988). This principle was applied in Tights, Inc. v. Kayser-Roth Corp., 442 F. Supp. 159, 162 (M.D.N.C. 1977). There, the court considered whether supposed widespread infringement artificially depressed the “established” royalty and necessitated an adjustment of that figure. In that case, the depression of the “established” royalty was detailed by the court: “[B]etween August 1, 1968 and October 16, 1968, the royalty rate decreased from $0.25 to a negotiated rate of $0.02. This Court finds that the $0.05 licenses with Hudson Hosiery and Hanes Corporation were negotiated by the plaintiff in the face of infringement occurring within the industry. Further, the first $0.02 license was negotiated on October 16, 1968 as a result of settlement of a suit against defendant involving the Rice patent. Subsequently, in rapid succession, the $0.05 licenses to Hudson Hosiery and Hanes Corporation were renegotiated to a $0.02 royalty rate. From this time until the patent expired, the record shows that approximately forty-five licenses having a $0.02 royalty rate were granted.” The court recognized that members of the hosiery industry were interested in the patent and that plaintiff was a fledgling corporation anxious to license the Rice patent: “This Court finds that the infringing activities within the hosiery industry prior to August 1968 influenced the market for the Rice patent. The result was an artificial depression of the royalty rate to $0.05 and then to $0.02. The Court further concludes that granting the first $0.02 license effectively limited future licensing negotiations to a $0.02 royalty rate. The
Analysis 49
continuation of the infringing activities between 1970 and 1975 by defendant indicates a disregard of the Rice patent within the industry. Factors of competition and economics placed plaintiff in an intractable position and forced upon plaintiff the depressed royalty rate. This Court finds that neither royalty rate of $0.05 or $0.02 represents a ‘reasonable rate’ which the statute, 35 USC § 284, sets as a minimum standard for damages flowing from infringement of a valid patent.”
4.05 Analysis Litigating the “established royalty” factor begins with understanding the market and its participants. Critical to understanding how to litigate this issue is an understanding of the patenting—and licensing—practices of the major participants in the market. Finding an established royalty in this context is very similar to finding the value of an asset or the market price of an item. When there is not a market for the patented technology at issue, there is simply insufficient data with which to determine that a royalty rate is “established.” Thus, the analysis begins by determining whether there are sufficient data points on which to base a reliable opinion that a particular royalty rate is “established.” Only in those cases where there is something approaching a “market price” for the patent—a market price that the accused infringer would be likely to accept in the hypothetical negotiation—will this factor overcome the other economic factors that the parties would consider. It is important that both parties examine this issue with great care, since courts and juries pay very close attention to this factor—if an established royalty is reliably proven, it is likely that this will be the reasonable royalty rate actually awarded. First, it is obvious from the case law that the “established royalty” at issue here bears no resemblance to any kind of “standard” royalty in the industry. Such “historical” royalty rates, often years, or even decades old, are completely meaningless in an economic sense and are used by lazy experts, lawyers, and courts to bypass the difficult analysis that is necessary to determine an appropriate reasonable royalty. For a plaintiff, to determine whether the reasonable royalty factor can even be useful, the plaintiff ’s patent portfolio and the plaintiff ’s licensing practices must be examined. If the plaintiff has never licensed the patent-in-suit, or any similar patent, this factor is unlikely to be applicable. If the plaintiff has only licensed the patent in the settlement of prior patent litigation, the court is also unlikely to approve the use of this factor. If the plaintiff has licensed other patents in its portfolio, but not the patent in suit or one similar to it, this data should be gathered, but it is unlikely that it will be sufficient to qualify under this factor.
50
Chapter 4 Finding the Price of the Patent
If the patentholder has licensed the patent-in-suit or a similar patent, the licenses should be examined to determine whether a reliable “price” for the patented technology can be extracted. If the patentholder has engaged in a licensing campaign for this patent, it is unlikely that the licensing executive or the company’s counsel will have been careful to establish a “price” for the patent. Usually, companies are more interested in raising money and obtaining a quick return on the research and development that went into developing the technology than holding to any economic niceties. Most often, the company will charge whatever it can get without the expense of bringing a lawsuit. Targets that are large and might make substantial use of the technology may not be forced to pay their “fair share” simply because the patentholder is unwilling or unable to finance a years-long litigation against that particular target and will simply take what it can get. The best situation for the plaintiff (at least usually the plaintiff) is one in which the patentholder has been able to consistently enter into licenses for a consistent running royalty with a sufficient number of market participants so that there can be said to be a “price” for a license for the patent rights. An even better situation is where there is evidence that the licensors recognize that there is some kind of “market” license rate for the patent and sign up for such a license at that rate without a substantial amount of negotiation. A less favorable situation, although still workable, is one in which the licensed rates are not the same for all parties but there is some rationale—other than simple bargaining power—for the differences in the rates, such as the way the patent was being used or the profitability of the licensed product. This measure at least would give an economist some data on which to base an opinion that the royalty was somehow “established.” Often, however, a patentholder will enter into a lump-sum license with a target. This benefits the patentholder in that it enables the company to raise a substantial amount of cash quickly and benefits the target by capping its liability and giving it the ability, usually for the remainder of the patent term, to actually use the patented technology in its own products without any further expenditure. The lump-sum process, however, makes it much harder to determine a reasonable running royalty, which is the measure most likely to be applied in patent cases. Where the patentholder’s efforts have procured a number of lump-sum, paid-up licenses of varying amounts with targets of varying sizes and with widely disparate uses for the technology, it may be difficult, but not impossible, for a plaintiff to tease out an established royalty from this data. This is particularly true in an instance where, as is common, the licensing campaign has been largely unsuccessful, with many targets simply ignoring the patentholder’s demands. Although, as seen above, some courts and juries have, in fact, determined that a “reasonable royalty” would include a lumpsum payment, this is still rather unusual and would probably work to the disadvantage of the plaintiff.
Analysis 51
A similar, although not as great, a problem, is one in which the patentholder has, in fact, entered into percentage royalty agreements but the percentages are not consistent—based not on the target’s business or products, its profitability, or its use of the patented technology but simply, as is common, on the bargaining power of the parties. Royalty rates that vary substantially from each other, without any discernable reason for doing so, will be difficult to fit into an “established” royalty analysis. Another factor, even where there are a substantial number of licenses with consistent percentage royalty rates, is the conduct of the actual negotiations between the patentholder and licensees or prospective licensees. When the patentholder has been able to easily obtain its desired royalty rate (usually the case where the patentholder is a large, intimidating player, such as IBM, who can obtain agreement from smaller companies simply by suggesting that the alternative to a license is a long and expensive lawsuit), it is easy to presume that the defendant would have also agreed to this rate in the hypothetical negotiation. However, when the patentholder has had trouble licensing its patents, with a substantial number of targets either rejecting the proffered license or simply ignoring the patentee’s inquiries, the extent to which a particular rate might be considered to be “established” may be called into question. This latter situation may, in fact, work to the benefit of the defendant, as in the Mobil case. If the defendant can live with the established royalty, but the plaintiff has gotten greedy in the litigation and has asked for much more, the defendant can argue that it should not have to pay more than the patentholder’s other licensees (and would not have done so in the hypothetical negotiation) and that, in fact, the plaintiff had been having trouble even procuring that level of royalty. This latter argument, although economically valid, does raise a recurring public policy question: Should an infringer that has forced the patentholder to file suit and to spend substantial legal fees to pursue the case not pay more than a party that voluntarily entered into a license? In fact, doesn’t this damages measure simply reward infringement? Perhaps it does, and this is a good argument that a plaintiff can use against restricting it to the established royalty. Another factor in the analysis is whether the plaintiff may include patents other than the patent-in-suit in proposing an established royalty. At least the Mobil court approves of this analysis, as long as the other licensed patents being considered are similar to the patent-in-suit (the “similarity” of the patents to be included obviously is a matter ultimately for the court). Patents of relatively the same scope and in the same family would be prime “similar” patents for inclusion—although, as a practical matter, it would be common |to include all of the patents within the same family in the same license in the first place. So, what other kinds of patents might be considered “similar” or “comparable?” The Mobil opinion does not say, although as an economic matter, the issue is certainly determinable. It would seem as though the patents
52 Chapter 4 Finding the Price of the Patent
would have to relate to the same basic technology and have a similar scope or a similar utility economically; that is, being able to practice the particular invention would give the user a similar economic advantage. From the defendant’s perspective, the decision of how to proceed will depend on the relative success of the plaintiff ’s licensing efforts. If these efforts have been fruitful, the plaintiff will usually try to obtain that same result as a reasonable royalty, and if there have been enough instances of successful licensing, its chances of obtaining that result in court are good. In this circumstance, for a defendant, any effort to prove that the royalty the plaintiff has actually been able to obtain from third parties is, in fact, higher than the amount that should be awarded in the litigation is difficult. However, this line of argument is not impossible if the defendant can show some defects in the plaintiff ’s logic. First, these licenses may be too few in number to justify considering the royalty obtained to be a “market” rate. Clearly, if the plaintiff has only been able to make two or three “sales,” the price the plaintiff may have obtained for its patent may not reliably reflect what these parties would have agreed to. Remember, as the Supreme Court held in Rude, an established royalty must be “paid by such a number of persons as to indicate a general acquiescence in its reasonableness by those who have occasion to use the invention.” Second, the licenses may too old or too infrequent to establish a “market price” at the time of the hypothetical negotiation. Licenses that were entered into five or six years ago or two or three years apart may not be reliable evidence of a consistent price for licensing the patents to justify imposing that price in the litigation at hand. Again, as the Supreme Court held in Rude, “[s] ales of licenses, made at periods years apart, will not establish any rule on the subject and determine the value of the patent.” As shown above, this is not an insuperable problem since, with sufficiently sophisticated analysis, rates for licenses distant in time and under different market conditions can be adjusted to the present day. Third, the license may have been to companies whose size and/or use for the patents was quite different that that of the defendant. For example, a relatively high royalty rate may have been paid by relatively small companies with limited bargaining power, whose licensing of the patent-in-suit was critical to their continued existence. That rate, however, may not be appropriate or applicable to a much larger defendant whose use of the patent was not that important as an economic matter and who could well have made the choice of using a different technology or forgoing the patented process or invention altogether. In this case, even where the royalty may have been “established” for one set of licensee, this defendant would have been unlikely to pay that rate in the hypothetical negotiation. Fourth, the defendant can make a good case that there is no established royalty or that an established royalty could not be discerned where all or most of the prior licenses are lump-sum licenses, especially where such licenses
Discovery
were granted to disparate kinds of companies. The nature of such licenses, in the absence of a provision setting forth the method by which the lump-sum had been calculated (if there was one) makes it almost impossible for anyone to reliably calculate an “established” running royalty. Fifth, where the plaintiff has introduced lump-sum licenses as evidence to support its claim for a particular running royalty rate (or vice versa), the defendant can dispute the methodology by which the expert “converts” one royalty rate to the other. Since the expert’s analysis will normally involve consideration and analysis of economic factors that the parties are unlikely to have taken into account, the plaintiff ’s use of such “different” licenses can be easily undermined—especially if the plaintiff ’s expert (like the plaintiff ’s expert in Lucent v. Gateway) has not taken care to find a sufficient basis to do such a conversion. Finally, as the Federal Circuit discussed extensively in Lucent v. Gateway and ResQNet, the defendant may argue that the licenses used by the plaintiff to support an established royalty are not for the patent itself and/or are too dissimilar to the patent to be useful. Although different courts have certainly applied this rule with various levels of rigor (Judge Rader in ResQNet requiring virtual identity between the licensed technology and the patent in suit), this is an important tool for any defendant to employ where, as often happens, a plaintiff will simply throw as many licenses as it can find (with high royalty rates) against the wall to see what sticks. Indeed, it may well be to the defendant’s advantage if it is able to show that the only “established” royalty is a lump-sum payment. This payment is likely to be substantially lower than the amount the plaintiff is seeking and is less likely to reflect the various economic considerations that would otherwise enter into the calculation of a reasonable royalty. Indeed, even if this lumpsum payment is not considered to be an established royalty, a defendant may well use it as a way to argue for a lower royalty than the plaintiff is seeking—at least in comparison.
4.06 Discovery If the royalty sought by the plaintiff far exceeds what the defendant could potentially establish as a “standard” royalty rate, the defendant has an incentive to establish that there is such a rate and that it is a low one. The plaintiff, clearly, is already in possession of virtually all of the information that could be used to prove an established royalty. The defendant would be well advised to do sufficient discovery to determine whether, as in Mobil, there is actually a relatively low “established” royalty that the plaintiff does not want to have revealed and what that royalty is.
53
54
Chapter 4 Finding the Price of the Patent
[A] Obtain Licensing Materials Conducting discovery to determine whether there is an established royalty is deceptively simple. For a defendant, the process begins, obviously, with obtaining all of the licenses entered into by the patentholder for the patent-in-suit. There may be some resistance by the plaintiff to producing these materials because of their sensitivity and confidentiality, but the real reason, in most cases, is that these licenses will show that the plaintiff has licensed its patent for far less than it is seeking in the lawsuit. Since there is no legitimate reason for not producing these documents, a defendant will eventually be able to obtain these documents, either voluntarily or through a motion to compel. A more interesting discovery issue will be obtaining information regarding the actual scope of these licenses, the applicable royalty rate (especially in the case of lump-sum licenses), and the circumstances under which they were entered into. This process may involve a more detailed examination of the plaintiff ’s business than many would normally consider necessary for this factor—an examination of how the patented invention is used, both by the patentholder and by licensees, and a comprehensive investigation as to the negotiations that led to the various patent licenses.
[B] Know the Patent’s Utility Obviously, one of the prime criteria for determining any royalty rate, even a “standard” royalty rate, is the economic advantage the patent gives the licensee—the benefit that unfettered use of the patented invention can give to that company. If the plaintiff actually uses the patented invention in its business, the defendant can gain some kind of perspective as to the worth of the invention to a prospective licensee, since that information may be difficult or expensive to obtain from licensees. Where the patented invention is a technology that is central to the plaintiff ’s business or critical to the operation of its products, the utility of the patent to the operations of a licensee (at least one that is in the same industry) should be fairly evident and easy to discern—without the patented invention, the product could not be sold or would have to be changed so extensively that it would either be unprofitable or would be unmarketable. If this is the case, however, it is unlikely that a patentholder who is actually a participant in the industry and, presumably, a competitor of these licensees, would have actually licensed its patent to enough of these companies for the royalty to be considered “established.” A more likely scenario is one in which the patented invention is an improvement that the patentholder may use in its business (perhaps to save costs) but that is (a) not critical to its operations and (b) valuable to competitors. The royalty would have to be set low enough to be attractive to licensees
Discovery
but high enough so that the money gained by licensing the patent is greater than the competitive advantage lost by giving the right to use the patented invention to a competitor. This appears to have been the case with the xylene isomerization process involved in the Mobil case, above. In some cases, as in Mobil, the royalty granted to licensees may well be uniform, and it will be easy for a defendant to prove that there was an “established” royalty at what it was. However, this rate may be harder to discern if the royalty rate was set based on other criteria, such as the revenue gains made by the licensee or its cost savings, or, in particular, if the patentholder and the licensee entered into a lump-sum royalty. Where the advantage to the defendant is substantial enough, however, this should not pose an insuperable obstacle, if the defendant is tenacious enough to gather enough facts.
[C] Economic/Market Models First, the defendant should obtain, first from the plaintiff and then, if necessary, from the licensees, the actual economic advantage gained by the use of the patent. Did the patent increase sales? Did it cut costs? Both? The plaintiff cannot reasonably try to avoid producing this information because, if there is little provable economic advantage to using the patented invention, this will affect the plaintiff ’s damages case with respect to many other Georgia-Pacific factors. This information may be more difficult to obtain from the patentholder’s licensees, because all such evidence will have to be subpoenaed. The information the defendant may be seeking will often be quite confidential and will probably be extensive, if the information is to be economically useful. Indeed, the defendant, if it is a participant in the industry, may be reluctant to subpoena this information, if the company either has a commercial relationship or hopes to have such a relationship in the future with the licensee. However, if the “worth” of the invention cannot be reliably obtained from the patentholder or if the royalty is a lump-sum, subpoenaing third parties may be the only method available to a defendant if it wishes to make a determination as to a “standard” royalty. Where the royalty rates for third parties vary or are lump-sum, a defendant should determine, for each licensee, what use the licensee is making of the patented technology. The defendant should obtain adequate information about the licensee’s operations that use the patented technology, both before and after the licensee started using the technology or entered into the license. Enough information should be gathered to determine what economic effect the use of the patented technology had on the operations of the licensee, either through increased production or profitability or decreased cost. Then, the defendant should attempt to determine the relationship between the
55
56 Chapter 4 Finding the Price of the Patent
benefit and the royalty paid by the licensee to get some kind of “baseline” for the effective royalty being paid by the licensee—this is particularly important, obviously, when the royalty is lump-sum. When the defendant has made this determination for all of the licensees, it should try, if possible, to determine whether there is sufficient commonality from the baseline royalty rates generated from the various licenses to establish any kind of “established” royalty rate that would be substantially lower than the rate being sought by the plaintiff. If any kind of economic case exists for an “established” royalty (even a generated one), the defendant should argue that, in the hypothetical negotiation, it would not have paid more than the effective rate being paid by everyone else. This analysis may also bear fruit even if the defendant is not able to prove that the plaintiff had an established royalty for its patents. In cases where the defendant has difficulty in proving that the plaintiff was licensing its patents on any kind of consistent basis, this will, in most cases, show a substantial softness in the demand for a license for the patented invention.
[D] Using Your Expert and Attacking Your Opponent’s As with most of the economic criteria relevant to proving damages, the most appropriate choice of expert, for both parties, would be an economist. This type of expert will be better able to make the determination as to whether a royalty rate is truly “established” as an economic matter. In addition, if there is a question of whether a particular rate is established, and the amount of that rate is more in question, such an expert will be able to regularize the rates that have been agreed to by the various licensees. Where the licenses at issue are lump-sum licenses, having an economist is invaluable in making any type of determination as to what the “effective” royalty rate is for the various licensees and the economic benefit gained by the various licensees. Putting together an “established” royalty in the absence of actual licenses that have the same rate may be a challenge for any party. However, it would likely be easier for a defendant to put this “established” rate across in the face of an excessive royalty demand by a plaintiff than for a plaintiff to essentially put together a “house of sticks” of licenses of various sizes and amounts. It will be easier for any expert to present an effective case on this point if the “established” royalty is expressed in terms of the “price” for the right to use the patented invention. The presentation the expert will make on this point will essentially be one of regularizing the various licenses that the plaintiff has made with various parties and determining a common “effective” price for the license rights. Attacking an opponent’s expert on the issue of an established royalty is fairly straightforward. Because the court-made rules on this issue are fairly strict, the most effective attack is to show that the plaintiff has not entered
Discovery
into enough licenses for the rate to be “established” and/or that the licenses the plaintiff has entered into were too remote in time from each other to show that there was any established price for the patent rights at issue. Another attack might be that, even though the licenses being proffered were not in settlement of a lawsuit, they were entered into under threat of litigation and did not represent a “market” negotiation similar to that in the hypothetical negotiation. If the defendant, and not the plaintiff, is attempting to establish a royalty rate, the plaintiff might also attempt to show that the various amounts of the royalties negotiated in these licenses were the product of the differences in bargaining power, and did not have any relationship to the utility of the patents or the economic use being made of them by the licensees. This, however, is a dangerous strategy, because it may very well lead the jury to believe that, as an economic matter, the patent is not very valuable. Such a tactic should only be used in the case where the defendant’s expert has put together a fairly strong case for an established royalty that is less than the plaintiff is seeking, where the licenses were obtained when the plaintiff had much less bargaining power (or against much larger licensees), and where these licenses do not reflect the true economic value of the patents with regard to this particular defendant.
[E] Particular Issues Where Plaintiff Is an NPE The issue of what constitutes an “established royalty” where the plaintiff is an NPE is an interesting question—especially for the NPE itself. Since the business of the NPE is licensing and since, in many cases, the NPE has established some kind of established royalty—or an least one that is based on certain characteristics of the target—should this “established royalty” be considered under Factor 1 as a consideration the parties would take into account in the hypothetical negotiation? The answer, for the NPE, would obviously be yes. It would argue that any royalty it has managed to establish through its negotiations with its licensees would represent the royalty it would demand—and get—in the hypothetical negotiation. In fact, it would argue that, since few of the other economic considerations that apply to plaintiffs who use their patents to compete in the marketplace apply to its business, there will be less variation in the royalty rates it negotiates with prospective licensees. For example, since the NPE is not adjusting its royalty demands based on whether licensing (or not licensing) its patent will affect its ability to compete with the licensee, the “established royalty” represents more of a “true” price for the patent rights. This argument will be strengthened if the NPE consistently licenses its patent rights for a uniform rate—or at a rate that is based on some consistent metric which can be made to fit any prospective licensee.
57
58
Chapter 4 Finding the Price of the Patent
For any prospective defendant, however, being required to pay the same royalty that the NPE has managed to obtain through a concerted licensing campaign will almost always represent a defeat on the damages front. The arguments against using this royalty as an “established” royalty are basically the same as those that generally preclude using royalties that are obtained through litigation or under threat of litigation—these royalties, which were obtained under duress, do not represent a true business negotiation and are tainted with litigation considerations (litigation costs and the prospect of an impending injunction) that parties to the hypothetical negotiation would not consider. The problem with the defendant’s analysis in this regard is that the business of the NPE is licensing under the threat of litigation (or, indeed, actual litigation). Unlike the traditional patent plaintiff, the NPE, especially where the NPE is a patent troll, has no other business that is not “tainted” by litigation considerations. Indeed, it is hard to imagine how the hypothetical negotiation could be imagined without taking these litigation considerations into account. The plaintiff ’s argument should be that the royalty rates it obtains do represent a “purer” price for the patent rights—because this royalty rate is unsullied by the economic effect that giving up the monopoly on the patent rights at issue would have on the plaintiff ’s ability to sell products. Certainly, the plaintiff would argue, if it has managed to license the patent rights at a consistent rate, this would itself indicate that such price is also unaffected by the defendant’s unique economic circumstances and would provide strong proof that the rate it had managed to obtain was “established.” A patent troll might also argue that the disruptive effect of litigation or the threat of litigation on the royalty rates could be accounted for by an economist, since, for the troll, this factor is present in every negotiation by definition. An economist, the troll would argue, could take into account the consistent effect of such litigation threats on the royalty rate obtained and could then come up with a “litigation free” rate that could be used to satisfy the “established royalty” factor. It would be inequitable, the troll would argue, to preclude the jury from giving any consideration to the “established royalty” it had obtained through hard negotiation, simply because it was obtained through threat of litigation. This factor, the troll would further argue, represents a real economic factor that should be taken into account in setting a reasonable royalty.
CHAP T ER
5 Gauging the Infringer’s Price Range Licensing-In Practices Factor 2: The rates paid by the licensee for the use of other patents comparable to the patent-in-suit.
5.01 Relevance and Application
59
5.02 Analysis
62
[A] Determining the Type of Patented Technology
63
[1] Core Technology
63
[2] Peripheral Technology
63
[B] Is the Patented Technology Essential to the Product?
63
[C] Defendant’s Strategy
64
5.03 Discovery and Using Your Expert (and Attacking Your Opponent’s)
65
5.01 Relevance and Application The rates actually paid by the hypothetical licensee for other intellectual property has historically been given very little weight by the courts although, other than a lack of data, there would appear to be little reason not to give this factor as much weight as that of an established royalty. The positions the parties would have been likely to take in the hypothetical negotiation are highly relevant. If the information is available, it is very important to know for how much the patentholder would have likely licensed its patent—what the patentholder expected to receive as a return on its investment in obtaining patent rights. Likewise, if the accused infringer has licensed intellectual property similar to that at issue in the case or for similar purposes, this may at least establish a ceiling for the defendant’s willingness to invest more money in licensing the plaintiff ’s patent, rather than simply forgoing use of the technology altogether or working around it. This factor—the defendant’s licensing practices—is most often employed by analyzing not the licensing activities of the individual defendant but rather 59
60 Chapter 5 Gauging the Infringer’s Price Range
those of its industry. This situation was presented in Mobil, where Mobil argued that this factor did not apply because Amoco did not offer any evidence of the rates Amoco paid for other patents that were comparable to those infringed. The court in that case “interpret[ed] this factor broadly to include rates for other technology available to produce” the product at issue. Another good example is P&G v. Paragon Trade Brands, 989 F. Supp. 547 (D. Del. 1997). In that case, which involved patents for making disposable diapers, the court also employed the factor of licensing rates to analyze the “licensing customs of the industry.” As the court noted, “this factor presumes that a willing licensor and licensee would be guided to some degree by the royalty rates and bases of licenses on comparable patents in the industry” but noted that “courts rarely give this factor decisive or substantial weight due the generally unique character of each patented invention.” The court found these licenses, however, to be of limited utility because there was little similarity between the hypothetical license involved in the litigation and other patent licenses in the disposable diaper industry. Such similarities are obviously important to determining a market rate on which the parties would have agreed. First, the court noted that most of the industry’s licenses which were between competitors (like the parties to the litigation) were cross-licenses or were litigation settlements—both of which are of limited utility in determining a market rate. Many of the remaining licenses were between P&G and individuals or corporations not involved in the manufacture or sale of disposable diapers and were therefore not sufficiently comparable to be of use in the analysis. Indeed, there was testimony that, unlike these agreements, licenses between competitors “can be expensive” and “when negotiations are between competitors a relatively high royalty rate can result.” In fact, the court found only one license that was sufficiently reliable to take into account—one that, while not between competitors, allowed the licensee to sell the invention to a competitor. In Bose Corp. v. JBL, Inc., 112 F. Supp. 2d 138, 166 (D. Mass. 2000), JBL introduced evidence regarding the licensing practices of a third party, Dolby Digital Electronics, a company that commonly licenses its “surround sound” decoding technology and “signal noise reduction” technology to various loudspeaker companies to show that the licensing practices of the industry were relatively low—approximately 50 cents, or less, per unit. However, as the court noted, unlike Bose, Dolby does not manufacture speakers, is not a competitor to the speaker companies themselves, and essentially makes its business by licensing its technology. The court found, therefore, that the Dolby licensing practices and rates were not comparable for purposes of a royalty analysis here. In Schneider (Eur.) AG v. SciMed Life Sys., 852 F. Supp. 813, 848 (D. Minn. 1994), SciMed presented evidence of the royalty rates it had paid to license what it claimed were comparable patents. Although these licenses were agreed
Relevance and Application 61
to in settlement of litigation, a factor that the court noted “detracts from their usefulness in arriving at a royalty rate in this case,” the court used these rates as a reality check on the royalty rates the defendant claimed were reasonable for a recovery in the case at hand. Similarly, in H.B. Fuller Co. v. National Starch & Chemical Corp., 689 F. Supp. 923, 950 (D. Minn. 1988), involving a patent for a disposable diaper adhesive, the court also used a prior litigation settlement as a point of reference for the reasonable royalty award. Interestingly, in that case, this comparable license was used both as a check on the royalty rate and on the royalty base. In that case, National, the patentholder, had argued for a reasonable royalty rate of 2.5 percent of the diaper sales made by the infringer’s customer, while Fuller argued that the royalty should be 3–4 percent of the revenue from the sales of the infringing adhesive. To determine both issues, the court looked at the parties’ licensing of what both parties agreed was a similar patent—the Collins patent. Prior to the instant lawsuit, Fuller and National were involved in litigation over the Collins patent. In that suit, Fuller sought damages for infringement while National challenged the validity of the Collins patent. The lawsuit involving the Collins patent ended in 1985 in a settlement between the parties. As a condition of that settlement, Fuller sold the Collins patent to a patent management firm, Hilliard-Lyons, which in turn issued licenses to both Fuller and National. Under the terms of those licenses, Fuller and National each agreed to pay a royalty of 5.5 percent of the net sales price of the claimed hot melt adhesive. The rough similarity between the Collins patent settlement and the case at bar suggests that the 5.5 percent royalty rate is probative of a reasonable royalty rate here. Yet because the Collins settlement terms embodied not only business judgment regarding the value of the Collins patent but also compromised claims of infringement and invalidity, the settlement royalty rate is not definitive evidence of the proper royalty here. Nonetheless, the Collins royalty agreements provide some evidence of a reasonable royalty.
This factor has been little used, primarily because of the lack of available and relevant data. However this need not be the case; with the proper research, discovery, and analysis, this factor can be a valuable component of the hypothetical negotiation analysis. One of the most prominent recent opinions dealing with this factor is the Federal Circuit’s decision in Lucent v. Gateway, 580 F.3d 1301 (Fed. Cir. 2009) where the analysis of the “established royalty” related almost completely to the in-licensing practices of Microsoft. In that case, the Federal Circuit emphasized that the considerations determining which licenses to use and how much weight to give them was the same under Factor 1 and Factor 2—the licenses proffered by a party to support an argument that there is some kind
62 Chapter 5 Gauging the Infringer’s Price Range
of stable royalty or that a defendant would be willing to license patents at a particular rate must involve similar technology to that covered by the patents actually at issue in the case.
5.02 Analysis The licensing factor is basically the flip side of the first Georgia-Pacific factor. Instead of measuring the price at which the seller/patentholder is willing to charge for the patent rights at issue, this factor measures the willingness and ability of the customer—the accused infringer—to pay for those patent rights. The specific issue here is the price the accused infringer would normally pay for patent rights of the type at issue in the litigation. As the courts have interpreted this factor, consideration is also given to the price that has been paid by other companies who are similar to the accused infringer for comparable patent rights. The first place to look as to the applicability of the licensing rate will obviously be the defendant itself. Does the defendant “license-in” any patents or other intellectual property? If so, what are the terms and scope of such licenses? Are they broad cross-licenses? Does the defendant enter into lumpsum licenses or ones that call for a running royalty? If the latter, is there a “standard” royalty that the defendant normally pays? Another important factor is the type of technology the defendant chooses to license-in and the use that it makes of this licensed-in technology. Does the defendant primarily develop its own technology based on its own research and development, or does it acquire its technology from others? Does the defendant make a practice of licensing-in core technology (which may come at a high rate), or does it develop such core technology on its own, only licensing-in peripheral technologies (e.g., “interface” or “standards” technologies that would allow its products to work with or connect to other products)? What percentage of the defendant’s profits has the company been willing to devote to paying license fees? And, for all of these relationships, are the other patents the defendant is licensing-in “comparable” to the patents-in-suit (although this factor is less important than it might appear)? The first issue, then, is whether the defendant has ever licensed-in any patents at all. If it has not, the consideration of this factor is essentially at an end. If the defendant has licensed-in patents, the crucial questions are why does it license other company’s technology rather than develop such technology itself, and how “core” is that technology to its business? And, what is the relationship between these patents and the patents that are the subject of the lawsuit? Some defendants may simply not be innovators in developing the technology on which their products are based—their talents may lie in integrating
Analysis 63
the technologies or packaging the innovations made by others into a product that can actually be sold. Their expertise may be, not in the engineering development, but in accurately gauging consumer needs and integrating innovations, where others did not. In order to develop its product, the accused infringer will have to have somehow acquired, by license or otherwise, the intellectual property rights to the technologies it is integrating. The price the defendant is willing to pay to acquire the rights to these technologies in comparison to the use it is making of these rights and the profit it is deriving from such use is highly relevant to determining what price the defendant would have been willing to pay for the patentholder’s rights in the hypothetical negotiation.
[A] Determining the Type of Patented Technology [1] Core Technology For example, if the defendant is willing to pay a relatively high price to acquire a core technology and is also willing to devote a substantial portion of its profit (or substantially raise its price) to do so, this is a strong indication that if the plaintiff ’s rights are also critical to the defendant’s ability to sell its product, the defendant would have been willing to pay a relatively high royalty for the privilege of using such rights. An objective measure of how much a defendant might be willing to pay could be the percentage of the price of the product that represented the license fees paid to others. [2] Peripheral Technology Conversely, if the defendant does not make a practice of licensing-in core technologies but, for example, develops such technology itself and chooses to license-in peripheral technologies (for which there are alternatives, or that are not critical to the operation of the product) at a much lower price, this would also be a clear indication that if the technology at issue is equally peripheral, the reasonable royalty rate for the patent-in-suit would be comparably low.
[B] Is the Patented Technology Essential to the Product? Another wrinkle in this analysis is where the defendant’s “licensing-in” is primarily or solely restricted to “essential” standards patents, which may be required for the operation or sale of the defendant’s products. The economic worth of such “essential” standards patents is obviously skewed by the requirement that all market participants take a license to such patents, whatever their actual utility in their products, simply because they are essential.
64 Chapter 5 Gauging the Infringer’s Price Range
Although the particular economic factors relating to standards patents will be dealt with elsewhere in this work, the important factor here is that the defendant’s willingness to pay to license an essential standards patent may have little or no relationship to the amount that defendant might have been willing to pay the plaintiff in this litigation to license the particular (nonstandards) patent at issue in the litigation at hand. This is particularly true where the standards patent is part of a “package license” administered by a group such as MPEG-LA.
[C] Defendant’s Strategy The analysis the defendant needs to perform, then, is to marshal the facts to show one or more of the following: (1) The defendant does not license-in patents comparable to those involved in the lawsuit. (2) The defendant does not make it a practice to pay a substantial percentage of its profits or of the price of the product at issue to license-in technology that is used in that product; (3) Even if the defendant does pay a substantial amount to license-in some patents, these high royalty rates are anomalous and are restricted to patents that are either “core” to the defendant’s products or are standards patents that are critical to enable the defendant’s products to be sold in the marketplace or to interact with other products. It would also be useful for a defendant to show that its competitors have similar licensing in practices. Clearly, the direction the defendant chooses to jump in this regard will depend on the comparability of the patents it has historically licensed-in and the patents-in-suit in relationship to the rates at which the defendant has, in fact, licensed in patent rights. If the defendant has historically paid a low price to license-in patents, its best tactic is to show a substantial similarity between such patents and the patents-in-suit. If the defendant has historically paid a premium in this regard, it will want to show the greatest dissimilarity possible between these patents and the patents it has licensed from others to incorporate into its own products. If the defendant has paid a relatively modest amount to license such patents, the defendant will want to show the greatest possible similarity between these licensed-in patents and the ones on which it is being sued. If there is no real relationship between the licensed-in patents and the ones at issue in the lawsuit, the defendant will want to emphasize, if it can, that it has refused to pay more than a modest amount to license-in patents, even if those patents are critical to its products—choosing, rather, to “work around” those patents or develop the technology itself.
Discovery and Using Your Expert (and Attacking Your Opponent’s)
A history of successfully negotiating a license agreement with a wellfunded opponent is also useful for defendants to demonstrate. Where a large player (such as GE or IBM) has attempted to intimidate the defendant into entering into a license based on an questionably applicable patent portfolio, it is useful for a defendant, if possible, to be able to show that it stood up to this licensor and negotiated a much more reasonable royalty than was originally offered—especially if the defendant can show that it got a better deal from this powerful licensor than its competitors. The plaintiff ’s analysis of the defendant’s licensing activities, of course, is intended to show that, based on its past practices, the defendant would have been willing to pay a relatively high price (or a high percentage of its profits or the price of the product at issue) for the patent rights under consideration. Showing that the defendant often licenses-in any technologies—or that others in its industry do—may go far to show that the defendant would have been willing to license the plaintiffs technology at a substantial rate. A showing that the defendant makes a practice of licensing core technologies or must license technologies that enable its product to work with other products may also serve to demonstrate the defendant’s practices in this regard. In terms of comparability, the plaintiff ’s tactics will, obviously, be dictated by whether the defendant’s other licensed-in patents bear a high or low royalty rate. The higher the rate, the more comparable the plaintiff will want to show these patents are to the patent-in-suit. If the other licensed-in patents bear a low royalty rate, the plaintiff will argue that these other patents are merely peripheral to the defendant’s business—unlike the plaintiff ’s patents, which, it will argue, go to the very ability of the defendant to compete.
5.03 Discovery and Using Your Expert (and Attacking Your Opponent’s) The discovery on this issue will primarily be done by plaintiff. It will need to make sure that it asks for and obtains all of the license agreements the defendant has entered into as licensor—however minor. The plaintiff should not restrict itself to asking for patent licenses but should ask for all licenses relating to intellectual property. The plaintiff should also ask for the correspondence showing the negotiation of such licenses, because this may reveal a bargaining position with respect to those licenses that is different than would have existed in the hypothetical negotiation between the plaintiff and defendant. If the defendant does not have a history of licensing-in, or if the history it does have is inconsistent or inconclusive, and if there is enough money involved in the case, both parties might consider taking discovery from third parties that are in a similar competitive position as defendants, for the purpose of determining their practices with regard to licensing-in patent rights
65
66 Chapter 5 Gauging the Infringer’s Price Range
comparable to those offered by the plaintiff. This discovery might be particularly fruitful with regard to standards patents (or claimed standards patents) because there will be a more substantial “customer base” of licensees for these patents. This type of analysis, however, is more likely to assist defendants in showing that comparably situated parties would be likely to agree to modest royalties because of the rules of most standards bodies that patentholders are required to license such patents on “fair, reasonable and non-discriminatory” rates. Where a party asserting standards patents is asking for excessive rates, any license is more likely than not going to be the product of litigation, which, as noted above, is not applied to the issue of reasonable royalty. An expert’s task with regard to examining the defendant’s licensing practices is very similar to the procedures employed in determining whether there is an “established” royalty for the patent-in-suit. The data on which the expert will rely are the licenses that the defendant has actually entered into, the use to which it puts those intellectual property rights, the money it makes from those rights, and how much it pays for them, in relation to the cost of obtaining those rights. Essentially, the expert is determining the price the defendant is normally willing to pay for “goods” of this type for the purpose of estimating what this defendant would have been willing to pay, in the hypothetical negotiation, for the right to license the patent-in-suit. Where the defendant licenses-in through lump-sum licenses, the expert will, as in the case of determining an established royalty, be required to determine a running royalty rate based on this lump-sum and based on the use the defendant actually made of these other lump-sum licenses. Attacking the other side’s expert is also relatively straightforward. An attack on the reliability of the expert’s “price” figure will concentrate primarily on showing that the other patents the defendant has licensed-in have little or no comparability to the patent-in-suit and that the prices the defendant paid for those rights are simply irrelevant. Where lump-sum licenses are involved, the expert may be attacked for his conversion of such licenses to running royalty and, indeed, for using such licenses at all in this analysis.
CHAP T ER
6 Keeping It Exclusive How Valuable Is That License? Factor 3: The nature and scope of the license as exclusive or non-exclusive, or as restricted or non-restricted in terms of territory or with respect to whom the manufactured product may be sold.
6.01 Relevance and Application
67
6.02 Analysis
69
[A] Who Makes (and How to Make) the Exclusive License Argument
70
[B] Defendant’s Strategy
71
6.03 Discovery
72
[A] Use Your Economic Experts
73
[B] If the Plaintiff Is an NPE
73
6.01 Relevance and Application The third Georgia-Pacific factor relates not to the economics of the relationship between the parties or the market value of the patent but rather to what “product” is being offered in the hypothetical negotiation. Although both of these factors are highly relevant as to whether the license that the fact finder decides the parties would have entered into would have been exclusive or non-exclusive, the way this factor plays out is highly dependent on the very different nature of these two different licenses. Indeed, an exclusive patent license is not much different than owning the patent itself. Exclusive licensees of a patent have standing to sue for infringement on the theory that they have virtually an ownership interest in the patent. They partake in the economic monopoly given to a patentholder of being given the right to exclude all others in the market from using the claimed invention—often, in fact, even the patentholder is contractually barred from practicing the patent. 67
68 Chapter 6 Keeping It Exclusive
Accordingly, an exclusive license is normally viewed as being more to the advantage of the licensee—which acquires rights that benefit it over its rivals—than to the licensor that is thereby restricted from granting patent rights to anyone else. Thus, if the court finds that, in the hypothetical negotiation, the patentholder would actually have granted an exclusive license, the royalty rate must appropriately reward the patentee for giving up these other opportunities. Exclusive patent rights are also often granted in relatively concentrated industries, where there are few players, by someone outside the industry— perhaps a patentee who cannot make money from its patent rights. If the patentholder licenses a valuable patent right to just one of these players— a right that would give that company an advantage over its rivals—the patentholder may make more money from that exclusive license than from giving a non-exclusive license to all of those companies to incorporate the invention in either products. One of the market participants may be willing to pay a premium price for the license, not just so that that company can use the patented invention but to be able to claim in the marketplace that it is the only company whose products have this advantage. For whatever reason, the distinction between exclusive and non-exclusive licenses has not been the subject of much judicial analysis. The court, however, did consider the issue in Penda Corp. v. United States, 29 Fed. Cl. 533 (Ct. Cl. 1993), which involved the alleged infringement by the U.S. Postal Service of the plaintiff ’s patent on plastic pallets that it had acquired from a third-party vendor. The plaintiff claimed that it should be compensated at the rate that would be demanded for an exclusive license to the patent. Although the parties agreed that an exclusive license would command a premium rate, they profoundly disagreed that the royalty in this case should be analyzed as though it was an exclusive license. The plaintiff ’s expert testified that “as a rule of thumb in the licensing community, an exclusive license is worth two times a nonexclusive license because the grantor of an exclusive license assumes the obligation to exclude all others, to protect the licensee, and to preserve the licensee’s right to practice that invention.” The defendants’ expert agreed that “a promise of exclusivity may double the value of a license, but maintained that the license here being valued was not exclusive. Under a nonexclusive license, the licensor grants only a bare right to work the patent, but gives the licensee no market control.” The court, finally, agreed that the hypothetical license would not have been exclusive because there was no indication that the plaintiff would have performed other obligations normally associated with an exclusive license, such as undertaking to defend the licensee’s interest against others. Indeed, given that the U.S. government was the actual defendant in this case—pending in the Court of Claims—it was unlikely that the hypothetical license at issue would be found to be exclusive since, as the court noted,
Analysis 69
the U.S. government is granted, under the doctrine of eminent domain, a non-exclusive right to any patent it uses and pays the appropriate license fee as a “taking.” Likewise, in Ziggity Systems, Inc. v. Val Watering Systems, 769 F. Supp. 752, 826 (E.D. Pa. 1990), involving a patent on a watering system for poultry, the court took into account the type of license the parties would have entered into in the hypothetical negotiation in setting the reasonable royalty. “Because [the plaintiff] Ziggity is an actual competitor with no plans to leave the market, the license that it would grant would be non-exclusive. Normally, non-exclusive licenses have less value than exclusive licenses. However, in this case, since Ziggity is the only other manufacturer and seller of the patented device, a non-exclusive license would still have considerable value in allowing defendants to retain their nearly 30 percent market share. Furthermore, the license would most likely not be restricted in terms of territory and types of customers.”
6.02 Analysis The weight that this factor of exclusion or restriction should be given in the Georgia-Pacific analysis has a great deal to do with the business the plaintiff is in, the business the defendant is in, and their competitive position vis-à-vis each other. In some manner this factor measures the strength of the competition between the parties, but it also has a great deal to do with the value of the monopoly the patent provides to both the plaintiff and defendant and, indeed, even the perceived value that this monopoly provides in the marketplace. Indeed, this is one of the few Georgia-Pacific economic factors that can profitably be used by an NPE. As the courts have recognized, an exclusive license to a patent is the equivalent of actually owning that patent. The exclusive licensee, especially one whose license is not delimited by territory or other scope of use restrictions, has the same monopoly the owner of the patent has—the exclusive right to use the patent at issue and the right to exclude others from using it. Indeed, in some cases, an exclusive licensee has the right to sue for patent infringement on its own, to protect those valuable rights. An exclusive license, therefore, is not something that is granted lightly— or cheaply. An exclusive license to a valuable patent that would provide a competitive advantage in the marketplace would normally fetch a high royalty in the hypothetical negotiation or otherwise. If a plaintiff can convince a jury that it would have granted this particular defendant an exclusive license, rather than a non-exclusive license, it can justify a quite substantial damages award. The question at issue, then, is when can a plaintiff convincingly argue that in this particular case, it would have granted this particular defendant an
70
Chapter 6 Keeping It Exclusive
exclusive license? The answer to this question depends to a large part on the plaintiff itself and its position, if any, in the marketplace.
[A] Who Makes (and How to Make) the Exclusive License Argument A plaintiff who can most successfully make the argument that in the hypothetical negotiation it would have essentially bargained its patent rights away is either an individual or an NPE. As the Ziggity Systems court recognized, a patentholder that is a competitor selling products in the marketplace will not grant an exclusive license to its competitor. In contrast, a plaintiff that does not actually practice the patent itself or use the patent in its business would not suffer any competitive harm from essentially selling its patent, since it does not use or need the patent; its business model is, of course, making money from other businesses that do (use (or want to use) the patented technology in their businesses. This plaintiff would have to make a business decision as to whether it would be better off financially by licensing the patent to one party for a large amount of money or to a number of market participants for a lesser amount per licensee, but where the license amount, in toto, may be higher. This analysis will be driven by the nature of the competitive marketplace in which the patented invention would be useful. Would the patented invention give one market player a substantial advantage over its competitors? Would one competitor pay the plaintiff extra to keep the technology out of the hands of its rivals? Would licensing this technology exclusively enable one competitor to substantially increase its market share? Or its prices? Would there be a particular advantage in the marketplace for one company to be able to advertise that it was the only company that had the right to use this patented feature? Here is an example of this: The inventor, Dr. Engine, has invented an improvement for a snowmobile engine that will make the snowmobiles not only run quieter and more reliably but also make them more environmentally friendly. There is also evidence that consumers will pay 15 percent more for a snowmobile that has this feature over one that does not. There are, at the time of the hypothetical negotiation, four companies in the snowmobile industry: Flake, Inc., Drift Corp., Shovel Co., and Plow, Ltd. Plow is the only infringer, and during the course of its infringement has advertised not only that it had the infringing feature but also has emphasized that it was the only snowmobile manufacturer to have this feature. A good argument could be made that, in the hypothetical negotiation, the parties would have agreed to an exclusive license rather than a non-exclusive license. Dr. Engine would have been able to demand a premium price from Plow for providing his valuable improvement exclusively to that company. Plow would also be willing to pay substantially more in royalties to keep this
Analysis 71
improvement from its rivals and be able to charge consumers a premium price for its snowmobiles. This market strategy would be confirmed by Plow’s later trumpeting of its ability to offer this infringing feature and to thereby charge more than its rivals. Another important factor would be whether Dr. Engine would be able to charge more for one exclusive license than for four non-exclusive licenses. If the analysis showed that this feature was that valuable for one company to practice exclusively, then the court will likely find that the parties would have entered into an exclusive license. Another factor that may be convincing in this analysis is the plaintiff ’s previous licensing strategy, if any. If the plaintiff has made it a practice to shop these patent rights around and has offered (even unsuccessfully) non-exclusive licenses to other companies in the marketplace, it is much less likely that it will be able to convince a jury that, in this case, it would have departed from that practice to license this patent to this particular defendant exclusively. A different result may be obtained, however, where the market is concentrated and the plaintiff has tried to market the patent exclusively (albeit unsuccessfully) to the market participants—even including the present defendant. This practice provides a real-world confirmation that this rational patentholder would have “held out” for the big money and chosen to maximize its return through benefiting just one of the market players. Again, it is more likely that the plaintiff will successfully be able to argue that it would have granted an expensive exclusive license rather than a cheaper non-exclusive license where the market in which the patented invention would be beneficial is concentrated. In such a case, it is more likely that one participant would choose to invest in obtaining these patent rights where it is more likely to see an increase in its market share and/or prices as a result of being able to use these rights exclusively. This situation creates a competitive advantage that will, presumably, enable one party to afford the steep price that the plaintiff would have charged for these rights. Thus, the factors that will maximize the chances of convincing a jury that the plaintiff would have granted a high-priced exclusive license rather than a low-cost non-exclusive one are (1) a plaintiff that is not actually using this patented technology in its own business; and (2) a relatively concentrated “target” marketplace where having the exclusive right to this particular patented technology will actually pay off for the defendant. This strategy will, of course, dovetail with the plaintiff ’s overall damages strategy of convincing the fact finder that its technology is extremely valuable.
[B] Defendant’s Strategy The defendant’s strategy here is to devalue not only the technology itself but also the claimed advantage the exclusive use of this technology would give to
72
Chapter 6 Keeping It Exclusive
a market participant. For example, if infringement of the patent is widespread in the marketplace—with essentially everyone in the market already arguably using this feature—obtaining an exclusive license to the technology would not be worth it for an individual defendant. Since that defendant would not be able to claim that it was the only market player with access to this technology, it would then have to sue the rest of the players in the market to gain this patent monopoly—not an attractive prospect. A defendant could also argue that having the sole right to use this particular feature, although useful (say, for decreasing costs), would not present enough of a competitive advantage to warrant paying the vastly increased costs of obtaining the exclusive right to use the technology. This defendant might show that its particular competitive advantage over its rivals was based on some other aspect of its product that would not be advantaged by being the sole user of this technology. A defendant might also point to the lack of competitive advantage given it (or other market participants) by having the exclusive use of some similar feature—or even show that its infringement of the patent (if it is the only such offender) has not enabled it to increase its market share or its prices.
6.03 Discovery Discovery regarding this factor will normally be conducted by the plaintiff of the defendant and will serve the purpose of showing that an excusive license would benefit the defendant more than a non-exclusive license, what effect such a license would have had on the defendant’s business, and the profit the defendant would have made in taking an exclusive license. Another relevant factor would, of course, be whether the defendant makes it a practice to license patents exclusively—discovery that would have been conducted in support of Factor 2. Information that the plaintiff will need to advance this analysis will be the benefit the defendant gained by infringing the patent in the first place. Did infringement cause the defendant to increase its market share? Increase its prices? Increase its prices more than its competitors would have been able to? The greater the competitive benefit gained by the defendant, the stronger will be the argument that it would have paid the price to be the only one in the marketplace with the right to use the plaintiff ’s invention. This factor requires (as do many other factors) a close scrutiny of the defendant’s sales and pricing of products that utilize the patented invention. Where the invention involves just one component or aspect of the infringing product, teasing out the competitive benefit of the patented invention itself may be more complex, but on the discovery front it is important for the plaintiff to know as much as possible about the sales and pricing of any products
Discovery
that use the patented invention, as well as similar products that do not. The ability to show extremely high profitability associated with the infringing product, if that profitability can be associated with the patented feature, will go far to justify the high royalties associated with exclusive licenses. The plaintiff will also need to fully explore the promotion of the infringing product by the defendant. The defendant’s promotion of the aspect of the infringing product that is covered by the patent—especially if the defendant promotes that it is the “only” one in the market that has this feature—will support the plaintiff ’s argument that the defendant would have exclusively licensed the patent. For the defendant, discovery that would show that it would have licensed the patent non-exclusively is much simpler, because most of the relevant analysis will come from its own files. The most convincing reason that would justify a finding that the plaintiff would have licensed the patent non-exclusively is, of course, that the plaintiff is already using the plaintiff in its own product. Granting an exclusive license to the defendant would normally prohibit the patentholder from using the patent itself—a party willing to pay the necessary price for an exclusive license would not wish to leave the plaintiff as a competitor in the marketplace. If the plaintiff ’s business is such that it would suffer competitive injury if it was forced to stop selling its products that used the patented feature or was forced to eliminate that feature from its products, it is unlikely that the plaintiff would be willing to grant an exclusive license. Additionally, a showing that there are multiple players in the marketplace who are also arguably infringers may also serve to reduce the probability that the license granted in the hypothetical negotiation would be held to be exclusive.
[A] Use Your Economic Experts The presentation relevant to this factor is similar to many of the other “economic” Georgia-Pacific factors—the expert must be prepared to do a market study analyzing the defendant’s use of the patented invention, what profit is made from using the invention, and what competitive injury would be sustained if the defendant was not able to use it. The additional analysis necessary for this factor is to further analyze what the benefit would be to the defendant if it was the only competitor permitted to use this feature and to construct a hypothetical market based on that assumption.
[B] If the Plaintiff Is an NPE This factor of exclusivity is, in fact, almost perfect for an NPE to use to dramatically increase the reasonable royalty—especially if the defendant is
73
74 Chapter 6 Keeping It Exclusive
the first “target.” Since the plaintiff does not, by definition, use the invention itself, it will suffer no competitive injury by giving the exclusive right to use the invention to one of the market participants that do manufacture and sell products. The only real question is whether the exclusive royalty rate exceeds the total of the potential non-exclusive royalty rates. This question, obviously, is dependent on the amount one infringer could make by having a monopoly on this feature. An interesting question is whether an NPE plaintiff could pull this argument off more than once—could a plaintiff argue convincingly in multiple cases that in each case’s hypothetical negotiation, it would have granted (and the infringer would have taken) an exclusive license? Although theoretically, such an argument could be made, it would be a hard sell to the fact finder that a patent troll plaintiff that had already either licensed the patent in a settlement or obtained a verdict and damages award would have granted an exclusive license in the case at bar—even though there is no theoretical reason that, at the time the defendant started infringing, it might not have entered into such an agreement.
CHAP T ER
7 Keeping It to Yourself The Hypothetical Negotiation Where the Seller Does Not Want to Sell Factor 4: The licensor’s established policy and marketing program to maintain its patent monopoly by not licensing others to use the invention or by granting licenses under special conditions designed to preserve that monopoly.
7.01 Relevance and Application
75
[A] Sample Scenario: Tiny Motors Corporation
76
[B] Establishing Historical Practices
77
7.02 Analysis
79
7.03 Discovery and Using Your Experts
80
7.01 Relevance and Application The factor of the patentholder’s preference not to license its invention takes into account the basic economic principle of supply and demand and, in some respects, dovetails with the previous factor. As the court noted in Super Sack Mfg. Corp. v. Bulk-Pack, 1992 U.S. Dist. LEXIS 22500 (E.D. Tex. 1992), “[p]laintiff’s established policy of not licensing the patents at the time of infringement would tend to raise the reasonable royalty because a licensee would own a more scarce and valuable item than if the patent had been licensed to many entities.” Where the patentholder—who, obviously, for this factor to apply, must actually use the patent in its own products—historically has not licensed its patent so that it may maintain its monopoly on using the invention, it would be very resistant, in the hypothetical negotiation, to granting a license to the accused infringer for any purpose. The patentholder would be primarily interested in preserving its valuable monopoly to maintain its competitive
75
76 Chapter 7 Keeping It to Yourself
edge, rather than losing this advantage and compensating itself by means of generating license fees. This factor, in fact, emphasizes the monopoly nature of a patent and its power to exclude. The greater the resistance of the patentholder to licensing its patent for competitive reasons, the higher the reasonable royalty rate. The patentholder, of course, must be prepared to meet the accusation that the reason that the patent has not been licensed is that it is so worthless that no one wants to license it.
[A] Sample Scenario: Tiny Motors Corporation Suppose Tiny Motors Corporation has advanced the technology of small industrial motors by coming up with an especially small model that it is able to sell for double the price of its competitors. Its patent directly relates to its ability to achieve the same or better performance in a smaller package—a feature that is very valuable to its customers. Tiny Motors, in fact, has developed a niche market for its small motors, but it is a small startup, and will easily be overrun by its large competitors if it allows them to compete using its invention. It also has made the business decision that, despite the size of its competitors and the money it could gain by licensing its patent, it will make more money in the long run by refusing to license its patent to anyone and maintain its monopoly in its niche market. In this way, it figures, it will be able to build the company through selling products rather than selling intellectual property. This business strategy and its refusal to license its patent is well documented and is undisputed. As an economic matter, this refusal will markedly increase the value of the patent in the hypothetical negotiation in which the patent holder must “license” the patent whether it wants to or not. If Tiny Motors was forced to license its patent to a larger company—whether a competitor or not—it would demand a very high royalty in exchange for doing so. A similar situation was presented in Novozymes A/S v. Genencor Int’l, Inc., 474 F. Supp. 2d 592 (D. Del. 2007). In that case, the plaintiff, Novozymes, held patents on enzymes that are used in the production of fuel ethanol and had a “general policy of not licensing what it considers ‘core technology’ outside of its corporate family.” The company defined “core technology” as “business interests in which Novozymes has a strong market position and, often, a strong patent position.” The company considered the patents at issue to cover “core technology” in the area of fuel ethanol production. Interestingly enough, even given this general policy, the company had licensed its core technology “when it really is worth it,” such as in the context of joint development agreements and in settlement of litigation. Even with these conditions, however, the court found that Novozymes’ general refusal to license its “core technology” warranted setting a relatively high royalty rate. Indeed, the court noted, Novozymes refused to license one
Relevance and Application 77
of the patents to the present defendant even in the settlement of a prior litigation between the two parties. Id. at 608. Likewise, in Promega Corp. v. Lifecodes Corp., 1999 U.S. Dist. LEXIS 21094 at *37 (D. Utah 1999), the plaintiff testified that, at the time of the hypothetical negotiation, it “had the general policy of not granting licenses for any of the patents it held.” Although the court took into account that, in a prior litigation, the plaintiff had been willing to negotiate with the present defendant in an attempt to settle the action, a “closer examination of those 1991 negotiations shows that the situation was unique, and that the offer by Promega to grant Lifecodes a sublicense was prompted by a desire to settle the lawsuit. The 1991 negotiations were not an indication of Promega’s general licensing policy.” Particularly important to the court was that there was no evidence that Promega had ever licensed the patent at issue to a direct competitor. The two limited field licenses that had been granted by Promega differed significantly from any license Promega would have granted the defendant and were not to a direct competitor. Moreover, these licenses “were for limited uses, in fields in which Promega was not competing.” The court therefore found that Promega’s unwillingness to license the patent at issue argued in favor of a higher royalty rate. Another good example was presented in P&G v. Paragon Trade Brands, 989 F. Supp. at 610. In that case, P&G’s general counsel testified that the company had a general policy of not granting licenses under its patented technology. The court found that, even though P&G had entered into a crosslicense for some patents, “the record in this case establishes that at the time of the hypothetical negotiation P&G had a policy of not licensing its patents covering major innovations in diaper technology.” In evaluating how the hypothetical negotiation would have progressed, the court noted that “[a] lthough an assumption underlying the hypothetical negotiation is that the patent owner would have granted the infringer a license at a rate that would have enabled the infringer to utilize the invention, the patent owner’s bargaining power is clearly greater if it followed a consistent policy of refusing to grant licenses.” Indeed, the court found that P&G had not licensed any of its major innovations in diaper technology for the past thirty years, other than licenses that were the result of settlements of patent litigation. Accordingly, the court found that P&G’s history of refusal to license major innovations argued for a higher reasonable royalty in that case.
[B] Establishing Historical Practices The most important consideration in litigating this factor is establishing the historical practices of the plaintiff in refusing to license its patent. A plaintiff that can prove it has a corporate policy of refusing to license its patent (like Novozymes had) will be in a better position to convince the court that, in the
78
Chapter 7 Keeping It to Yourself
hypothetical negotiation, it would have firmly resisted such a license than a plaintiff who simply had never entered into such a license. The distinction made by P&G is also significant—a company might very well agree to license patents that did not cover its core technology but refuse to license “major innovations.” Even in the absence of a written policy, this conduct is likely to be convincing as to how the patentholder would have acted in the hypothetical negotiation. In the absence of some provable policy of refusal to license, a plaintiff ’s position in this regard is subject to a counter-argument that the lack of any licensing history indicates simply that the patent is not very valuable. A plaintiff must be prepared to counter this argument by showing, if available, opportunities or requests to license the patent in suit or a demonstration (as with P&G) that the patent at issue represents a major innovation, the licensing of which would affect the plaintiff ’s ability to compete. A similar argument was made by the government in Brunswick Corp. v. United States, 36 Fed. Cl. 204, 213 (Ct. Cl. 1996). There, the court found that “[t]he evidence shows that Brunswick’s Defense Division had a wellestablished practice of not licensing-out technology in areas where it could occupy a controlling market position. This was more the case where Brunswick felt it could secure a dominant proprietary position in a specific, growing, and freshly-cultivated market, such as the one at issue. While defendant argues that Brunswick’s purported refusal to license was the inevitable result of its inability or failure to license, the evidence presented at trial simply does not support this position.” Also, as we can see, the fact that a plaintiff who may have refused to license its patent in a commercial setting may have considered licensing (or may even have licensed) the patent in the settlement of a prior litigation is not fatal to this argument. As in the “established royalty” factor, the courts recognize that licensing in the context of the resolution of litigation is very different in economic terms to the hypothetical commercial negotiation that is used to determine a reasonable royalty. In litigating this factor, both parties must be very careful in accumulating facts and presenting their case as to the reasons a patentholder did not license out its patents. Where a plaintiff is in a strong market position, such as Brunswick or P&G, and uses its patents to maintain its monopoly over a key technology that is critical to its competitive position, this can be a very strong factor in increasing the reasonable royalty rate. Such a policy—the more formal the better—indicates that the patentholder would have virtually been willing to walk away from the table in the hypothetical negotiation rather than license its patent, which argues for a high royalty rate. The problem is that the refusal to license can be characterized as an inability to license— which, obviously, would drive the royalty rate down substantially. Counsel preparing to make this argument should carefully marshal evidence as to the reason the patentholder has not licensed the patent-in-suit.
Analysis 79
7.02 Analysis For a non-NPE plaintiff this factor is potentially the most effective economic factor that, given the right factual situation, will justify a substantial increase in the reasonable royalty rate. This factor takes into account most strongly the economic power given to a patentholder by the monopoly right the patent gives to the owner to be the only player in the marketplace with the right to practice his invention. If the patentholder can prove that, at the time infringement began, it actually intended to exercise that legitimate monopoly power, the economic justification for a very high royalty rate is strong. Obviously, for the patent monopoly factor to apply at all, the plaintiff cannot have previously licensed (or even tried to license) its patent. The patent will have to be part of its core technology and be important to its competitive position in the marketplace. To be convincing, the plaintiff will need to show that it uses the patented invention to maintain a monopoly position in at least a niche market and that this invention enables it to maintain its market share and keep its prices high. It will need to prove that this invention is the primary factor that distinguishes it from its competition and that giving up this monopoly position would cause it competitive injury that would only be compensated by a high royalty rate. In some respects, this is the flip side of Factor 3, focusing on the competitive benefit to the plaintiff, rather than to the defendant. The plaintiff will need to be prepared to show not only that it has not licensed the patent at issue but also that it had, at the time the infringement began, legitimate competitive reasons not to do so. It should be able to emphasize the competitive benefits it gains from having a monopoly position with respect to the patented technology. It will also benefit from being able to show that having the sole right to this technology gives it a particular advantage over this particular defendant. For a plaintiff who has never licensed the patent-in-suit, the analysis of the usefulness of this factor begins with an examination of its business. First, does the plaintiff use the patent in its products? How? How important is that patent to the competitiveness of his products, that is, how would not having that feature affect the plaintiff ’s ability to compete in the marketplace? How much would eliminating that feature—or allowing its competitors to have it—affect its ability to keep its prices high? How much is the patent worth in terms of profits as opposed to the licensing income the patent could bring in? For a defendant, the burden will be showing that the plaintiff ’s claims that it “refused” to license its patent are not credible—that it is more likely that the patentholder never had the opportunity to license its patent or never thought of it. Since it is unlikely that the plaintiff has actually refused to license its patent (i.e., it rejected a request to license), its unwillingness to license the patent-in-suit will undoubtedly be based on the testimony of its executives— testimony that the defendant must be prepared to rebut.
80 Chapter 7 Keeping It to Yourself
The next, and more interesting, issue, is the effect such refusal to license will have on the royalty rate. When analyzed in terms of the hypothetical negotiation, the question is at what price would the plaintiff who, for competitive reasons, has refused to license its patent, actually license it to the defendant? This becomes an even more interesting issue the more the plaintiff and defendant are direct competitors and the more the patent at issue is central to the plaintiff ’s ability to compete with the defendant. To the extent that the plaintiff is able to gain “monopoly profits” through its exclusive use of the patented technology, at what price would the plaintiff give those profits up? As a practical matter, the plaintiff will argue that, in the hypothetical negotiation, it would have demanded that it be made whole and that it would only have licensed its patent at a rate that would have allowed it to recover the profits—and expected future profits—it would have made had it maintained its exclusive use of the patented invention. As the Seventh Circuit noted in Brunswick Corp. v. Riegel Textile Corp., 752 F.2d 261, 267 (7th Cir. 1984), “[a]s a rational profit-maximizer Brunswick would charge its licensees a royalty designed to extract from them all the monopoly profits that the patent made possible; and the licensees would raise their prices to consumers to cover the royalty expense.” Assuming the plaintiff makes a convincing case that it actually had a policy of refusing to license its patent, this economic argument makes sense. The next stage of the analysis, then, is to determine what profits are legitimately associated with the plaintiff ’s exclusive use of the patented invention. Although this will normally be a task for the economic expert, the end point will be a determination of what level of royalties it would take to fully compensate the plaintiff for the loss of its exclusivity in using the patented invention. How much does this loss affect its profit margin? How many sales would it lose to the defendant? What would be the effect on its prices? How would this affect the plaintiff’s ability to compete in the future?
7.03 Discovery and Using Your Experts The discovery on the patent monopoly issue will, of course, primarily be done by the defendant, because the plaintiff will have full access to information regarding its own market behavior and pricing considerations. The initial discovery to be done by the defendant will be to determine whether, in fact, the plaintiff had a corporate policy of refusing to license its patent or simply did not have the opportunity to do so. Depositions should be taken of the appropriate management and technical personnel as to the willingness of the company to license the technology and whether the company had ever received any inquiries as the availability of such technology for licensing. If the defendant suspects that inquiries or overtures may
Discovery and Using Your Experts 81
have been made, but this information is not forthcoming from the plaintiff, consideration may be given to subpoenaing likely licensees. If the plaintiff claims that it has a “policy” of not licensing the patent-in-suit or similar patents, the defendant should examine those claims closely, since the situations in which a party has a clear written policy of not licensing patents is likely to be rare. More likely, this “policy” will be, at best, amorphous and will represent the honest opinion of management as to what their policy would have been had they considered the issue or if a potential licensee would have approached them. Although the plaintiff may claim, for purposes of the litigation, that it would have been economically disadvantageous for it to license its patents to its competitors, this may not necessarily have been the case if the royalty amount were high enough or if the licensee’s field of use was restricted in some manner. If the defendant knows, or even suspects, that the plaintiff may try to justify a high reasonable royalty rate using this theory, it should push very hard in discovery to obtain all of the information it can that would undercut any claim by the plaintiff that it would have refused to license its patents, given the opportunity. This discovery may be more complicated than it might first appear since, as in the P&G case, the plaintiff may actually have licensed some of its patents but taken the position that for other “core” patents it has a corporate policy not to license them to competitors. It is certainly worth the defendant’s while to verify that the plaintiff actually has such a policy and how longstanding it is or whether it is simply pretext. Discovery should also attempt to unearth the economic reasons for the plaintiff to adopt this policy—whether the technology at issue would be useful to other players in the marketplace and how “core” the patent-in-suit is to the plaintiff ’s ability to compete. The defendant, when making an argument that the patent-in-suit is not actually that central to the plaintiff ’s competitive position, must, of course, keep in mind that if damages are in fact being awarded to the plaintiff, the jury has already found that the defendant is using the patented invention and thus must think it has some competitive value. Any defendant who is thinking of making this argument must be prepared to point out substantial competitive differences between its business and the plaintiff ’s. The next stage of the defendant’s discovery will be to determine the level of “monopoly profits” the plaintiff earns from having sole use of the patent-in-suit. The defendant should demand all available data regarding pricing and the pricing history of the plaintiff ’s products that use the patented invention, as well similar products that do not use that feature, for comparison purposes— all of which should be accumulated in discovery. The defendant should also accumulate such data regarding its own infringing products, including data that shows there is little sales or pricing difference between products that do and do not contain the patented feature since, if that is proven, the plaintiff will have a hard time arguing that “monopoly profits” are associated with the sole use of the patented feature.
82 Chapter 7 Keeping It to Yourself
Determining the value of a license when a plaintiff claims a patent monopoly is another instance where an economist expert is particularly useful. If the plaintiff can make a convincing case that it would have gotten substantially more economic benefit from refusing to license the patent-in-suit than from allowing its competitors to use it at a price, the experts need to reliably establish how much that competitive benefit would have been worth to the plaintiff. The effect of the plaintiff ’s sole use of the patented feature on the plaintiff ’s pricing should be examined closely. Another issue, particularly appropriate for economists, is the effect of the plaintiff ’s monopoly use of the patented feature on market definition. If the plaintiff insisted on keeping sole possession of the patented invention, other players in the market would be required to compete based on non-infringing features that they believed the consumer would prefer. New entrants to the market might well have been kept at bay because of the substantial product development and research costs of coming up with a non-infringing product. The plaintiff may have been able to not only keep its prices high but also to maintain its market share by refusing to license its patent—this, indeed, is the likely scenario that was presented to P&G that was able to keep its substantial market share by refusing to license its core technologies, thus forcing competitors to develop their own diaper technologies, at substantial cost. Where, on the other hand, the plaintiff licenses its core technologies, or would have been willing to do so, the structure of the market will be quite different. Instead of being forced to develop competing technologies, all the competitors would be able to use the plaintiff ’s patented technology. Companies that might have been unable or unwilling to spend the money to develop a product to enter the market may actually be able to become market participants. Competition, in this circumstance, will be based much more on price and the efficiencies of the various market participants rather than on the attributes of the products themselves. The reasonable royalty value of the patent will depend on a completely different set of economic factors than if the plaintiff chose to maintain its patent monopoly. Working with experts on this very important factor is primarily a matter ensuring that your economist formulates a reliable market model taking into account the effect of the plaintiff ’s maintaining—or not maintaining—its patent monopoly.
CHAP T ER
8 Selling Your Enemy the Stick to Beat You with The Hypothetical Negotiation Where the Plaintiff and Defendant Compete Factor 5: The commercial relationship between the licensor and licensee, such as whether they are competitors in the same territory in the same line of business or whether they are inventor and promoter.
8.01 Relevance and Application
83
8.02 Analysis
86
8.03 Discovery and Using Your Experts
89
8.01 Relevance and Application The factor that, more than any other, is virtually designed to drive up the reasonable royalty rate is one in which the patentholder and the accused infringer are direct competitors. Among all of the economic criteria, it is hard to imagine one that would be more probative or more easily understood by a court or jury. In the hypothetical negotiation, it would seem obvious that, where the plaintiff and the defendant are head-to-head competitors, the plaintiff would charge a very high price to the defendant to license the very patent that enables it to maintain a competitive advantage. This factor has been covered in some detail in the context of a plaintiff refusing to license its patent to an infringer. However, this Georgia-Pacific factor considers the situation in which the plaintiff might actually license to certain companies but might be more reticent when confronted with licensing the patent to a company that could do it competitive injury. Indeed, in this context, a plaintiff might be faced with a decision as to whether to license the patent to a competitor or not, depending on whether the patentholder thought it could make more money licensing than it would lose in sales in the marketplace. In some cases, a small plaintiff might choose to get out of the
83
84
Chapter 8 Selling Your Enemy the Stick to Beat You with
market altogether if it thought it could make more money licensing than it could ever make selling its product. When examining this factor of competitive parties, and the effect its analysis has on the reasonable royalty rate, it is important to determine whether the plaintiff and the defendant are actually competitors and whether their competition is impacted by the patent-in-suit. What is critical is the effect that their competition, at least as of the date of the hypothetical negotiation, may have on the deal they may reach in this negotiation poses the challenge in using this factor. The obvious principle that one competitor will normally be unwilling to go out of its way to help its rival was recognized by the court in Novozymes A/S v. Genencor Int’l, Inc., 474 F. Supp. 2d 592, 608 (D. Del. 2007). There, the court recognized that an infringement of a patent by a direct competitor is a direct threat to its investment of time and money. A competitor’s infringement of a patent is normally a direct attack on the business of the patentholder and enables the infringer to more effectively compete. In the hypothetical negotiation, therefore, the patentholder would be loath to give its direct competitor access to its proprietary technology and would only be willing to license that technology at a relatively high rate—one that would enable the patentee to recoup the losses it would incur by permitting the defendant to compete with a license. Indeed, where the patentholder is seeking to maintain a monopoly on its technology, it would be even more unwilling to grant a license to a direct competitor, thus pushing the rate even higher. The court, while recognizing that the 20 percent royalty rate requested by the plaintiff “is higher than the rates in other licenses offered by the parties and the average rates reported for the relevant industries,” the fact that the parties are direct competitors justifies a higher “reasonable royalty.” This observation was echoed in Telemac Corp. v. US/Intelicom Inc., 185 F. Supp. 2d 1084, 1101–02 (N.D. Cal. 2001), where the court noted that Telemac, the plaintiff, “would not have willingly licensed a direct competitor such as USI and, if forced to do so, would only have licensed USI at the highest possible royalty rate it could obtain. In effect, in order to license a direct competitor, Telemac would have required significantly higher royalty rates to compensate it for the risks of quality, fraud, and general price erosion caused by USI. This fact weighs in favor of applying a higher reasonable royalty rate for USI’s infringing activity than that applied to Telemac’s non-competitor licensees. Obviously, where a plaintiff and defendant are direct competitors in selling a product covered by the patent-in-suit, the plaintiff will usually choose to seek lost-profits damages attributable to the sales lost by the plaintiff due to the infringement. This remedy will usually result in a higher damages award, if applicable. In some cases, however, the plaintiff ’s lost-profits remedy may not be available for some reason, or the plaintiff may simply choose not to pursue it.
Relevance and Application 85
The same economic factors, however, apply in the reasonable royalty context—the plaintiff supposedly loses a sale of its product for each sale made by the defendant of the infringing product. In the hypothetical negotiation, the plaintiff will seek to recover at least the profits it would have made on that sale. In the reasonable royalty context, the analysis of the effect of competition on the hypothetical negotiation is relatively straightforward. A patent is the right to exclude others—usually competitors—from using one’s invention. An inventor is normally motivated to do the research necessary to come up with an invention by competition. Indeed, in the corporate world, most inventions are developed because of competition—the development of improvements or new products that will enable the company to more effectively compete against its rivals. Interesting issues arise, however, where the competitive relationship between the parties is not as clear. Such a situation was presented in Union Carbide Chems. & Plastics Tech. Corp. v. Shell Oil Co., 425 F.3d 1366 (Fed. Cir. 2005). In that case, Union Carbide claimed that Shell had infringed its patents on the use of silver catalysts for the production of ethylene oxide. The wrinkle in the damages analysis here was that the patents were not actually owned by Union Carbide Corporation, which did produce and sell ethylene oxide, but rather by a subsidiary holding company that did not sell any products or, indeed, have any purpose other than owning and enforcing the patents. The district court, indeed, characterized Union Carbide as a nonexclusive licensee of the patent at issue and noted that “the present case presented a problem of first impression for this court, namely, the extent to which the impact on a nonexclusive licensee may be a factor considered in a reasonable royalty analysis where the nonexclusive licensee is the parent corporation of the patent holder and the patent holder is solely a technology holding corporation.” Over Shell’s objections, the court permitted Union Carbide’s damages expert, in performing his reasonable royalty analysis, to take into account the effect that granting such a license would have on the business of the patentholder’s corporate parent, not on the business of the patentholder itself. The court did, however, bar the expert from characterizing the hypothetical negotiation as between the corporate parent and Shell, and required him to make clear that the holding company would take into account, in that negotiation, the effect that such a license would have on the fortunes of its patent. Id. The Federal Circuit agreed, noting that the relationship between the holding company and the parent who was in competition with Shell “goes far beyond a licensor/licensee arrangement. . . . Because of the genuine relationship between these companies, the district court decision properly permitted consideration of these sales. Simply put, the holding company would not enter any negotiation without considering the competitive position of its
86 Chapter 8 Selling Your Enemy the Stick to Beat You with
corporate parent, Union Carbide Corporation. Shell is a direct competitor of Union Carbide Corporation in EO production and MEG sales. Therefore any hypothetical negotiation with the holding company must necessarily include the reality that the economic impact on the Union Carbide Corporation would weigh heavily in all decisions.”
8.02 Analysis Before one can even begin to determine the effect of competition between the plaintiff and the defendant on a reasonable royalty, one must determine whether the plaintiff and the defendant actually compete at all and, if so, how. One must examine the intersection of the arena in which these two companies compete and the economic benefits bestowed by the patented invention to determine how much the patent would be “worth” in this competitive context. The first step in this analysis is to define the market in which the plaintiff and the defendant compete. The most economically significant form of competition for purposes of analyzing the damages that may be obtained by the plaintiff is, of course, where the parties directly compete against each other in selling products that embody—and depend on—the patented invention. In this case, it is likely that any sale of an infringing product by the defendant will result in the loss of a sale by the plaintiff. Where the parties directly compete with each other in this manner, however, the most lucrative, and obvious, remedy for the plaintiff will be in the form of lost profits. The details of that analysis are covered elsewhere in this work. What about the situation where the competition between the parties is not as clear, direct, or obvious or is less clearly related to the patented invention? What if the sales of the defendant’s product do not depend on the employment of the patented invention? What if the patented invention is relatively unimportant to the plaintiff ’s product? What if the parties’ competition with each other is indirect (i.e., at different levels of distribution) or is relatively tangential, where, for example, the defendant competes with the plaintiff in the sale of accessories for the defendant’s primary product? How should the effect such competition may have on the reasonable royalty be measured? Before the effect of the parties’ competition on a reasonable royalty can be determined, however, one must first examine the ways in which the parties compete with each other. This requires defining the market in which the parties compete with their rivals—and each other. The process of market analysis is familiar to any antitrust practitioner. As the Federal Circuit held in Intergraph Corp. v. Intel Corp., 195 F.3d 1346 (Fed. Cir. 1999), the “relevant market” is “the market in which sellers compete, based
Analysis 87
on products that are in competition with each other.” The “outer boundaries of a product market are determined by the reasonable interchangeability of use or the cross-elasticity of demand between the product itself and substitutes for it.” The Intergraph court quoted the Third Circuit’s opinion in SmithKline Corp. v. Eli Lilly & Co., 575 F.2d 1056, 1063 (3d Cir. 1978), defining the relevant market as the market wherein producers “have the ability, actual or potential, to take significant amounts of business away from each other.” Indeed, the most commonly used form of market definition—and the one most likely to be accepted by the courts—is the one used by the Department of Justice and the Federal Trade Commission in merger cases: the Horizontal Merger Guidelines. Those guidelines describe an economically reliable way of determining whether the plaintiff and defendant compete and the structure of the market in which they compete. Essentially, what is bring measured is cross-elasticity of demand—the response in the demand for one good to a change in the price of another good. Under the Horizontal Merger Guidelines, a product market is defined by the primary product (here, the product covered by the patent) and the substitutes recognized by the consumer. When the producer of the relevant product raises its price a “small but significant and nontransitory” amount, to which products do its customers go? As the guidelines state, “[A]ssuming that buyers likely would respond to an increase in price for a tentatively identified product group only by shifting to other products, what would happen? If the alternatives were, in the aggregate, sufficiently attractive at their existing terms of sale, an attempt to raise prices would result in a reduction of sales large enough that the price increase would not prove profitable, and the tentatively identified product group would prove to be too narrow.” Under this analysis, the party “will begin with each product (narrowly defined) produced or sold by each merging firm and ask what would happen if a hypothetical monopolist of that product imposed at least a ‘small but significant and nontransitory’ increase in price, but the terms of sale of all other products remained constant. If, in response to the price increase, the reduction in sales of the product would be large enough that a hypothetical monopolist would not find it profitable to impose such an increase in price, then the [party] will add to the product group the product that is the nextbest substitute for the merging firm’s product.” The market analysis, however, is merely preparatory. What this factor seeks to measure is the real effect that competition has on the reasonable royalty. The effect of this factor can be measured in stages—all of which will be biased by the relative positions of the parties. The first stage is where the parties are the only two parties in the relevant market, where they sell the same products, both of which are indisputably covered by the patent. While this situation would, obviously, justify a high
88 Chapter 8 Selling Your Enemy the Stick to Beat You with
reasonable royalty, it is much more likely in that situation that the plaintiff would choose to pursue—and would be likely to recover—its lost profits resulting from the infringement. Such a remedy would, in most circumstances, justify a higher damages recovery than a reasonable royalty. The next stage is where the relevant market may contain more than the two parties to the lawsuit, but where the plaintiff and the defendant still sell the same product, both covered by the patent. Although this situation would also justify a high royalty, here it is also likely that the plaintiff will do better if it chooses to seek to recover its lost profits. Next comes the situation where the plaintiff and defendant do not sell the same product but do compete with each other in that their products are considered sufficient substitutes for each other to be considered in the same relevant market. The defendant’s product, however, still uses the patented invention (or there would, obviously, be no infringement). Here, where the defendant is using its infringement of the plaintiff ’s patent to enable it to compete, the utility of the patent to the defendant is less clear, as is the interest of the plaintiff in using the patent to exclude the defendant from the market. The reasonable royalty in this circumstance will depend on a measurement of the competitive harm the defendant is causing to the plaintiff by infringing and the competitive advantage the plaintiff gains by exclusion. As discussed in the section on hypothetical negotiation, each of these measures can be represented by the pot of money associated with the advantage each gains through use of the patent. Where the degree of competition is less than head to head, competition between the parties is still an important factor in the reasonable royalty analysis; its effect is just more challenging to measure and analyze. The “territorial” competition discussed in this Georgia-Pacific factor is of this latter type—where the parties are not clearly direct competitors. In this circumstance, the parties’ competition is not quite head to head, but is tempered by other factors. The plaintiff would not have as great an interest in completely excluding the defendant from the marketplace as it would if it were competing with the defendant in all regional markets. Indeed, the plaintiff might be glad to receive some revenue from a geographic market it did not cover from selling its own products. Another stage is where the parties are indirect competitors—that is, the parties are at different levels of distribution, such as where the plaintiff makes a component that is included in its customers’ products and the defendant competes with those customers by selling a product that contains an infringing component. In this stage, the plaintiff would still have an incentive to charge a relatively high royalty in order to preserve the revenue it receives from selling its own product to its customers, but this royalty would be tempered by the amount it would be able to obtain from licensing the patent to the defendant—as long as it could obtain the same amount from both, the plaintiff should not care by which method it receives payment. Thus, the marginal
Discovery and Using Your Experts 89
profit the plaintiff obtains from selling its product to its customers will probably be the upper limit of the reasonable royalty rate.
8.03 Discovery and Using Your Experts The discovery the parties conduct on this factor will be similar to any of the factors that involve market analysis. The most important issues will be the structure of the market in which the parties compete, the participation of each of the parties in that market, the effect of the patent on the ability of the parties to compete in that market, and the effect the defendant’s infringement has had on the market and the ability of the plaintiff to gain an advantage. Thus, as with the other market-related factors, each party must obtain from its opponent complete sales and pricing data for as many years as it is available as well as the parties’ forecast of its forecasts of what the market would look like in the future. Each party must also do a full investigation of its own documents to obtain this information. The primary job here is for the economic expert. This expert must construct the market and examine the effect of the defendant’s infringement on the plaintiff ’s ability to compete in that market. The reasonable royalty will primarily be measured by the amount the plaintiff thinks it will need to compensate it for the losses it suffers as a result of the defendant’s using the patent to compete with it—directly or indirectly. The expert will calculate the amount the plaintiff would have thought was in the defendant’s pot in the hypothetical negotiation and the amount that the plaintiff believed that should be in its pot if it were able to exclude all others from using the patent. The trick here is to account for the fact that, in some circumstances, the plaintiff may make more money from licensing the patent than it ever could by competing in the market—where the size, efficiency, or market reach of the defendant exceed anything the plaintiff could accomplish.
This page intentionally left blank
CHAP T ER
9 Boosting the Royalty Rate with Unpatented Products Mercy Sakes Alive! Looks Like We Got Us a Convoy! Factor 6: The effect of selling the patented specialty in promoting sales of other products of the licensee, the existing value of the invention to the licensor as a generator of sales of its non-patented items, and the extent of such derivative or convoyed sales.
9.01 Relevance and Application
91
9.01 Analysis
94
[A] Plaintiff ’s Considerations
94
[B] Defendant’s Perspective
95
9.03 Discovery and Using Your Experts
95
9.01 Relevance and Application Factor 6 reflects the reasonable principle that, in the hypothetical negotiation, the plaintiff would seek compensation for all of the disadvantages that it would suffer as a result of licensing the patent-in-suit and losing its own sales of product to the defendant rather than maintaining exclusive use of the patent and denying the defendant those sales. Thus, if, as a result of selling products that are covered by the patent, the plaintiff also sells other products at the same time (convoyed) or later (derivative), the plaintiff will tend to charge more to license the patent than if sales of the primary product did not drive sales of these other products. The inclusion of the plaintiff ’s sale of unpatented products in the damages calculation might, at first blush, seem controversial; defendants would argue that this impermissibly expands the scope of patent protection to include products which are not even arguably covered by the claims. However, this factor, in economic terms, is entirely rational. A plaintiff would be unlikely to grant a license to a patent covering one of its products where a substantial 91
92 Chapter 9 Boosting the Royalty Rate with Unpatented Products
portion of its revenue is gained from the sale of peripheral products if it could not be compensated for these peripheral sales as well. In the hypothetical negotiation, a plaintiff would insist on recovering all of its lost profits arising from the defendant’s compensation of any royalty for its patent, not just those restricted to the patented product. For example, a plaintiff that has a patent on digital cameras and that also sells such cameras may make a substantial amount of revenue from the sale of bags or tripods or printers. If, in the hypothetical negotiation, it is forced to license one of its competitors that will sell cameras in competition, for each camera sale it loses, it will also lose sales of these peripheral products. Any rational plaintiff would seek to be made whole for these sales as well and would insist that any royalty also compensate it for this additional lost revenue. Including revenue for the sale of these peripheral products as a factor that might increase a reasonably royalty is not granting royalties on nonpatented items, rather it is simply recognizing the economic reality of the hypothetical negotiation—that a plaintiff will take all economic factors into consideration, not just those associated with the patented product itself. As the court explained in P&G v. Paragon Trade Brands, 989 F. Supp. 547, 610 (D. Del. 1997), “[c]onvoyed” or “derivative” sales occur where the sale of one thing is likely to cause the sale of another, such as selling a razor and then also being able to sell the blades to go with it.” The Federal Circuit noted in TWM Mfg. Co. v. Dura Corp., 789 F.2d 895, 901 (Fed. Cir. 1986), “[w]here a hypothetical licensee would have anticipated an increase in sales of collateral unpatented items because of the patented device, the patentee should be compensated accordingly.” “Factor 6 turns on the theory that a willing licensee would be more willing to set a higher royalty rate during a hypothetical negotiation if it could expect to derive a collateral benefit from convoyed sales flowing to the infringer. Conversely, the patent holder would enter hypothetical negotiations to offset the damage caused by such collateral sales by the infringer.” Brunswick Corp. v. United States, 36 Fed. Cl. 204, 214 (Ct. Cl. 1996). Although most often this factor is used by the plaintiff to justify a higher royalty rate than the patented product might justify by adding in the profits the plaintiff obtains from selling accessories and follow-on products, this concept has been seized upon by plaintiffs where the product covered by the patent generates no revenue at all. This principle was presented to the Federal Circuit in Trans-World Mfg. Corp. v. Al Nyman & Sons, Inc., 750 F.2d 1552, 1568 (Fed. Cir. 1984), where the plaintiff held a design patent for an eyeglass display rack. This rack was, however, not sold but was given away by the plaintiff as a way of promoting the sales of the product the plaintiff was selling—the eyeglasses. The question was whether the jury could take the increased sales of eyeglasses resulting from using the patented display in determining the reasonable royalty for the display rack.
Relevance and Application 93
The Federal Circuit found that this was permissible. “By supplying the patented racks for displaying the eyeglasses, Nyman used “the patented [invention] in promoting sales of” the non-patented eyeglasses. Trans-World may be able to prove that Nyman’s infringing use of the displays played an important role in the retail sales of Nyman’s eyeglasses. Furthermore, the extent of the profits from such sales could be relevant in determining the amount of a reasonable royalty. If, for example, sales were increased because of the infringing use of the displays, that fact could affect the amount of royalties a potential licensee would be willing to pay.” An increasingly common use of this factor has also been by a plaintiff showing that the defendant used the infringing product to increase the sales of the defendant’s convoyed or derivative products. The plaintiff ’s argument here is that, because the defendant used the sales of the infringing product to drive sales of other products, licensing the patent would have been worth more to the defendant and it would have been willing to pay a higher royalty. This argument was made in Union Carbide Corp. v. Graver Tank & Mfg. Co., 282 F.2d 653, 672 (7th Cir. 1960), where the court found that the defendant, “if it had been negotiating with Union Carbide for a license, would have taken into consideration all advantages which might accrue to it in determining a royalty which it would be willing to pay. A license to sell the patent flux would have enabled [the defendant] to expand its business, increase its sales of noninfringing materials and thereby increase its profits.” A similar result was obtained in Ball Aerosol & Specialty Container, Inc. v. Limited Brands, Inc., 514 F. Supp. 2d 1051, 1056 (N.D. Ill. 2007), a case involving a patented “candle tin comprised of a hollow candle holder in which a candle is placed and a cover that, when the candle is lit, is to be used as a base upon which to place the candle so that heat transferred through the bottom of the candle tin does not scorch the surface that the candle tin would otherwise be placed upon.” In that case, the plaintiff claimed that the defendant’s sale of the infringing item, in competition with the plaintiff, helped the defendant sell other, nonaccused items “by employing marketing strategies such as providing customers with the Accused Candle Tin at no cost after customers purchased a non-Accused Candle Tin, selling the Accused Candle Tin at a discounted rate to customers that purchased a non-Accused Candle Tin, and offering a leather travel case to customers for the Accused Candle Tin.” Because, in many cases, the defendant either gave the accused item away for free, or at a severely reduced price, this theory enabled plaintiff to take into account the entire economic benefit, which was gained by the defendant in infringing the patent—a benefit the defendant would have been unlikely to give up in the hypothetical negotiation. The court agreed with the plaintiff that these non-patented items should be taken into account in setting the royalty rate, noting that the “Federal Circuit has found that convoyed sales are generally appropriate for damages under a lost-profits calculation but that such sales should not be
94 Chapter 9 Boosting the Royalty Rate with Unpatented Products
credited to a patent owner who does not sell the patented invention.” While the “royalty rate should not reflect the profits attributable to the non-infringing unpatented products, [since] the Accused Candle Tin was marketed with non-infringing products, such as a travel case or non-Accused Candle Tins, which, in turn, increased the overall sales to Limited Defendants,” the royalty rate for the patented candle tin was increased.
9.02 Analysis [A] Plaintiff ’s Considerations Litigating this issue of whether non-infringing unpatented products should affect the royalty for the patent-in-suit presents special challenges for both plaintiffs and defendants. The plaintiff will want to make sure that all possible products and services that could arguably be affected by any loss of sales of the patent product are properly included in the analysis. The plaintiff should be careful to include not only obvious “convoyed sales,” such as peripherals, but also should be creative in including other products whose sale would be promoted by the sales of the patented product and that the loss of sales of the patent product would affect. There is no reason that the plaintiff could not include the loss of the sale of associated services in this analysis, as long as they are logically and economically connected. The plaintiff should always present this evidence in the context of showing how the sale of the unpatented products or services would affect the royalty rate for the patented product— that is, the need for the plaintiff to make itself completely whole for all of the injury it would suffer by this unwanted competition by charging an appropriate royalty on the patented product. The plaintiff ’s argument will obviously be enhanced if the defendant is a competitor and it can be shown that the defendant’s sales of its infringing product promote its own sales of other, non-infringing products. Such a showing will, obviously, make it much more difficult for the defendant to argue “overreaching.” Additionally, as shown above, the plaintiff can also use this fact to further increase the reasonable royalty by showing that licensing the patent would have been even more valuable than it would otherwise appear. The analysis, as set forth above, is a particularly valuable point to make for the plaintiff where either the plaintiff ’s patented product or the defendant’s infringing product is either a loss leader or is given away for free. Noting the substantial economic advantages of giving one valuable product away for the purposes of promoting the sales of another product (as Microsoft, for example, has done throughout its history) may enable the plaintiff to generate a substantial royalty award even if the defendant’s revenue from the sale of the infringing product is relatively low.
Discovery and Using Your Experts 95
[B] Defendant’s Perspective From the defendant’s perspective, the objective will be to show that the plaintiff is overreaching and is attempting to obtain royalties on products that have no real relationship to the patent. It should argue that the plaintiff ’s attempt to link these products is unsupported by real economic evidence and is largely anecdotal. This issue puts a premium on the presentation of rigorous economic and financial evidence from both sides that will show a real economic relationship between the patented and unpatented products or services.
9.03 Discovery and Using Your Experts Discovery on this point is part and parcel of the market discovery and analysis that should be undertaken with respect to every Georgia-Pacific factor. For Factor 6, however, it is important to focus the discovery specifically on the non-patented products that might not normally be analyzed. The parties’ promotion of their products and the bundling of accessories and other subsidiary products need to be examined closely. If necessary, discovery should be taken of the parties’ distributors to gather evidence of how the patented and infringing products are actually sold to consumers. The sales and marketing personnel of both the plaintiff and the defendant should be closely questioned on this point. The relevance of requests for information on non-patented products may not be immediately obvious to your opponent or to the court. A request for substantial financial data on products that do not embody the patent or that have not been accused of infringement will appear to be overreaching if the party receiving such a request does not understand the relevance of this factor. A party seeking to do this analysis must be prepared for substantial pushback if it is aggressive in conducting discovery on this issue. However, if the effect on sales of the non-infringing products is taken seriously by the plaintiff, it can result in substantial discovery as to the sales of a complete product line on the part of both the plaintiff and the defendant. Indeed, if there is enough money involved, the best way of proceeding would be for the expert to conduct a market study to find out which products or services are actually promoted by the sales of the patented product. Real reactions from consumers as to what products they actually buy together will make the parties’ arguments on this issue more convincing.
This page intentionally left blank
CHAP T ER
10 How Much Time is Left? The Effect of an Expiring Patent Factor 7: The duration of the patent and the term of the license.
10.01 Relevance and Application
97
10.02 Discovery
98
10.01 Relevance and Application The economic rationale underlying the consideration of the duration of the patent in setting a reasonable royalty is fairly obvious—normally, the longer the time between the hypothetical negotiation and the expiration of the patent, the more the patent is worth since, without a license, the defendant would have barred from using the patented invention for a longer period. Thus, the defendant would pay more for the right to use the patent for a longer period of time. As the court noted in Brunswick Corp. v. United States, 36 Fed. Cl. 204, 214 (Ct. Cl. 1996), “Factor 7 embodies the conventional wisdom that the longer the remaining duration of a patent term, the more willing a hypothetical licensee is to pay a higher royalty rate. This principle rests on the fact that the longer the duration of the patent, the more likely the patent holder is to cultivate goodwill, an intangible economic asset representing the ability of a business to generate income due to business reputation, market position, management, technology, customer relations, and other elusive indicia of earning power, which would almost certainly persist and benefit the patent holder long after the patent expired.” The duration of the patent may be less of a factor, however, in highly innovative industries, such as the computer industry, where the “shelf life” of any particular innovation is fairly short. This, in fact, was noted by the court in P&G v. Paragon Trade Brands, 989 F. Supp. 547, 610 (D. Del. 1997), involving the apparently low-tech disposable diaper industry. In that case, the court noted that “[t]he theory behind giving weight to the patent’s duration is that
97
98
Chapter 10 How Much Time is Left?
the parties would have been more likely to have negotiated a higher royalty rate the longer the remaining term of the patent, because a longer term would better allow the licensee to establish stronger customer relations.” However, in that case, this factor was determined to have a neutral impact on the royalty rate since “[b]oth experts indicated that the benefits of a new feature in the disposable diaper industry do not last for very long” and therefore “the duration of the patents is irrelevant.” Thus, the strategic battle on this issue will depend on the length of time until the patent expires and the defendant’s immediate, versus long-term, need to utilize the patented invention. If the patent has a long remaining life, the defendant will argue that, because of rapidly changing technology, the competitive advantage it would gain from licensing the patent would not depend on the duration of the license. In a high-technology industry, it could convincingly argue that the only real use it could have made of the patent would have been for two to three years and that it would not have paid more to license the patent for ten to twelve years—the license, it would argue, would be of no more competitive advantage after this short initial period. If the patent term is reaching its end, the plaintiff will make this same argument. It will claim that the defendant (who, of course, is presently infringing the patent) would have paid a substantial amount to use the patented invention in the short-term and that, because the competitive advantage the defendant would gain by licensing the patent is immediate, the fact that the patent is close to expiring would not depress the royalty rate.
10.02 Discovery Discovery on this issue will center on the present use the defendant is making of the patented invention and the defendant’s future plans (or, at least, the plans it was making at the time of the hypothetical negotiation). The more central the invention is to the defendant’s product line and its ability to compete—and the harder it would have been for the defendant to work around the patent— the more the length of the remaining patent term will drive up the royalty rate. The defendant’s argument will emphasize not only its own product development but also an examination of the market in general and how fast that market evolves technologically. An industry expert would be particularly valuable on this point.
CHAP T ER
11 Buy My Product, Buy My Patent! How the Success of a Patentholder’s (or Even an Infringer’s) Product Can Raise the Royalty Rate Factor 8: The established profitability of the product made under the patent, its commercial success, and its current popularity. Factor 11: The extent to which the infringer has made use of the invention and any evidence probative of the value of that use.
11.01 Relevance and Application 11.02 Discovery
99 102
11.01 Relevance and Application The success of a patented product represents another economic consideration that the plaintiff will argue would have been important to the defendant in the hypothetical negotiation. The more popular and profitable the product sold by the plaintiff that is covered by the patent, the more the defendant would have paid to license that patent to use in its own product. As such, there are three complementary analyses that are relevant to this factor, assuming the proper identification of the plaintiff ’s products that are covered by the plaintiff: (1) How popular are the plaintiff ’s products? (2) Why were these products popular—because of the patented invention or for some other reason? (3) Would the same aspects of the invention that made the plaintiff ’s product popular also make the defendant’s infringing product successful? The first question is how popular are the plaintiff ’s products that are covered by the patent? This question brings up additional considerations: How is that popularity measured? Market share? Revenues? And, given the particular competitive relationship between the plaintiff and the defendant, how much of a factor would this have been in the hypothetical negotiation in terms of persuading the defendant to pay a higher royalty rate?
99
100 Chapter 11 Buy My Product, Buy My Patent!
The popularity of the plaintiff ’s products can obviously be measured in a number of different ways, which need not necessarily be measured by the revenues attributable to the patented products themselves. The plaintiff ’s products may be popular in a particular market niche, but one that is particularly prized in the industry. The patented product may be particularly profitable in comparison to the other products the plaintiff sells or may enable the plaintiff to foster a company-wide image of being cutting-edge (i.e., Apple) or sophisticated and high-tech (i.e., Bose), which may well be valuable to both the plaintiff and defendant. The patented product (as in the previous discussion of “convoyed sales”) may help the plaintiff sell other products or accessories and be popular to both the plaintiff and the defendant in this way. The more relevant issue in this inquiry, however, is why the patented products are popular and whether this popularity is attributable to the patented invention. This, not surprisingly, is usually the primary controversy regarding this factor. The court relied on this factor to increase the amount of Bose’s royalty in Bose Corp. v. Jbl, Inc., 112 F. Supp. 2d 138, 166 (D. Mass. 2000): “Mr. Barry [Bose’s expert] testified that Bose and JBL collectively have made approximately $400 million in sales of products incorporating the invention, and enjoyed roughly 20 percent profit margins on some products. Although JBL argued that the ‘721 patent covers only the port tube and speaker enclosure, and that the commercial success of the products cannot reasonably be attributed to the port design, I have already found that the port design substantially contributed to the demand for, and success of, the products.” The fact that the patented invention was the reason for the patented product’s popularity was also important to the court in Schneider (Eur.) AG v. Scimed Life Sys., 852 F. Supp. 813, 849 (D. Minn. 1994): “Schneider’s Monorail sales may be used as a basis for evaluating the established profitability, commercial success, and popularity of products made under the ‘129 patent. The profitability, success, and popularity of Schneider’s monorail products is primarily due to the rapid-exchange capability, which is the monorail’s patented feature. The record establishes that Schneider’s rapid-exchange catheters were highly profitable, popular, and successful in February 1991.” The reason that Factor 8 is important in the hypothetical negotiation is twofold. First, as previously demonstrated, where the plaintiff derives substantial competitive advantage from having exclusive use of the patented invention, it will be loathe to give up that advantage, particularly where that product is popular and it can be shown that the patented invention is the reason for that popularity. The plaintiff will, obviously, not be eager to create a new competitor and will demand a high price. Second, the more popular the invention has been shown to be in the hands of the plaintiff, the more valuable it will be to the defendant and the more the defendant would pay for a license to use that technology in the hypothetical negotiation. The court found that this would have been a particularly
Relevance and Application 101
important issue for the defendant in Ziggity Systems, Inc. v. Val Watering Systems, 769 F. Supp. 752, 827 (E.D. Pa. 1990), not only because the plaintiff had already shown the patented product to be popular (and profitable) but also because that popularity had opened up the market for the defendant’s product. As the court noted, “[b]y 1987, the patented invention was the standard nipple drinker of the market. Its popularity thrust Ziggity from obscurity to market dominance in a few short years. As evidenced by each parties’ sales, the patented drinker has remained popular. In 1987, defendants would not have been faced with the licensing of a new or unknown product. After four years of sales, defendants knew by 1987 that the patented nipple drinker would sell, even at a price higher than most other nipple drinkers. As of 1987, Ziggity’s incremental profit on their nipple drinkers was 36.02 percent and its net operating profit was 23.51 percent.” This door, obviously, swings both ways. The defendant can point to the relative lack of success by the plaintiff in selling its own patented products as a way of arguing that the royalty rate should be more modest. Although, in Mobil Oil Corp. v. Amoco Chems. Corp., 915 F. Supp. 1333, 1360 (D. Del. 1994), the court found that “the commercial success and popularity of Mobil’s ZSM-5 based technology is without question,” it also found that “[a]fter 1977, Mobil’s success slowed. It encountered many rejections and was forced to grant concessions to several of its licensees.” Although Mobil argued that Amoco would have expected to reap substantial profits from using the infringing technology, the court accepted Amoco’s estimates and noted that “the total royalties and lease payments paid to Mobil by all of its other xylene isomerization licensees combined during the period of infringement is only approximately 200 million dollars,” substantially less than Mobil estimated would have come from Amoco alone. The court, therefore, declined to use this factor to increase the reasonable royalty rate. Where a plaintiff ’s own products are not sufficiently popular (or, in the case of NPEs, where the plaintiff does not sell a product), the plaintiff has often argued that the popularity (or expected popularity) of the infringing product is relevant to the reasonable royalty analysis. Although, properly, the court should look at the amount the defendant expected to make selling the infringing product, the court may well look at defendant’s actual sales, using information that would not have been available to the parties in the hypothetical negotiation (which, of course, occurs when the defendant starts infringing). Courts have been very sympathetic to plaintiffs on this point, not wanting the defendants to get an advantage on this point where their products are popular because they infringe. Schneider (Eur.) AG v. Scimed Life Sys., illustrates the first point, the court noting that “SciMed’s infringing sales may also be used as a basis for evaluating these factors. In February 1991, SciMed anticipated extremely high profits from the sale of the EXPRESS based on the rate at which the rapid-exchange segment of the PTCA market was growing. SciMed expected
102 Chapter 11 Buy My Product, Buy My Patent!
to share in the success of the Schneider monorail products, which is evidence of the strength of the Bonzel patent.” Fresenius Med. Care Holdings, Inc. v. Baxter Int’l, Inc., 2006 U.S. Dist. LEXIS 42159, 10–11 (N.D. Cal. 2006), represents the second point, using the actual sales made by the infringer as well as the importance of the reason the defendant’s products (on whose success the plaintiff based this factor) were profitable. In that case the patented feature was a touch screen for a hemodialysis machine; the defendant argued that the reason its products were successful was unrelated to that feature. It noted that the plaintiff ’s products had been subject to frequent product recalls and were perceived in the marketplace as unsafe and unreliable. The defendant further argued that the market’s perception was that the accused infringer’s products were safer and that it was this factor, rather than its use of the infringing touch screen, that made its product popular. The plaintiff ’s analysis of this factor in some aspects dovetails with its obviousness defense—the commercial success of the patented invention being one of the indicia of non-obviousness. It must establish that its products that are covered by the patent are both successful and profitable. This will show that the invention itself is valuable and that it would have been valuable for a competitor to include in its own products. The plaintiff will argue that the defendant would have paid a high price to include this feature in its products and would have been willing to pay to the plaintiff a substantial portion of its marginal profits attributable to this feature. The challenge for the plaintiff is to demonstrate that the patented feature is the reason its products are successful. The challenge for the defendant with regard to this factor, where it is confronted with a successful product covered by the patent—either its own or the plaintiff ’s—is to decouple the patented feature from the popularity of the product. If it cannot show that the patented feature has nothing to do with the profitability of the product, it must demonstrate as many factors as possible that make the product popular. If there is enough money at stake, this would be a very good reason for the defendant to commission a market study to determine why the plaintiff ’s product is popular, and to establish as many reasons as possible to explain its popularity. The fuzzier the connection between the patented invention and the popularity of the product, the less important this factor will be to the overall analysis.
11.02 Discovery Discovery on this issue will overlap with the discovery necessary for many of the other factors. The goal will be to try to determine why the other party’s products are popular. Internal sales and marketing documents will be
Discovery
very important, as well as communications between the party and its distributors and customers. All promotional materials should be requested to determine whether the party itself believes that the patented feature is worth promoting—clearly, if a plaintiff who claims that its patented invention made its product successful has not even bothered to include that feature in its advertising, that will counter its argument that the defendant would have paid a high price to include the feature in its products. On this same score, it is very important that each party’s experts actually interview customers to find out why they buy the party’s product. Subpoenas can profitably be issued to the opponent’s customers to obtain the same information. The opinions of people who actually buy the product as to whether they think that the patented feature is a convincing reason to buy the product can often be more probative than any other evidence that can be presented on this score.
103
This page intentionally left blank
CHAP T ER
12 Why New and Improved Costs More Than the Old Stuff The Better Your Invention, the Higher the Royalty Rate Factor 9: The utility and advantages of the patent property over the old modes or devices, if any, that had been used for working out similar results. Factor 10: The nature of the patented invention, the character of the commercial embodiment of it as owned and produced by the licensor, and the benefits to those who have used the invention.
12.01 Relevance and Application
105
12.02 Analysis
107
12.03. Discovery
108
12.01 Relevance and Application The factor of a patent for an improved product, which attempts to incorporate the technological “value” of the patented invention into the reasonable royalty analysis, has not been substantially employed by the courts to any great extent. This factor can, if properly applied, be a powerful tool in the hands of a defendant where the plaintiff ’s invention, while attached to a popular product, does not actually represent a substantial technical advance. There are two ways of looking at the product improvement factor in terms of using it in the reasonable royalty analysis. The first is to consider the factor on its face: The economic value of an invention is measured, at least in part, by the advances the invention has made over what went before. If the patented invention is just a minor improvement over the prior art, for the most part it will not be that valuable—neither to the defendant in the hypothetical negotiation nor to anyone else. Why would the defendant pay a substantial amount to license or a consumer pay a substantial amount to buy a minor improvement over what they would already pick up on the shelves for less. The patentholder 105
106
Chapter 12 Why New and Improved Costs More Than the Old Stuff
must justify why its product—the patent—is more valuable than its “competition” (the prior art) by showing why it is better and how it represents a substantial advance. In the hypothetical negotiation, the defendant will have a good argument as to why it would not pay much to license a patent that did not substantially improve on the prior art—the defendant could simply “go across the street” and use that technology, rather than plaintiff ’s. If this improvement factor is being viewed as measuring the “value” of the patent in a technological sense, the analysis will focus on the prior art being examined on the liability side of the case and the difference between that art and the patented invention, as could be recognized by persons of ordinary skill. This analysis is more likely to benefit the defendant in that it is unusual for any patent to be such a dramatic advance over the prior art as to impress a jury. Such an analysis in an appropriate context will also focus the jury’s attention on the fact that the patented feature may simply be a relatively minor component of a larger product and that the advance in the prior art represented by the patented invention will only represent a technological advance as to that one component—not the entire product. The other way of using this factor is quite different in application, but not in essence. It is to view the “prior art” not the way patent attorneys and the U.S. Patent Office view it, but as an alternative method the defendant could have used to do business without infringing—its right to use non-infringing substitutes for the infringing product that it could have turned to at the time of the hypothetical negotiation. Obviously, if the defendant can convincingly argue that, if it had had an alternative product that did not infringe and was acceptable to the market and that was available at the time of that negotiation, it would have paid very little to license the product. The primary issues that are important in the analysis of this factor, assuming the alternative is agreed not to infringe, are (1) Was the noninfringing alternative acceptable to the marketplace? (2) Was it available at the time of the hypothetical negotiation? (3) What effect would the defendant’s substitution of the alternative product have on its own sales and profitability? The first factor is normally the most contentious and is interwoven, to some extent, with the third factor. The defendant must do more than to show that there was a theoretical alternative that it could have used to avoid infringement; it must also show that this alternative was acceptable to the marketplace. If the defendant cannot show that its customers would have settled for this alternative, its threat, in the hypothetical negotiation, to use that substitute instead of licensing the patent would have been empty. The question that the plaintiff will raise is if the alternative product was acceptable to the market, why didn’t the defendant sell that product instead? This is a particularly important argument for the plaintiff to make if the defendant continued to sell the infringing product rather than the alternative even after it was sued for infringement. If the alternative product was acceptable to the defendant’s customers, the plaintiff will ask why the defendant did
Analysis 107
not immediately reduce its litigation risk and substitute the non-infringing product for the infringing one. The reasons that the defendant will have to own up to—that the alternative product was not quite as good or quite as popular or could not sell for as high a price—will tend to increase the amount it would have paid in the hypothetical negotiation. Another relevant factor will also be the “changeover” costs. Even if the defendant’s alternative product would be acceptable to the market, the defendant might have substantial “retooling” costs associated with insisting that its customers purchase the non-infringing substitute rather than the infringing product. If the defendant can successfully show that the alternative product would have been acceptable to its customer base, it may very well have a convincing argument that, in the hypothetical negotiation, it would only have paid a royalty equal to the amount of its “changeover” costs, and that would be all the license would be worth to the defendant. Another important issue is whether the non-infringing alternative was actually available for the defendant to turn to at the time of the hypothetical negotiation. Some courts have not required the defendant to show that the substitute was actually available for sale as long as it can show that the substitute was “in the wings.” Zygo Corp. v. Wyko Corp., 79 F.3d 1563, 1571–72 (Fed. Cir. 1996). Knowing that the availability of an acceptable alternative was imminent is generally considered to strengthen the negotiating position of the defendant in the hypothetical negotiation and argue for a lesser royalty. This situation was presented in Novozymes A/S v. Genencor Int’l, Inc., 474 F. Supp. 2d 592, 606 (D. Del. 2007), where the court noted that “the parties in a hypothetical negotiation would consider available, or soon to be available, alternatives to the infringing product.” The court considered, however, the fact that the alternative was not, in fact, available for over a year after the hypothetical negotiation would have taken place as indicating that the market entry of this substitute would have been “uncertain” to the parties as well as the fact that the alternative was not a “perfect substitute” for (and was, in fact, “inferior” to) the infringing product as countering the mitigating effect of this substitute on the reasonable royalty. However, it is significant that the court gave substantial consideration to the economic effect of the imminence of an unavailable alternative that was not, in fact, actually available to the marketplace for over a year.
12.02 Analysis This product-improvement factor, although rarely used, could be a real gold mine for a defendant using either of the theories discussed above. The defendant should scour the prior art, especially that discussed in the prosecution history, to narrow the differences between the patented invention and
108
Chapter 12 Why New and Improved Costs More Than the Old Stuff
that art. It should convincingly present the case that the technological advance claimed in the patent is not really much of an improvement and that its “value” is limited. It should make sure to find as many examples as possible of real-world uses of the technology that the patentholder already admits is prior art and emphasize the success of those products. Since all of the prior art will, by definition, be in the same technological niche as the patented invention, a lay jury may very well be convinced, after an effective presentation, that the patented improvement is not really worth much and that it does not represent enough of an improvement over the prior art to warrant the imposition of a substantial royalty. Such a presentation will probably work better for a defendant than one that concentrates on finding acceptable non-infringing substitutes. While the “prior art” approach focuses on the value of the technology (which a jury is unlikely to fully appreciate), the “non-infringing substitutes” approach focuses on the value of the use of the technology, which may end up being quite different. In this latter approach, the defendant will be forced to show not only how little the patented invention differs from the art that is in the field but also to show that this other, non-infringing technology could have been used in its product, that its customers would have bought products using that technology, and that the defendant could have kept its prices up using that alternative technology. This, obviously, is a much more difficult task, which the defendant should avoid if at all possible.
12.03 Discovery Discovery on the improvement factor will also overlap with that many of the other factors and will be conducted almost entirely by the plaintiff—the defendant’s analysis will be primarily internal and will depend less on outside discovery. The plaintiff will need to find out what alternatives the defendant had available, or was even considering, at the time of the hypothetical negotiation and whether (if they were not on the market) they would also infringe the patent. It should seek to counter any claims that the patented technology has little value over the prior art by showing that the prior art cited by the defendant is either unworkable, unacceptable to the marketplace, or could not have been effectively used by the defendant. For the plaintiff, it must concentrate on showing the economic value of the patented technology to the defendant—that, after all, is what the hypothetical negotiation model is intended to measure. Assuming the substitute was not also an infringement, the plaintiff will need to fully explore the reasons the defendant did not sell the substitute into the marketplace, rather than the infringing product—especially after the lawsuit was filed. The needs and desires of the defendant’s customers will need to
Discovery
be fully explored, and the acceptability of the alternative will need to be fully analyzed. To a certain extent this analysis will dovetail with that for the previous factor—the popularity of the patented invention. If the patented feature is the one most desired by the defendant’s customers, an alternative that does not contain that feature will either be unacceptable to the marketplace or will sell for a much lower price. Where the claimed alternative was not available at the time of the hypothetical negotiation, the “imminence” of the alternative would need to be thoroughly examined. Claims that the alternative was “in the wings” should be carefully examined, as, under close scrutiny, those “wings” may turn out to be made of paper.
109
This page intentionally left blank
CHAP T ER
13 The Smaller the Bang, the Smaller the Bucks Allocating the Value of the Patented Component Factor 12: The portion of the profit or of the selling price that may be customary in the particular business or in comparable businesses to allow for the use of the invention or analogous inventions. Factor 13: The portion of the realizable profit that should be credited to the invention as distinguished from nonpatented elements, the manufacturing process, business risks, or significant features or improvements added by the infringer.
13.01 Relevance and Application
111
13.02 New Developments for the Entire Market Value Rule
114
13.03 Analysis
121
13.04 Discovery
121
13.01 Relevance and Application Factor 13 covers one of the most contentious issues in patent damages—how to account for the common situation where the patented invention covers one aspect or component of a much larger product. When a royalty rate is awarded, the question arises whether it should be applied to the entire product or just to the infringing component. This issue has caused a virtual war between those companies that are often targets of patent infringement lawsuits (usually large computer or electronics companies such as Samsung or Apple) that claim large patent infringement verdicts are making it impossible for them to compete and those lobbying groups that represent individual inventors and NPEs that claim “apportioning” the reasonable royalty to the infringing
111
112 Chapter 13 The Smaller the Bang, the Smaller the Bucks
component of a larger product cheats these patentholders out of their legitimate recovery and encourages infringement. Both sides’ arguments, however, simply reflect their individual proponent’s economic and political agendas and misunderstand the economic rationale underlying patent damages. Reasonable royalty analysis going back to GeorgiaPacific can easily cope with this issue in a manner that rewards the patentholder for the true economic value of the invention. A core principle used by the courts in apportioning the reasonable royalty to a component of a larger product is the entire market value rule, which is covered later in this work in more detail with respect to the lost-profits remedy. As the Federal Circuit explained in Imonex Servs. v. W.H. Munzprufer Dietmar Trenner GmbH, 408 F.3d 1374, 1379 (Fed. Cir. 2005), “the entire market value rule permits recovery of damages based on the value of the entire apparatus containing several features, where the patent related feature is the basis for customer demand.” As the Federal Circuit noted in the landmark Rite-Hite case, “the entire market value rule permits recovery of damages based on the value of a patentee’s entire apparatus containing several features when the patent-related feature is the basis for customer demand.” Rite-Hite Corp. v. Kelley Co., 56 F.3d 1538, 1549 (Fed. Cir. 1995). Indeed, there is a real analytical and conceptual difference between the use of the term “entire market value rule” when it is applied in the context of a reasonable royalty award and when it is applied to lost profits. Indeed, these differences are so substantial that the term is really a misnomer when applied in the reasonable royalty context. When a plaintiff is claiming that it lost profits because of infringement as a result of lost sales, he is really arguing that “but for” the infringement, it would have made the sale. For the plaintiff to successfully make that argument, it must prove that the patented feature, infringed by the defendant, was the reason that the consumer purchased the infringing product. Since the “lost” profit is attributable to the “lost” sale of the entire product, the plaintiff must show that the reason that the entire sale was lost was because of the infringement of the patented feature—i.e., that the “entire market value” (the reason the consumer purchased the product) was tied up in the patented feature or component. In the context of reasonable royalty, where the royalty is usually measured by a percentage of the revenues gained by the defendant in selling the infringing product, the term “entire market value” is usually used to refer to employing the total revenues for a product as the royalty base, as opposed to the revenues that might be attributable to a separate component or to the economic value of a particular feature. Since it is often possible to allocate the value of the patented feature or component as a percentage of the value of the overall product, it is, in theory, easier to allocate the royalty base that should be attributed to that component or feature. This would arguably make the decision of whether to rigorously employ the entire market value rule less
Relevance and Application 113
critical. Indeed, where the royalty base can be easily allocated, it would appear that the rule need not be applied at all. However, since the courts continue, by and large, to misapply the entire market value rule in reasonable royalty cases, the rule needs to be analyzed in that context. To reference the “flying bicycle” hypothetical explained in more detail later, suppose that the plaintiff had patented a flying bicycle and the infringing product was also a flying bicycle. If the plaintiff sought and obtained an award of a reasonable royalty, since the patent covered the entire infringing product, the royalty base to which the reasonable royalty percentage would be applied would reasonably be the defendant’s entire sales of flying bicycles. Suppose, however, that the plaintiff ’s patent was not for a flying bicycle but rather for a mechanism that enabled small non-motorized vehicles (including scooters and skateboards) to fly. In suing the defendant flying bicycle manufacturer for infringing the patent, the plaintiff could expect to be able to show that the only reason consumers would purchase the defendant’s flying bicycle was because it could fly—thus, the “entire market value” of the defendant’s product was covered by the plaintiff ’s patent, and it would be reasonable to apply the reasonable royalty percentage to all of the defendant’s revenue from selling this infringing product. However, what if the patented invention was for a special brake that was particularly effective in stopping flying bicycles in bad weather? Obviously, the particular patented invention is not the entire reason consumers buy the defendant’s infringing product. However, there is no revenue associated with the defendant’s sale of these brakes to form a royalty base on which to apply the royalty rate. Moreover, it is unlikely that either the defendant (or the plaintiff, if it is also in the flying bike business) sells these brakes separately. How, then, is the reasonable royalty to be applied? The answer is easier than it looks and much easier than the combatants over “apportionment” make it appear. The issue was presented and the answer provided in P&G v. Paragon Trade Brands, 989 F. Supp. 547, 613 (D. Del. 1997). In that case, P&G asserted a patent on the “barrier leg cuff” for a disposable diaper, a feature that helps prevent the leakage of waste material from the leg openings of the diapers. Although P&G’s expert opined that this feature was valuable and would tend to increase the reasonable royalty rate, the court disagreed, finding that if “the patented feature forms only a small part of the product, either physically or economically, it is generally the case that a licensee would have been less disposed to agree to a high royalty” and that this GeorgiaPacific factor “attempts to take into account the relative contribution of the patented feature to the success of the product.” For this particular feature, the court held that the patented feature “is only a single element in a complex system that forms a disposable diaper” and that “the inclusion of several other essential features not covered by the [asserted] patents . . . is required to successfully market and sell disposable diapers in this
114 Chapter 13 The Smaller the Bang, the Smaller the Bucks
country today.” The court held that the fact that the patent covered only one component of the infringing product “would have negatively impacted the royalty rate.” Similarly, in Mars, Inc. v. Coin Acceptors, Inc., 511 F. Supp. 2d 435, 439 (D.N.J. 2007), the court determined the reasonable royalty rate based only on the patented coin tube sensor portion of the accused coin changers rather than on the entire changer. Thus, the solution to the apportionment dilemma is simple and straightforward. Where the patented invention is for a device that is a component of an infringing product, where that component is not sold separately, and where it is not the “basis of consumer demand” for the infringing product, the royalty base should remain the revenues gained from sales of the entire product (since that, as a practical matter, will be the only source of reliable data), but the royalty rate should be adjusted to account for the economic contribution the patented invention makes to the popularity of the defendant’s product. Thus, in the flying bicycle example, suppose that, once the defendant started using the infringing brake, it was able to increase its price $5 on a base price of $1,000 or that its price, all else being equal, was .5 percent higher than its rivals that did not offer this feature. Alternatively, suppose that the price did not change as a result of the adoption of this feature but that, as a result, the defendant’s insurance rates went down or its returns decreased. Or assume these comparisons were attributable to the plaintiff ’s own sales of such products. In such instances, the royalty rate, which could still be applied to the same base, would reflect the actual economic contribution of this particular feature, whether in enabling the defendant to increase revenue or reduce costs. The rate would be adjusted to represent that contribution, while the royalty base would remain easy to determine. Thus, where the component has a relatively modest, but real, impact on the defendant’s sales, the royalty rate might be quite low, if the royalty base is substantial. Thus, the economic problem of apportionment in the reasonable royalty context is relatively easy to solve. However, seeking lost profits presents different problems that are much harder to resolve.
13.02 New Developments for the Entire Market Value Rule The most politically sensitive issue in patent damages law, and the one that has caused the most controversy, both in the courts and in Congress, is under what circumstances damages can be awarded with respect to products—or components of products—which indisputably do not infringe. How do we award damages when the patented invention covers only a small component
New Developments for the Entire Market Value Rule 115
of a larger product? How do we make sure that inventors are properly compensated for the infringement of their patent without giving them a windfall by awarding damages on components they had nothing to do with inventing? Until recently, the courts had utterly failed in setting out a clear, easy-toapply, and economically rigorous solution to this problem. Litigants, judges and juries were left at sea to figure out the proper equitable way to compensate an inventor for infringement. With damage awards regularly in the hundreds of millions of dollars, Congress tried to bring some order to this chaos—but with no greater success. However, in a pair of decisions by the two Federal Circuit judges who have taken the lead in dealing with this issue—Judge Rader and Chief Judge Michel—the court is finally providing the direction needed to bring order and economic reality to the process of awarding damages for patent infringement. When the patented invention is truly the reason that consumers purchase the product, it is fair—as well as economically realistic—to award damages based on an entire product. For example, in a case involving Bose’s patent on its design for loudspeakers, Bose was able to show that the basis for customer demand for its products was the improved bass performance made possible by the patented invention. Bose Corp. v. JBL, Inc., 274 F.3d 1354 (Fed. Cir. 2001). The Federal Circuit held that, as such, Bose was entitled to recover damages based on the entire value of its loudspeaker product, rather than simply the value of the particular feature covered by the patent. However, in the technology marketplace, this situation rarely presents itself. Most technology products contain a legion of components and features provided by hundreds, if not thousands, of suppliers. For most of these products, it is folly to assume that the “entire market value” of the overall product is represented by a particular component or a particular feature. Where infringement results from the inclusion of a minor component or feature, “allocation,” if improperly applied, can cause economically absurd results. An example from the software industry demonstrates this problem: Say you are Microsoft. You are being sued by the inventor of a particular word processing program feature—one that enables the user to change the color of the font on a selected passage with just a keystroke, rather than laboriously highlighting the text and using the menu. In your last version of Word, you implemented this feature, along with 1,200 other changes, some of which were intended to provide new functions to the user and others that, behind the scenes, made the software work more efficiently. Assume further that your latest version of Word is held to infringe this patent and that the patent is held to be valid. Assume finally that this latest version of Word sold 300 million copies and that the retail price was $100.
116
Chapter 13 The Smaller the Bang, the Smaller the Bucks
What is the most equitable way of awarding damages in this situation? And the solution that makes the most economic sense? Clearly, the best way would be to determine the “value” of the patented feature to Microsoft and its customers. The more valuable Microsoft would have considered the feature to be to the users of Word, the more Microsoft would have paid the patentholder to be permitted to use it. The more important the feature, the higher the royalty rate. The parties could have determined the value (or the popularity) of this feature in a number of ways. They could have looked at Microsoft’s advertising and marketing literature to see if Microsoft highlighted the “color changing” feature as a way of selling its product. They could look at reviews of the product to see if the press thought that the feature was valuable or would be popular with consumers. They could commission consumer surveys to determine the importance that Word customers gave to this feature and whether the presence or absence of this feature made any difference to their buying decision or to the price they would have paid to buy the product. Indeed, using the same economic measure tools used in antitrust cases, the parties could have obtained a fairly accurate measure of the economic value of the patented feature by determining the effect of the feature on the price that a significant group of consumers would have spent on the product. Thus, if including the patented feature increased Microsoft’s profits on Word by 2 percent, there would be a solid basis to argue that Microsoft would have paid a royalty representing half of those profits to the patentholder. Such a result would be equitable, sensible, and would make complete economic sense. However, nobody does this. Nobody. Yet, as a result of two 2009 decisions written by Judges Rader and Michel, which give litigants, courts, and juries two very different—but economically valid—ways of allocating damages, the tide may be turning Judge Rader’s analysis of this issue came out of his sitting by designation as the trial judge in Cornell University’s patent litigation against HewlettPackard. Cornell v. Hewlett Packard, 609 F. Supp. 279 (N.D.N.Y. 2009) This case posed a fairly typical situation—where the unit accused of infringement was only a tiny component of a much larger product. Specifically, the patent claimed technology that covered only a small part of what HP calls the “instruction reorder buffer” (IRB), which is itself a part of a computer processor. The computer processor, in turn, is part of a CPU module that, combined with other components, becomes a “CPU brick.” Sets of CPU bricks are, in turn, incorporated into a “cell board,” which is then inserted into a server. The primary question for Judge Rader in making a determination as to a reasonable royalty award was the breadth of the royalty base. Initially, Cornell had sought damages based on the revenue from HP’s entire server and workstation systems, which, as Judge Rader noted, “include
New Developments for the Entire Market Value Rule 117
vast amounts of technology beyond the infringing part of the processors.” Despite Judge Rader’s pre-trial warning that he would closely scrutinize Cornell’s damages case, when trial commenced, Cornell had not revised “its attempts to prove damages far beyond the scope of the claimed invention.” Id. at 283. Alarmed, Judge Rader interrupted the trial to hold a Daubert hearing to determine whether Cornell’s damages expert’s use of the entire market value rule was proper. At that hearing, Cornell was unable to prove that the patented invention “drove demand for HP’s entire server and workstation market” and “did not offer a single demand curve or attempt in any way to link consumer demand for servers and workstations to the claimed invention.” Judge Rader thus excluded the damages expert’s testimony that the value of HP’s entire server and workstation line should be used as the royalty base. Id. at 284. Since, as a result of this ruling, Cornell was left without a damages case, Judge Rader allowed them to come back the next day and to offer damages testimony based on the fact that the invention covered only a component of the overall system. The next day, however, Cornell fared no better. Instead of constructing their royalty base using servers and workstations, Cornell based it on “CPU bricks,” assuming that each infringing processor had been sold as a separate CPU brick, using the catalog price for the CPU brick, sold separately. This solution was equally unacceptable to Judge Rader, who noted that “Cornell simply stepped one rung down the HP revenue ladder from servers and workstations to the next most expensive processor-incorporating product without offering any evidence to show a connection between consumer demand for that product and the patented invention.” Cornell’s selection of the “CPU brick market” as a basis for its royalty claim was fatally flawed, according to Judge Rader, since, by “Cornell’s own admission, any market for HP’s CPU brinks was imaginary.” Id. at 287. After an eight-day trial, the jury awarded damages using a 0.8 percent royalty rate and a $23 billion royalty base—founded on Cornell’s theory that the royalty base should be composed of HP’s hypothetical sales of CPU bricks. HP asked that the court strike the damages award, requesting that the court hold that Cornell could not collect damages under the entire market value rule and reduce the royalty base to “account only for the value of the processors incorporating the patented technology.” Judge Rader granted that motion and proceeded, with an analysis of the scope and application of the entire market value rule along the way, to award damages to Cornell based only on the infringing processors. Perhaps reflecting his frustration with Cornell’s disregard of his orders and its attempt to squeeze the maximum amount of royalties out of what was clearly a relatively minor invention, Judge Rader took a very strict view of the application of the entire market value rule. He held that, to satisfy that rule, a
118
Chapter 13 The Smaller the Bang, the Smaller the Bucks
plaintiff must prove (1) the infringing components are the basis for customer demand for the entire product, (2) the infringing and noninfringing components must be sold together so that they are a “functional unit” or are part of a complete machine, and (3) the infringing and noninfringing components must be “analogous to a s